Scan for Haierwebsite

Haier BiomedicalUSA

Haier BiomedicalInternational

Haier BiomedicalInternational

@haiermedicalintHaier Biomedical

International

本报告以环保纸张印刷

This report is printed on recyclable paper.

2024 Sustainability Report Qingdao Haier Biomedical Co., Ltd.

Qingdao Haier Biomedical Co., Ltd.

Contents

Chairman's StatementAbout This ReportAbout Haier BiomedicalCompany Profile

Collaborative Research andInnovative EcologyAI-driven Innovative BreakthroughBenefiting Health by TechnologicalEmpowerment

0102

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

Escorting GovernanceCornerstone with ResponsibilityEcological Coordination andExcellent Co-creation

MilestonesHonors and Awards

Sustainability GovernanceAppendix

Environmental Management andGreen CollaborationResource Optimization andCircular DevelopmentCompliant Emissions and aClean FutureGreen Layout and ClimateTransformationBiodiversity and EcologicalProsperity

0304

FutureGathering Talents forHealthy Life

Ecosystem

Protecting Our Earth

People-centered, UnlockingPotentialSharing Health and Co-constructing CommunitySharing Sunshine along Belt andRoad

ESG Key Performance IndicatorsGRI StandardsUNGC PrinciplesReader Feedback

Chairman's Statement

High-tech Innovation: Construct a Sustainable Industry +AI EcosystemTechnological innovation is the core driving force for thedevelopment of Haier Biomedical. In the face of industrytransformation, we leverage new technologies such as AIand big data as engines to launch our life science strategy.Through the integrated EPS model of software, hardware,and services, we are creating comprehensive digitalintelligence solutions. This approach aims to reshape theentire research, production, sales and service process, builda digital traceability network, and establish a full-link qualitycontrol system, empowering scientific research and universalHealthcare with technological strength.In 2024, we fully embraced AI technology, concentrating ontwo key areas: scientific research and healthcare. By buildingan innovative system that integrates "data + algorithm +scenario," and advancing AI solutions like intelligent bloodmanagement and biopharmaceuticals, we evolved ourtechnology from a single tool into a thriving ecosystem.Through the collaboration of new platforms, products, andapplication scenarios, AI has become the foundation for ahealthier future. Harnessing the power of this ecosystem, weare accelerating breakthroughs across the life science.High-quality Development: Recreate a Sustainable Full-chain Green Ecology

Green is the background color for high-quality development.As a member of the United Nations Global Compact, weadhere to the concept of "ecosystem", and actively constructa green value chain covering the full cycle of procurement,manufacturing, logistics and products, which will help usachieve the "3060" carbon neutrality goals faster.In terms of technology, we independently develophydrocarbon refrigeration, dark green technology, andother low-carbon solutions and utilize them to reduce ourenvironmental footprints. In terms of operation, we advancethe upgrading of green processes and the construction ofintelligent factories and implement an energy conservationprogram for parks, promoting environmental protectionthroughout all production segments. In terms of ecology, werely on biobank resources and digital intelligence solutions tosupport global scientific research institutions in conductingbiodiversity conservation studies, safeguarding the Earth'slife blueprint.

High-level Openness: Advanced Building a SustainableGlobal Healthcare EcosystemHaier Biomedical has given a long-term commitment to beingglobal and serving the globe. At present, global healthcareresources are unevenly distributed and health inequalityis prominent. The going-global of Chinese life sciencecompanies is related to not only expanding the market, butalso assuming broader social responsibilities. We adhere tocarrying out the localization layout and globalization strategyconcurrently, continue to implement the strategy of "onecountry, one policy", accurately match overseas demand,and promote the "product + solution" going-global basedon our integrated network of research, production, salesand service. Products such as the intelligent blood solution,smart laboratories solutions, and solar-powered vaccinerefrigerators continue to expand into regions such as Asia,Africa, and Latin America. These solutions help upgrade localpublic health systems, benefiting more countries and peoplealong the Belt and Road, making health accessible whereverthe sun shines.Talent is the core of globalization. We adhere to the tenetof "maximizing the value of people" and, through building adiversified and inclusive team and implementing localizedoperation, explore the potential of employees and enablethem to play their value, share the development results withour employees across the globe, and gather the power ofcross-cultural innovation with an open attitude.In 2024, we moved forward steadily in transformation andmade breakthroughs during innovation. In 2025, HaierBiomedical will continue to treat technology as its peak andgreen as its pulse, and join hands with partners to tap thekinetic energy of AI technology, deepening low-carbonpractices and jointly building a new health ecosystem.Here please allow me to express my sincere thanks to ourglobal partners, users and employees. In the future, wehope to continue to cooperate with you towards the samegoal, make our efforts to do things that benefit the people,illuminating every corner with light of science and technology,and jointly building a beautiful view of "Well Life Forever".

Standing at the crossroads of a new era, the global industrial chain is accelerating its restructuring,the new healthcare infrastructure is entering a phase of deep adjustment, and the diverse healthneeds of the people are growing. The biomedical industry is embracing a higher mission.As a leading company in digital solutions for life science and medical innovation, Haier Biomedicaladheres to its original mission of "Making Life Better". Guided by the LIFE sustainability developmentphilosophy of "Intelligence enlightens life for a shared future", the Company has perfected its ESGgovernance system and established a three-tier governance structure. Focusing on four corefields - Leadership, Integrity, Future, and Ecosystem - Haier Biomedical diligently practices theseprinciples. It transforms technological innovation into global benefits, working towards the vision of"Well Life Forever".

Chairman of the Board of Qingdao Haier Biomedical Co., Ltd.

02030203

2024 Sustainability ReportSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixAbout This Report

LeadershipCreating an Intelligent Futurewith AI EmpowermentAbout Haier BiomedicalChairman's Statement

About This Report

Introduction

This is the fifth sustainable development report (hereinafterreferred to as "the Report") issued by Qingdao HaierBiomedical Co., Ltd. In the Report, Haier Biomedicaldiscloses practices and performance in fulfilling economic,environmental, social, and corporate governanceresponsibilities in 2024. This is to provide further visibilityto all our shareholders and present our consolidated keyperformance indicators for the fiscal year 2024.

Preparation Procedures

This Report is prepared according to fixed procedures,including determining the report boundary, identifying andcategorizing important ESG issues, collecting relevantdata and information, preparing the report, and verifyinginformation.

This Report amalgamates qualitative and quantitativeinformation based on the Company's public information,internal documents, and relevant statistical data.The Board of Directors of the Company has made acommitment that there is no false records or misleadingstatements in the Report, and is responsible for thetruthfulness, accuracy, and completeness of its content.

Reliability Assurance

After the review by the ESG working group, the Reportwas approved by the Board of Directors of the Companyon 28 March 2025.

Approval of the Report

The Report is available, to view and download, at thewebsite of the Shanghai Stock Exchange (www.sse.com.cn) and Haier Biomedical's official website (https:/www.haierbiomedical.com/).Address: No.280 Fengyuan Road, High-tech Zone,

Qingdao, ShandongTel: 0532-88935566Postcode: 266000Email: haierbiomedical@haierbiomedical.com

Access to the Report

Reporting Scope

The Reporting Scope is consistent with the annual reportof Haier Biomedical in 2024. The information hereof coversHaier Biomedical and the subsidiaries within the scopeof consolidation. The Reporting Period is from 1 January2024 to 31 December 2024. Accordingly, the period maybe extended to a time before the release of this Report in2025.

This Report is prepared in accordance with the GuidelinesNo. 14 of the Shanghai Stock Exchange for Self-Regulation of Listed Companies—Sustainability Reporting(Trial) issued by the Shanghai Stock Exchange (hereinafterreferred to as the "SSE"), while meeting the sustainabledevelopment reporting standards of the Global ReportingInitiative (GRI) and referring to the questionnaire of S&PGlobal Corporate Sustainability Assessment (CSA). Inaddition, this Report is prepared based on the currentdevelopment level of the Company and the actual ESGsituation.

Reporting Guidelines

For concise, coherent and easy reading, "Qingdao HaierBiomedical Co., Ltd." in the Report is also referred to as"Haier Biomedical", "the Company", or "we".

Definitions

About Haier Biomedical

Company Profile

Founded in 2005, Haier Biomedical is a listed company underIncaier, the big health ecology brand of Haier Group. It waslisted on the Science and Technology Innovation Board ofthe Shanghai Stock Exchange in 2019 (stock code: 688139).Based on the transformation from a company of IoT, HaierBiomedical serves as a service provider of digital scenariosolutions for life science and medical innovation. The Companyaims to create the best user experience for a wide range ofuser groups, such as hospitals, biotechnology enterprises,universities & colleges, scientific research institutions,disease control and prevention centres, plasma stations, andprimary public health authorities. It provides comprehensivedigital solutions with multiple types of products and servicesfor scenarios, including smart laboratories, in-hospitalmedication, smart public health, and smart blood distribution.Leveraging industry-leading technologies, the Companyhas promoted scientific and technological innovation andled industrial reform. Since achieving breakthroughs in low-temperature biomedical technology and breaking foreignmonopolies, the Company has continuously invested in theR&D of new technologies, upgraded the UADV open R&Dmodel, and formed six technology platforms to accelerate thereinforcement, expansion, and extension of its business layout.Meanwhile, the Company actively implements national strategiessuch as Powering Country with Science and Technology Power,Digital China, and Health China, taking the lead in integratingemerging technologies such as IoT, AI technology, and CloudComputing. Additionally, it creatively launches comprehensivesolutions for digital scenarios, represented by smart blooddistribution and smart vaccination, and continues to expand thescenarios to cover smart laboratories, automatic in-hospitalmedication, physical examinations for public health, and more,leading the digital intelligence reform of the biomedical industry.As of the end of 2024, the Company owned 1,595 patentsand 392 software copyrights. It led or participated in therelease of 1 international standard, 29 national and industrialstandards, 3 local standards, 23 group standards, and 2

technical specifications for CQC certification. A total of 8categories of its products and solutions were "first" or "only."Additionally, the Company won 45 scientific and technologicalawards at or above the provincial level, and its 32 technologicalachievements were recognized as international leaders.Currently, a total of 35 items, including over 900 models of theCompany, have been awarded PRC registration certificatesfor Class II and Class III medical devices. Fifteen kinds ofculture medium have been registered as Class I IVD reagents.The Company's more than 400 models in total have passedoverseas certifications, including over 200 European UnionCE certifications, more than 70 US FDA certifications, morethan 140 US UL certifications, 8 US NSF certifications, 12US AABB certifications, and more than 40 US Energy Starcertifications. Among them, the ultra-low temperature superenergy conservation series products have broken the energyconsumption record for Energy Star certification, and thedisposable plasma separator products have passed the high-risk certification of the European Union for Class IIb devices.The Company has always adhered to the vision of "makinglife better", with its products and solutions now applied in over150 countries and regions worldwide. In the domestic market,the Company has served tens of thousands of end users inthe medical and health field, including hospitals, biotechnologyenterprises, universities and colleges, scientific researchinstitutions, centres for disease control and prevention, plasmastations, and testing institutions. Well-known customers inChina include Chinese PLA General Hospital (301 Hospital),Shanghai Ruijin Hospital, Wuxi Apptec, Shanghai FudanUniversity, China Centre for Disease Control and Prevention,Hualan Biological, Hengrui Pharmaceutical, and FosunPharmaceutical. In the international market, the Company'snetwork is continuously expanding, with over 800 resellerpartners joining the distribution network, strengtheningthe localized layout. Long-term and ongoing cooperativerelationships have been maintained with nearly 80 internationalorganizations such as the World Health Organization (WHO).

Incaier is a big health ecological brandestablished by Haier Group in 2019 after nearly20 years of involvement in the medical andhealth industry. At Incaier, we prioritise originaltechnology, emphasize clinical value, andpromote digital and intelligent integration, fullyengaging in three key sectors: life science,clinical medicine, and biotechnology.

MissionVision

Philosophy

Committed to Everyone' s LifelongHealth by Technology and ServiceInnovationWell Life Forever

Your HealthOur Priority

04050405

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Milestones

Successfully holding the Co-creationConference for Strategic Partners

Acting as the only domestic manufacturerattending the first plenary meeting of IEC/PC130

Ultra-low temperature digital and intelligentsample management equipment won the GoldPrize of the "Governor Cup" Industrial DesignCompetition of Shandong Province

Signing a memorandum of understanding withTogo, jointly promoting the construction ofChina-Africa health community

Monomer storage tank liquid nitrogen automatedworkstation and ARK flexible, extendableautomated workstation won Germany's iF DesignAwards

Unveiling of the China-ASEAN Marine AquacultureTechnology "Belt and Road" Joint Laboratory, co-established with the Universiti Malaya

Attending the 7th China International Import Expoand MEDICA Exhibition

Joining hands with Sinopec Dalian ResearchInstitute to set up the first bio-based liquid fuelstrain biobank for the petrochemical industry

Attending the 15th Arab Transfusion Medicine Forum

Successfully holding the Senegal's "Haier BiomedicalWeek" event

Medical refrigerator was awarded the T?V S?DMark certificate

Full-scenario intelligent vaccination mode won thePrize for Scientific and Technological Advancementin Artificial Intelligence of Shandong Province

Attending the 89th China International MedicalEquipment Fair and Analytica 2024 Munich,Germany - Analytical, Biochemical, andLaboratory Exhibition

Donating vaccination vehicles to Diqing TibetanAutonomous Prefecture and Zhengzhou

Qingdao HB TempCon Aviation Co.,Ltd., asubsidiary of Haier Biomedical successfullytransported APIs from Shanghai to Auckland,New Zealand

Awarded the title of Provincial Industrial DesignCenter

January

September

March

November

February

October

April

Digital-intelligence centrifuge production linewas officially put into production

The smart cell preparation panoramicsolution was successfully implemented onthe Juno cell automation sharing platformunder Leczcore

Establishing comprehensively strategicpartnership with Tianjin Institute of Medicine andHealth, Chinese Academy of Medical Sciences

The IEC international standard for medicalcryogenic storage led by Haier Biomedical wasofficially approved

The Charged Affaires and Presidential Adviser ofAmbass Embassy of Togo in China visited HaierBiomedical

The one-stop full-process solution ofsmart laboratories was implemented inZhongqiYuan(Ningxia) Biotechnology Co., Ltd.

Holding acquiring Shanghai Metash InstrumentsCo., Ltd., officially entering the scientific analyticalinstruments field

Participating in the release of theInitiative for GreenEnergy Transformation of the Pharmaceutical andMedical Industrial Chain

Supporting the Oxford University Research Center'sstudy on multiple myeloma

August June July May

December

06070607

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Honors and Awards

Name Organizer

China's Top 500 New Economy EnterprisesChina Enterprise Evaluation Association

China's Top 50 Medical Device Manufacturers 2023-2024

All-China Federation of Industry and Commerce

Medical and Pharmaceutical ChamberTop 100 "Listed Companies in China in ESG"Securities Times

Top 100 Best ESG Practices ofListed Companies in China by Wind

WindESG Dandelion 50 IndexChina Times

Yidong ESG+8 "Value 100" ListYidong

Category Name Award/Honor name Organizer

Scientific andtechnologicalinnovation

R&D and application of key technology forthermostatic, green and highly-reliablerefrigerating appliances used for safestorage of biomedicine

2nd Prize for Scientific andTechnological Advancement byChina National Light Industry

Council

China National LightIndustry CouncilKey technology research, equipment R&Dand application of metrological traceabilityof ultra-low temperature storage cabinet

3rd Prize for Scientific and

Technological Advancement byChina Instrument and Control Society

China Instrument andControl SocietyFull-automatic microbial culture andsmart screening technology platform andequipment

Excellence Award of the 6th "ChinaInnovation" Startup and InnovationCompetition and the QingdaoMunicipal Selection of the 7th

Entrepreneurship Competition ofShandong Province

Ministry of HumanResources and SocialSecurity of the People'sRepublic of ChinaDevelopment of intensive, automatic andintelligent cell culture technology

Gold Prize of 2023 Postdoctoral

Innovation and Entrepreneurship

Competition in Shandong, China

Ministry of HumanResources and SocialSecurity of the People'sRepublic of ChinaKey technology and application of smartmulti-axis motion control system

1st Prize for Technological Inventionof Shandong Province

Shandong People'sGovernmentThe 1st Haier biomedical ultra-lowtemperature digital and intelligent samplemanagement equipment across the globe

Gold Prize of the "Governor Cup"

Industrial Design Competition ofShandong Province

Shandong People'sGovernmentIntegrated workstation for storage andvaccination with the AI + digital intelligencevaccination clinic storage vaccinationintegrated workstation

Excellence Award of the "GovernorCup" Industrial Design Competition of

Shandong Province

Shandong People'sGovernmentR&D and industrialization of keytechnology for automated biologicalculture equipment

1st Prize for Scientific andTechnological Advancement byShandong Equipment Manufacturing

Industry Association

Shandong EquipmentManufacturing IndustryAssociationFull-Automatic Cell Culture Workstation 2024 Shandong Province First Set

(Unit) of Technological Equipment

and Key Core ComponentsPromotion and Application Guidance

Catalog

Department of Industryand InformationTechnology ofShandong Province

Digitaltransformation

IoT-based automated managementtechnology for the whole process ofvaccination

2nd Prize for Scientific andTechnological Advancement byChina National Light Industry

Council

China National LightIndustry CouncilInnovation and application of IOT-basedsmart vaccination model

2nd Prize for Scientific and

Technological Advancement of

Qingdao

Qingdao MunicipalPeople's Government

Industryleadership

Shenzhen Cybermax InformationTechnology Co., Ltd.

Standard innovative enterprise State Administration

for Market RegulationHaier Biomedical Technology (Chengdu)Co., Ltd.

Re-evaluation of the Third Batchof National Professional, Lean,Distinctive and Innovative "LittleGiant" Enterprises

Ministry of Industry and

Information Technology

of the People's Republic

of ChinaQingdao Haier Biomedical TechnologyCo., Ltd.

Re-examination for the NationalHigh-Tech Enterprise Certificationsuccessfully passed

Ministry of Industry andInformation Technologyof the People's Republicof ChinaQingdao Haisheng Zhonglian IntelligentTechnology Co., Ltd.

National high-tech enterprise Ministry of Industry and

Information Technologyof the People's Republicof ChinaQingdao Haier Biomedical Co., Ltd. Neurological Rehabilitation Key

Laboratory of Shandong Province

Department of Science& Technology ofShandong ProvinceQingdao Haier Biomedical Co., Ltd. Shandong Province Industrial Design

Center

Department ofIndustry andInformationTechnology ofShandong ProvinceQingdao Haier Biomedical Co., Ltd. Qingdao Private Leading Model

Enterprises

Qingdao MunicipalBureau of Industry andInformation TechnologyQingdao Haier Biomedical Co., Ltd. High-end talent platform of Qingdao

High-tech Zone

Qingdao MunicipalHuman Resources andSocial Security BureauShanghai METASH Instruments Co., Ltd. Professional, Lean, Distinctive and

Innovative SMEs in Shanghai

Shanghai MunicipalCommission ofEconomy andInformatization

Category Name Award/Honor name Organizer

Awards

Rankings and Lists

Economic Honor

08090809

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Governance Honors

Award/Honor name OrganizerGrade A for 2023-2024 Annual Information Disclosure WorkShanghai Stock ExchangeHuang Yanli received a 5A rating during the 2024 performance

evaluation of board secretaries of listed companies

China Association for Public Companies

Golden Bull Award for New Quality EnterpriseChina Securities JournalGolden Bull Information Disclosure AwardChina Securities Journal

Outstanding growth enterpriseJRJ.com

2024 Most Valuable STAR Market-listed Companychinastarmarket.cnExcellent Enterprise in New Quality Productive ForceStockstarAdvanced Unit in Investor Protection Work in the

Qingdao Jurisdiction for 2024

Qingdao Association for Public Companies

Social Honors

Award/Honor name OrganizerAAA Enterprise in Corporate Social Responsibility Evaluation China Light Industry Enterprise Management AssociationExcellent achievement in social responsibility of China's Light

Industry enterprises

China Light Industry Enterprise Management AssociationS&P Global's 2024Sustainability Yearbook (China Edition)S&P Global

ESG Golden Dawn Award Securities Market WeeklyYinghua ESG Value Award for A Shares China FundGold Cane Award - 2024 Top 10 Excellent Cases of China ESG

Dandelion Index

China Times2024 Listed Company with the Most Social Responsibility

Award

National Business Daily2024 Annual Public Welfare Enterprise jiediancj.com

Environmental Honors

Award/Honor name OrganizerGreen and efficient Stirling refrigeration technology was includedin the list of Best Energy Conservation Technologies and

Practices ("Top 10 for both")

Jointly issued by national ministries and commissions includingNational Development and Reform Commission, the Ministry ofIndustry and Information Technology of the PRC, etc.The green and efficient Stirling refrigeration technology formedical low-temperature storage cabinet was included in the

2024 Catalog of Green and Low-carbon Technology

Achievements of Shandong Province

Department of Industry and InformationTechnology of Shandong ProvinceZhiyuan Award - Environment-friendly (E) Pioneer Enterprise

Award

CLS.CN2024 Award for Contribution to Green and Sustainable

Development

syobserve.comAward for Excellence Enterprise in Cross-Strait Carbon Neutrality

and Sustainable Development

Institute for Cross-Strait Development and Institute for CarbonNeutrality of Tsinghua University, and the consortium legalperson Twenty-first Century Foundation (Taiwan)

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Sustainability Governance

Deeply entrenched in both life science and medical innovation, Haier Biomedical actively fulfills its socialresponsibilities and "respects" life with responsibility.Through implementing the LIFE sustainable development strategy and utilizing a sound ESG governance system, weestablish diverse communication channels for fully listening to the opinions of various stakeholders, improving theCompany's comprehensive ESG performance, and supporting sustainable development.

Sustainability Governance Structure

We have established a sustainability governance structure that clearly defines responsibilities, consisting of threelevels: the Board of Directors, the Strategy and ESG Committee, and the ESG Working Group. Based on this, we caneffectively manage sustainability-related risks and efficiently make decisions on matters such as setting objectives andimplementing policies.

The Board of Directors is the highest decision-making body on and ultimatelyresponsible for our ESG matters. Its responsibilities include reviewing andoverseeing the Company's ESG-related management policies, strategies,and related risks, keeping them in the right direction.

The Strategy and ESG Committee is led by the chairperson and composedof Board members. Its responsibilities include formulating ESG managementpolicies and strategies; Defining ESG development objectives, coordinatingarrangements for ESG work; Overseeing the planning and implementationof ESG initiatives; Reporting key ESG matters to the Board of Directorsperiodically.

The ESG working group comprises heads of ESG-related functionaldepartments. Its responsibilities include formulating the annual work planbased on the Company's ESG policies and strategies, executing specifictasks, and ensuring the achievement of objectives.

Participation by Stakeholders

Recognising the importance of communication with stakeholders, Haier Biomedical establishes a standardisedcommunication mechanism to ensure that it fully listens to and responds to stakeholder demands. This approach helpsthe company make management decisions more effectively, continuously improve its ESG management, and fulfil itsresponsibilities to all parties.

Key Stakeholders Issues Channels

Governmentsand regulators

Compliant operationsInformation securityAccountable marketing

Green manufacturingBiodiversityCorporate governance

GovernmentconsultationInformation disclosureTopic reporting

Working conferencesInquiries and answers

Shareholdersand investors

Corporate governanceCompliance operationProtection of intellectualproperties

Anti-corruptionInvestor relations

Information disclosureShareholders' meetingsPerformance briefing

Online platformsRoadshowsInstitutions' researchmeetings

Customers

Customers' rights andinterestsProduct InnovationCooperation andcommunicationProduct quality andsafety

Superior serviceAccountable marketingInformation security

Product launchSatisfaction survey

Customers'communication andcomplaint channelsOfficial WeChataccount

Suppliers andpartners

Protection of humanrightsResponsiblepurchasing

Supply chainmanagementAnti-corruption

Empowerment andtrainingWorking conferences

Industry activitiesOnline or offline regularcommunication

Employee

Employees' rights andinterestsOccupational healthand safetyEmployee developmentand trainingBalance between workand life

Talent attraction andretentionDiversity & equalopportunitiesProtection of humanrights

Employee symposiumsMeetings of employeerepresentativesLabor union

Employee trainingEmployees' complaintand reportingmechanismCulture discussionplatform

Environmentandcommunities

Community investmentLow-carbontechnologiesWaste managementWater managementEmission management

Energy and resourceconservationResponsiblepurchasingGreen officeClimate changeAccess to health care

Charity projects andfundraising platformsInformation disclosureMedia-relatedconferences

Regular communicationwith mediaJoining socialorganizations

Board of Directors

Strategy andESG Committee

ESG Working Group

12131213

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Material Issues

Sustainable Development StrategiesHaier Biomedical conducts regular questionnaire surveys of stakeholders to fully understand their opinions andexpectations regarding the Company's ESG issues. Based on the surveys, we update the library of sustainabledevelopment issues and the materiality matrix, include issues that significantly impact the Company's sustainabledevelopment in our focused fields, and highlight their descriptions in the ESG report. During the reporting period, weidentified a total of 13 issues of high significance, 12 issues of medium significance, and 5 issues of minor significance.

Closely complying with the Company's strategic vision, Haier Biomedical builds a unique "LIFE" sustainable development

model, and continuously optimizes and iterates the model based on the assessment results of material issues during the

reporting period, clearly guiding the sustainable development actions. We are dedicated to supporting and implementing

the United Nations Sustainable Development Goals (SDGs), and actively responding to the United Nations Global

Compact and its ten principles. Through these measures, we are committed to demonstrating our firm dedication to and

responsibility for sustainability to all stakeholders.

Sustainability Concept

Sustainability Model

Sustainability Model

Guided by the vision that "Intelligence enlightens life for a shared future", we are committed to respecting life with

sincerity, safeguarding life through technology, and collaborating to forge a sustainable future. With a steadfast focus on

protecting public health, we make every effort to advance our journey toward sustainability.

Reflecting on the insights from our materiality matrix and sustainability assessments, we have crafted and continuously

enhanced our LIFE model, which drives us toward efficient and effective sustainability governance. LIFE encapsulates

the four fundamental pillars of our approach: Leadership, Integrity, Future, and Ecosystem.

Product qualityand safetyR&DLow-carbontechnologies

CompliantoperationsCorporategovernanceRisk ManagementCustomers'rights andinterestsSustainable supplychain management

Superior serviceCooperation and communication

Protection of intellectual propertiesTalent attractionand retentionInformation security andprivacy protectionCommunication with stakeholders

Energy and resource managementWaste management

Emission managementAccountablemarketing

Protection of employees'rights and interests

Employee development and trainingAccess to health careClimate changeGreen office

RuralrevitalizationCommunity contributions

Recycling and circulareconomyBiodiversity protection

Occupational health and safety

Diversity & equalopportunitiesAnti-commercialbribery and anti-corruption

Significance to Haier Biomedical

Significance to stakeholders

Issues of medium significance

Issues of medium significanceIssues of high significance

Issues of minor significance

Environmental issues Social issues Governance topic

Leadership

IntegrityFuture

Ecosystem

Intelligence

EnlightensLife for aShared Future

E

GS

14151415

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

Ecosystem

Protecting

Our EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

FutureLIFE Pillar

LIFE Pillar

Boldly undertake our corporate responsibilities and share thebenefits of our growth with the industry and societyPersistently generate social value, address the evolving needsof society, foster equality, inclusivity, and diversity on a globalscale, and contribute to common prosperity

Protect natural environment and mitigate climate change forthe welfare of future generationsPromote the fusion of low-carbon principles with our businessoperations, aiming to build a sustainable, eco-friendly, andresource-efficient organization.Collaborate across various sectors and leverage HaierBiomedical's strengths to promote the green transformation ofthe entire value chain and support the protection of biodiversity

Embrace low-carbon technologies within our product R&D process to promote eco-friendly product designs and, promote greenproduct design, and ensure the compliance of the full product lifecycle management with the requirements of high standards forgreen development and compliance systemImplement green management and sustainability strategies, strengthen energy conservation and emissions reduction measures inthe operation, attach importance to energy conservation and emissions reduction and environmental impact during the productionstage of products, and strive to construct an environmentally responsible and sustainable operation mode During the reportingperiod, 100% of our product packages were made from either biodegradable or recyclable materialsMake active response to climate change, reduce greenhouse gas emissions and enhance adaptability to climate change withtechnological innovations and advanced management strategiesProvide innovative biodiversity conservation solutions to ecological balance and environmental protection

Leadership

Integrity

LIFE Pillar

LIFE Pillar

Foster innovation as the driving force behind our growth, aimingto become pioneers in life science and medical technologyLeverage our innovative breakthroughs to bolster global publichealth and serve national strategiesPropel the industry forward and collaborate to achieve mutualsuccess and shared benefits

Ensure compliant operations and achieve stable, high-qualitycorporate governanceKeep product responsibility in mind, and ensure the productsafety and quality, providing customers and industries withreliable products and services

Pursued innovative development approaches that resonate with contemporary trends, consistently deepened the user-centricityopen R&D system, deeply engaged users in the review and validation of R&D projects, and enhanced the product competitivenessApplied AI technology to accelerate the iteration and upgrading of core technologies and scenarios such as automated ultra-lowtemperature storage, intelligent sample management, and smart medication, and strived to inject new intelligent driving force into theglobal healthcare cause Strengthened innovation incentives, ensuring that our creative efforts are transformed into protected intellectual property.In 2024, Haier Biomedical applied for 298 new intellectual property rights, and owned a total of 1,987 intellectual property rights.Promoted the application of innovations, harnessing our technological prowess and resources to empower customers and contributeto life and health cause. In 2024, Haier Biomedical launched a total of 33 categories of products including 130 models, providingdiverse solutions for the public health field

Continuously deepened corporate governance, improved internal control and risk management mechanisms, and ensuredoperational compliance, laying a solid foundation for the Company's steady developmentStrengthened the construction of business ethics, and comprehensively enhanced employees' awareness of compliance to create anhonest and law-abiding corporate cultureUpgraded the supplier management system by integrating ESG concept into the whole process of supplier management During thereporting period, we required all suppliers to sign the environmental protection, social responsibility and integrity clauses, constructinga sustainable and mutually beneficial ecosystem together with our partnersThrough introducing advanced quality management technology and continuously improving production processes, strengthenedproduct quality management, ensured the outstanding quality of products and services and strived to achieve the objective of "zeroproduct defect". In 2024, we passed the certification of EU's Medical Device Regulation (MDR Certification)Continuously improved customer service quality, advancing the optimisation of user experience, and lifting the user satisfactionsteadily

Strive to protect employees' rights and interests by creating a diverse, equal and inclusive workplace During the reporting period, theproportions of technological innovation talents, talents with master's degree or above and industrial experts increased significantlyImprove the talent cultivation mechanism, broaden the employees' growth path, and enhance the attraction and retention rate oftalents. In this year, we granted 3.42 million A-share ordinary shares to 262 senior managers, core technicians and backboneemployees, sharing the Company's development results with core talents through equitiesStrengthen occupational health and safety management to protect employees' physical and mental healthKeep up with the pace of national digital transformation, share innovative wisdom with the industry and society, and provide medicaldigital intelligence solutions, advancing universal healthcareActively engage in social public welfare and charity, fulfill corporate responsibility, create social value, and repay the society bypractical actionsFocus on global issues concerning public health and people's health, assist less developed areas, and join hands with them to build aglobal public health ecosystem

Strategic Focus of Haier Biomedical Strategic Focus of Haier Biomedical

Strategic Focus of Haier Biomedical Strategic Focus of Haier Biomedical

Progress of Haier Biomedical in 2024 Progress of Haier Biomedical in 2024

Progress of Haier Biomedical in 2024 Progress of Haier Biomedical in 2024

Progress of Haier Biomedical in 2024 Progress of Haier Biomedical in 2024

UN SDGs UN SDGs

Progress of Haier Biomedical in 2024 Progress of Haier Biomedical in 2024

UN SDGs UN SDGs

UN SDGs UN SDGsUN SDGs UN SDGs

Strategic Focus of Haier Biomedical Strategic Focus of Haier Biomedical

Strategic Focus of Haier Biomedical Strategic Focus of Haier BiomedicalEcosystem

Haier Biomedical and SDGs

16171617

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

ESG Highlight Performance

RMB

million

Investment in R&D

1,595

Patents owned in total

Software copyrights owned in total

National, industrial, or group standards andtechnical specifications published under ourleadership or with our participation

World-leading technological achievements

Scientific and technological awards at or abovethe provincial level

0.70

The number of effective patents perRMB 1 million of revenue

0.17

The number of software copyright certificatesper RMB 1 million of revenue

Our full lifecycle energy conservation andcarbon reduction actions have achieved anannual electricity usage of

9.49

million kWh

The photovoltaic power generation in parksreached

1.416

million kWhaccounting for

12.98

%of the Company's total electricity usage

Anti-corruptioneducation sessionsfor middle and seniormanagers conducted

Over

Complianceeducation and trainingsessions

Working days due to work injuries

RMB502,000 worthof public welfare donations in total

RMB350,000was invested in environmental protection2,574

hourswere spent on environmental protection

Leadership Integrity Future Ecosystem

Passed ISO 14001 environmentalmanagement system review

Obtained the ISO 45001 certificationfor the occupational health and safetymanagement system

%

Percentage of womansenior managers

33.3

%

Percentage of womendirectors

%Supplier integrity agreements signing

%Rate of successfulcustomer complaintresolution

99.96

%

Customer satisfactionrate

%

Decrease in product defect rate

Quality training sessions conducted

%

Training coverage

%Integrity educationsessions for staff

Number of employees

2,807

Average training hours

35.26

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

19191818

Leadership:

Creating an Intelligent Future

with AI Empowerment

Haier Biomedical employs advanced technology as its pen and innovativeecosystems as its ink, continuously crafting a narrative in the AI-driventransformation of medical and health practices. We consistently enhanceour research and development capabilities, actively cultivate new qualityproductive forces, and integrate progressive technologies such as deeplearning algorithms, multi-modal data processing, and intelligent decision-making systems into our R&D and innovations. This effort fosters anAI-centred innovation framework that connects data, algorithms, andscenarios, creating an AI innovation matrix that spans laboratories,biopharmaceuticals, smart healthcare, and public health sectors. HaierBiomedical is dedicated to transforming AI from a technical device intoa decision-making powerhouse for life and health, thus reimagining ahealthier future through intelligence.

SDG-related responses in this Section

Performance Highlights in this Chapter

Leadership

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

World-leading technological achievements

Scientific and technological awards at or abovethe provincial level

0.70

The number of effective patents perRMB 1 million of revenue

0.17

The number of software copyright certificatesper RMB 1 million of revenue

RMB

millionInvestment in R&D1,595Patents owned in total

Software copyrights owned in total

National, industrial, or group standards andtechnical specifications published under ourleadership or with our participation

AI-driven intelligent biomedical solutions

Independent R&D

Scientific andtechnological

innovation

AI empowermentDigital intelligenceapplicationupgrading

Universities Scientific

researchinstitute

Industrypartners

......Users

Self-developed Co-research M&A Incubation

UADV open R&D systemSix technology platforms

Build an ecosystem ofco-creation and co-researchBuild a cornerstone forinnovation and development

R&D mode

Ecology

R&D systemand platform

Improve the quality and efficien-cy of operation and managementStrengthen full-chain quality

assurance

Upgrade scene-customization capabilityRealize personalized user experience

DigitalintelligencebiobankDigital operationIntelligent manufacturing

Digitalintelligencelaboratory

Digitalintelligencehealthcare

Digitalintelligenceblood systemDigital intelligence public health

2223

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

Co-research to open ecology

Incubation to open teams

Engage leading industry users in co-creationunder the leadership and participation of experts,focus on unmet scientific research and clinicalneeds, and quickly realize the transformation ofscientific research achievements

Build an open platform to gather innovativeelements, and promote the combination ofinnovation and entrepreneurship, making rapidbreakthroughs in projects

Self-developing to open resources

M&A to open boundaries

Fully utilize the foundation in industrial advantages,integrate resources in parallel, and implementproduct iteration quickly based on user demands

Focus on the Company's strategic directionand user demands, quickly fix the industrialshortcomings and own product iterations withfirst-class market competitiveness

Lean R&D ManagementAs pioneers in innovation and development of lifescience field and based on cutting-edge technologies,we clarify the innovation and development path underthe background of diverse market demands and digitaltransformation, actively explore and tap innovation anddevelopment opportunities, and build a comprehensivetechnological innovation system featured by collaborativeinnovation with multiple technologies and in-depthexpansion of multiple scenarios. We have always beendeeply entrenched in low-temperature technology andhave persistently made efforts in the application andintegration of intelligent and automation technologies.We strive to solve the issue of standalone hardware,software, and services in life science and medicalinnovation scenarios and to shape an industry model forintelligent development in the life science field.

Haier Biomedical Innovative Development Path

CollaborativeResearch andInnovative Ecology

R&D and innovation drive the strong internalmomentum of Haier Biomedical and serve as thecrucial foundation for the company's long-termstrategic layout and high-quality development. Byfocusing on enhancing R&D management capabilities,we continually integrate and expand global R&Dresources and are dedicated to creating an innovativedevelopment ecosystem that incorporates variousmodes such as aggregation, openness, co-creation,and co-research, all aimed at fostering continuousbreakthroughs in key technologies and products.

Independent cryogenic equipment innovations

IoT transformation and upgrade

Independent low-temperature refrigerationtechnology R&D , breaking foreign monopolies

Integrating IoT technology to create multiple

world first smart public healthcare scenarios

Focus on professional application scenariosto create a comprehensive, integrated"automated + digitalized + ecosystem" solutionLow-temperature industrial automation + lifescience EPS model innovation

To effectively drive technological innovations and continually enhance R&D management effectiveness, we haveestablished a systematic, modular, and platform-based R&D management model. We have also constructed astandardized R&D process framework and a collaborative innovation platform that spans across departments andfields, aiming to ensure the high-quality output of R&D results.

R&D Management Mode of Haier Biomedical

Additionally, we consistently expanded the channels and methods of R&D and innovation, leveraging our owntechnology accumulation, resource reserves, and platform advantages to establish an R&D framework comprisingfour forms: self-development, co-research, mergers and acquisitions, and incubation. This approach continuouslypromotes R&D and innovation upgrades through diverse and open R&D pathways.

Open R&D Pattern of Haier Biomedical

R&D process management Standard module management

Technology platformmanagement

Ensure the orderlyR&D activities withstandardized processmanagement.

Reasonably divide thecontent of R&D intostandard modules byfunction, technology, etc.to improve R&D efficiency.

Build cross-departmentaland cross-field technologyplatforms to integrateresources and advanceR&D collaboration andknowledge sharing.

During the reporting period,

Meanwhile, Haier Biomedical took advantage of thestandardized and efficient R&D management mode to improvethe proportion of its new products launched in time in 2024 by

% year-on-year

and made significant progress in module management, projectprocess management and informatization management,which reduced the material types by 11% through integrationand increased the reusability of modules by 2.49%, effectivelyenhancing the efficiency of R&D management.

the proportion of approvednew products by

% year-on-year

Upgrade scenario customization capabilitiesand realize personalized user experience

Service provider of AI-drivenintelligent biomedical solutions

we focused on

key R&D projects

comprehensively optimized

R&D capabilities

and the proportion of revenuefrom new products by

% year-on-year

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

2425

Chairman's StatementAbout This Report

Open R&D SystemAdhering to the concept of user-centricity, we consistently prioritise the needs of our users as the foundation forproduct design and R&D. We carefully consider user requirements at every stage of our product development process,effectively addressing users' pain points and accurately fulfilling their diverse needs. We have established an openUADV R&D system that encourages user participation throughout the entire process, from design to validation andapplication. This approach continually drives the transformation of product R&D toward a focus on user experience,ensuring the alignment between product development and user needs.Our users become involved in product development from the survey stage and actively participate in reviewing solutionsand prototypes. At the user validation stage, we incorporate user experience pain points into the closed-loop systemmanagement and control, ensuring that the products meet user needs once launched. After a product is put into use,we prioritise user experience and periodically collect user feedback to continually enhance and improve the product.

In 2024, we further strengthened the in-depth integration of product R&D project management and user participation. Atthe R&D project review stage, we added a user participation and validation process, enabling us to control the alignmentbetween products and user needs right from the source of R&D. This allowed us to collaborate with users to create awin-win situation.

UADV Open R&D System of Haier Biomedical

User participation in designUser needs are studied and scenarios are created from their perspectives

User participation in validationThe reporting standards for user experience before product launch areupgraded to accurately resolve pain points faced by our users

User participation in application

Zoom in on different user groups and create models that will become standard process systems

Co-creating R&D EcosystemHaier Biomedical believes that excellent R&D capabilities and abundant R&D resources are critical foundation forpromoting high-quality development. We advance the construction of R&D capabilities systematically, persistentlypromote the integration of internal and external R&D resources, and expand our R&D framework through the globalmarket, striving to build an industry-leading R&D and innovation ecosystem.Enhancing R&D CapabilitiesUp to now, Haier Biomedical has established science and technology innovation industrial parks and R&D-relatedbases in 9 provinces, cities, and regions across China. Additionally, we have deployed marketing, logistics, and servicenetworks in the United States, the United Kingdom, the United Arab Emirates, and other countries, which acceleratesthe internationalization of R&D and branding while continuously enhancing our influence and competitiveness. Duringthe reporting period, the Guangzhou Laboratory R&D Center of Haier Biomedical was formally established, and theconstruction of the Tianjin R&D Center began, further enriching our reserves of R&D resources and technologies.

Global Layout Map of Haier Biomedical

Haier Biomedical SafetyScience and TechnologyInnovation Industrial Park

Qingdao

YangtzeRiverDeltaHaier BiomedicalAdvancedTechnologyResearch Institute

NantongHaier BiomedicalfNantong Science andTechnology InnovationIndustrial Park

ChongqingGuangzhou

Haier Biomedical ChongqingScience and TechnologyInnovation Industrial ParkHaier Biomedical GuangzhouLaboratory R&D CenterChengduHaier BiomedicalChengdu Science andTechnology InnovationIndustrial ParkNigeriaGlobal User Experience CentreIndiaGlobal Marketing Centre

UAEUSGlobal User Experience CentreGlobal Logistics Centre

UK

TianjinGlobal Marketing Centre

Haier Biomedical Tianjin R&D Center

(under construction)ShenzhenHaier Biomedical

ShenzhenSoftwareResearch Institute

SuzhouHaier BiomedicalSuzhou Science andTechnology InnovationIndustrial Park

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

2627

Chairman's StatementAbout This Report

To consistently stimulate employees' vitality and enthusiasm for innovation, Haier Biomedical has established acomprehensive and diverse array of scientific research incentives to facilitate the conversion of innovative researchresults while ensuring that employees receive full recognition and rewards throughout the innovation process.In addition, we continue to increase our R&D investment to provide a continuous driving force for implementinginnovation and development strategies. During the reporting period, we made a total R&D investment of RMB 306million, which accounted for 13.41% of our total revenue, demonstrating the Company's vigorous trend of pursuingexcellent innovations and reinforcing core competitiveness.During the reporting period

which accounted for

13.41

%

of our total revenuewe made a total R&D investment ofRMB

million

Building International Test Capabilities

A powerful laboratory testing capability is a crucial partof Haier Biomedical's R&D framework. We continueto enhance the establishment of laboratories acrossmultiple disciplines, develop international testingcapabilities that encompass software, hardware,scenarios, and applications, and comprehensivelyaddress our R&D and innovation needs with elevatedtesting standards and systems. Meanwhile, HaierBiomedical has consistently upheld technological ethics.We are dedicated to advancing technological innovationsresponsibly, ensuring that all R&D, along with inspectionand testing activities, comply with social morals andlaws, and transforming technology into a powerful tool tofoster social progress and enhance human wellbeing.

Haier Biomedical's testing center has over 30laboratories that cover various fields such as overallmachine performance, reliability, high and low-temperature performance, electrical safety, EMC,mechanical environment, high-precision laboratory,physical and chemical laboratory, user experience, andIoT communications. The center is CNAS laboratorycertified for more than 200 tests under 48 internationaland Chinese standards. Besides, we actively deployuser experience research laboratories and, throughcontinuous validation of product performance anduser experience as well as simulation of user operationprocess, continuously optimize the refined productdesign and updating and iteration, striving to provide thebest user experience.

Laboratory of Haier Biomedical

Low temperature

performanceHigh and low temperature

laboratoryEMC laboratorySolar powered equipment

testing laboratoryExtreme load laboratory...

Dynamic balance testingBlast hut validationThree-coordinate measuringIoT laboratoryComputer board MFOP...

Cell CulturePlant cultureLyophilisation validationProgrammed coolingCentrifugation validation...

Refrigeration laboratory

General equipmentperformance laboratory

User validationexperiment centre

Focusing on cultivating internal R&D talents, HaierBiomedical persistently attracts external professionals,and strives to build a team consisting of high-quality R&Dtalents with excellent professionalism and abundantinnovative vitality, which will provide the Company with astrong support for making technological breakthroughsand transforming innovative achievements. In 2024,Haier Biomedical introduced more than 40 professionalsin various fields including biological culture, biosafety,sterilization, automation, low-temperature storage, etc.,further reinforcing our R&D capabilities.

As of the end of the reporting period

accounting for

29.75

%of all employeesHaier Biomedical had a total of

R&D personnel around theworld

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

2829

Chairman's StatementAbout This Report

As of the end of the reporting period, Haier Biomedical received several major international certifications, including theonly UL CTDP laboratory qualification in China, TUV Rheinland's witness testing laboratory qualification, TUV SUD'switness testing laboratory qualification, and the CNAS laboratory accreditation certificate.

Qingdao Key Labs

T?VRheinland AccreditationCertificate

T?V SUD Certificate

Letter of Appointment toCollaborating Laboratories

CNAS LaboratoryAccreditation Certificate

UL CTDP Laboratory AccreditationCertificateCreating an Innovative Ecology

By fully utilizing its advantageous internal and external technologies and resources, Haier Biomedical has created aninnovative ecosystem for collaboration and open cooperation, focusing on key R&D technology fields and innovation.This aims to continuously enhance resource integration and advance collaboration on R&D projects.Internally, we have established a comprehensive product and technology R&D platform that provides abundantresources and technical support for research and innovation through multidimensional perspectives from variousprofessional fields. We have formed six major platforms: automation, refrigeration, intelligent systems, precisionmanufacturing and materials, digitalization, and biotechnology, each of which has established a technical committee.These technical committees comprise internal technical teams, external expert groups, and representatives frommultiple resource partners, driving continuous breakthroughs and applications of key technologies through cross-fieldcollaboration.Externally, we actively build an open and collaborative innovation ecosystem. Through active and involved cooperationwith universities, scientific research institutes, industry partners, and various stakeholders, combined with collaborativedevelopment models such as co-construction, incubation, and commissioned projects, we merge cutting-edgeacademic ideas, advanced technologies, and extensive industrial experience, fully committed to establishing aninnovation model of "co-creation and collaborative research."

We maintain long-term cooperative relationshipswith renowned universities and scientific researchinstitutions to jointly conduct frontier technologyresearch, promoting deep integration betweenfundamental research and industrialapplications.

We collaborate closely with ecosystem partnersto integrate resources across the entire industrialchain, achieve complementary advantages, andjointly address industry challenges.

Working hand in hand with multiple partners tojointly establish and incubate R&D centers, wetightly integrate innovation resources with marketdemands to accelerate the transformation and

implementation of technological

achievements.

For specific technical requirements, we adoptcommissioned development approaches tointroduce external professional teams, enabling

rapid technological breakthroughs.

Refrigeration Technical CommitteePrecision Manufacturing andMaterials Technical CommitteeIntelligentisation Technical

CommitteeDigitalization Technical CommitteeAutomation Technical CommitteeBiomedical Committee

Haier Biomedical Innovation

Ecosystem

Universities

Scientific research

institutions

Users

……Industrypartners

R&D teams

Technicalconsultants

Haier Biomedical Technical Committees

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

3031

Chairman's StatementAbout This Report

Haier Biomedical and Xi'an Jiaotong University jointly established the Cell Research and TransformationJoint LaboratoryOn June 5, 2024, the "Cell Research and TransformationJoint Laboratory" co-founded by Haier Biomedicaland Xi'an Jiaotong University Biomedical ExperimentalCenter was officially inaugurated. In this collaboration,Haier Biomedical customized dedicated solutions forthe laboratory, innovating an "IoT+ Cell" model thattransforms the current unidirectional managementof cell cultivation in laboratories. This enables Xi'anJiaotong University to achieve comprehensive digitalinterconnection and full traceability across cells,personnel, experimental materials, equipment, andlaboratory environments, ensuring cell safety, personnelsafety, and laboratory safety while enhancing scientificmanagement capabilities. This strategic collaborationwill effectively promote the development of disciplinesand local basic research and clinical transformation,accelerating the transformation of cutting-edge cellulartechnology achievements from the laboratory toindustrialization, and contributing to the construction ofa Healthy China.

In 2024, we further deepened industry-academia-research collaborations, partnering with 7 universities and scientificresearch institutions including China University of Petroleum, Xi'an Jiaotong University, Harbin Institute of Technology,Shanghai East Hospital, National Stem Cell Translational Resource Center, Zhejiang University, and Shanghai Instituteof Ceramics, Chinese Academy of Sciences. Together we initiated 6 scientific research projects focusing on criticaland forward-looking technologies, effectively driving breakthroughs in industry challenges and transforming innovativeachievements, facilitating the integrated development of production, education, and research.

AI-driven InnovativeBreakthrough

Digital Intelligence DrivingInnovationIn 2024, through relentless efforts in R&D and innovation,Haier Biomedical's six major technology platformsachieved remarkable accomplishments acrossspecialized fields, launching 33 categories and 130models of new products throughout the year and offeringusers smarter and more efficient product and solutionoptions.

Haier Biomedical continues to explore and uncoveropportunities for product innovation and upgrades.It has made significant breakthroughs in the ultra-low temperature storage sector, establishing newindustry standards with cutting-edge technologies anddriving industrial upgrades through a comprehensiveinnovation matrix. During the reporting period, multiplecore technological breakthroughs were realized in theultra-low temperature storage field, comprehensivelyenhancing refrigeration storage efficiency and intelligentcapabilities.

Deepening Efforts in Ultra-lowTemperature Technology

Haier Biomedical leverages cutting-edge technologiessuch as AI as a driving force for innovation, continuouslyadvancing the iterative upgrade of core technologiesand scenarios like ultra-low temperature automatedstorage, intelligent sample management, and smartmedication. The Company is committed to using AIinnovation to redefine the precision and reliability ofbiomedical services, injecting a new intelligent drivingforce into the global healthcare cause.We are result-oriented, focusing on acceleratingthe upgrade of our research and innovation systemand enhancing our R&D capabilities while striving forcontinuous breakthroughs in products and technologies.We drive industry transformation through continuousinnovation and empower the public health sector withhigh-quality services and products, enhancing humanhealth and wellbeing.

Haier Biomedical released the Edmund Biobank Digital Intelligence Management Solution

From May 31 to June 2, 2024, Haier Biomedicalunveiled the Edmund Biobank Digital IntelligenceManagement Solution at the 3rd National AcademicConference on Biological Resource Managementand Utilization. The solution, through its original NAITtechnology for ultra-low temperature environments,focuses on six major upgrades: inventory, safety,identification, management, customization, anduser-friendly design. It addresses challenges suchas difficult inventory management, traceability,and control. The solution creates an integratedsystem combining "automatic inventory refrigerator+ software + RFID consumables + IoT", providingusers with a safer, easier, and more intelligent modeof pathogen and virus strain management. It leadsthe ultra-low temperature storage industry fromtraditional equipment to digital solution upgrades.

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

3233

Chairman's StatementAbout This Report

Haier Biomedical keeps pace with the development of the technological era, fully promoting the deep integration ofAI technology, digitalization, IoT, and product innovation. The company focuses on building a comprehensive smartecosystem platform and integrated solutions that cover all scenarios and services. During the reporting period, weleveraged advanced technologies and AI intelligent systems to successfully launch the new "AI+" smart products.We achieved the digital and intelligent integration of multiple products and solutions, fully empowering the digitaltransformation of fields such as medical scientific research and smart hospitals while continuously leading theconstruction of the new smart healthcare ecosystem.

Upgrading the "AI+" Innovation Matrix

Haier Biomedical Innovatively launched the Wuji New Generation stirling ultra-low temperaturestorage cabinetTo further address the long-standing challenges in ultra-lowtemperature storage, Haier Biomedical has developed the WujiNew Generation ultra-low temperature storage cabinet basedon its self-developed DeepGreen Technology. This productfeatures a broad temperature range from -20℃ to -86℃ with on-demand temperature adjustment, achieving ±2℃ uniformity andzero temperature fluctuation at single points within the cabinet,thereby better preserving sample viability. Additionally, theproduct incorporates an efficient refrigeration architecture andintelligent temperature control algorithms, enabling precisewide-range temperature regulation while significantly reducingenergy consumption. Through its low-carbon operation mode,it meets the dual requirements of scientific research institutions,CDC centers, and biopharmaceutical organizations for bothsample storage safety and environmental sustainability,providing green and sustainable specialized biobank solutionsacross multiple fields.

Haier Biomedical released of a full-scenario digital intelligence smart medication solution for hospitalsTo address the high occupational exposure risks, error-prone processes, and low efficiency in traditionalpharmacies, Haier Biomedical has implemented digital and intelligent upgrades across all in-hospital medicationscenarios, including outpatient/emergency departments, inpatient wards, operating rooms, and PIVAS center.This has led to the creation of the country's first smart medication solution covering all in-hospital scenarios.Relying on three core technologies independentlydeveloped by Haier Biomedical - 3D-AI visualrecognition self-learning, multi-robot bionic control,and high-speed motion control - this solution enablesAI recognition of drugs, prescription review, andautomatic liquid preparation. It achieves a fully digitaland digital intelligence closed-loop management of theentire process, including drug storage upon hospitalentry, internal drug circulation, liquid drug preparation,hospital pharmacy dispensing, and ensuring propermedication use by patients. This solution enablesfull traceability of drug usage information, completetransparency of drug circulation, and intelligentmanagement of equipment operation, ensuring safetyfor people, drugs, and high efficiency.

Haier Biomedical has unveiled the U-Vault Flex80 Smart Modular Fully Automated ULT Sample Storage

At the 2nd Special Committee Inauguration Conference and Academic Annual Meeting of the ClinicalData and Biobank Professional Committee of the Chinese Research Hospital Association, held fromSeptember 19 to 21, 2024, in Xiong'an, Haier Biomedical, in collaboration with Shanghai Jiao TongUniversity Affiliated Ruijin Hospital, launched the groundbreaking global fourth-generation biobank-U-Vault Flex80 Smart Modular Fully Automated ULT Sample Storage. This product is equipped withdual independent self-recovering -80 ℃hydrocarbonrefrigeration technology, AI low-temperature high-speedtransmission control technology, and the Kuidou AIself-decision-making model. It features an innovativedistributed expansion integrated structure, capable ofmeeting the needs of biobank construction at differentstages and supporting multi-site, multi-project, and multi-task operations simultaneously. The launch of this producteffectively addresses the industry's "three lows" (lowspace utilization, low safety in sample emergency transfer,and low sample access throughput). It brings users a new"three-high" experience - high intelligence, high safety, andhigh throughput - breaking through previous limitations.This accelerates the high-quality, high-standard, andhigh-efficiency development of biobanks in China.

Haier Biomedical's smart public health solution has successfully integrated with DeepSeekIn February 2025, Cybermax Technology, a subsidiary of Haier Biomedical,implemented DeepSeek's AI technology into vaccine reservation systems, deliveringmore precise and personalized vaccination services. Utilizing DeepSeek's naturallanguage processing technology, the AI assistant in the vaccine reservation systemcan swiftly comprehend diverse user expressions, provide accurate responses,and recommend optimal solutions based on individual needs and vaccinationschedules. The integration of DeepSeek marks a breakthrough in Haier Biomedical'stechnological innovation in the field of smart public health services and is also animportant step in the company's advancement of smart healthcare development.

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

3435

Chairman's StatementAbout This Report

Establishment of a New Internal PatentRisk Investigation Mechanism

Update of the Patent Technology Database

Building on the issuance of anti-infringementsearch report plans, we have introduced acoordinated patent reading, analysis, andscreening mechanism involving in-house patentengineers, technical leaders, and R&D teams. Thisenhances the agility and comprehensiveness ofpatent risk analysis, better adapting to the complexR&D scenarios involving rapid iteration andchanges in technical solutions, while fostering thetechnical team's capabilities in patent intelligenceanalysis and application.

We update the patent disclosure information of"patent citation clues related to Companies",focusing on the patent trends of innovativeenterprises within the industry. This providesaccurate intelligence support for identifying newtechnologies and mitigating patent infringementrisks.

Intellectual Property ManagementHaier Biomedical values every innovation and its impact, considering intellectual property protection and managementa key component of its R&D management. We strictly adhere to laws and regulations, including thePatent Law of thePeople's Republic of China, with clearly defined management processes for IP declaration, retrieval, and maintenance.While respecting others' intellectual property rights, we rigorously combat all forms of infringement. During thereporting period, we revised theIntellectual Property Regulations and Management Standardsto implement strategicadjustments in managing authorized patents, thus enhancing management efficiency.To further reduce potential infringement risks in R&D management processes, we have enhanced the internal patentinfringement risk assessment mechanism and updated the patent technology database this year. This not onlyeffectively lowers infringement risks but also boosts the patent management capabilities of our technical team.

Intellectual Property Management InitiativesWe conduct regular intellectual property training sessions foremployees to continuously strengthen foundational knowledgeamong technical and R&D personnel. During the reportingperiod, Haier Biomedical personnel participated in the "PatentFast-Track Pre-examination Service to Parks" seminarorganized by the Qingdao Intellectual Property ProtectionCenter. They engaged in in-depth learning of the patent pre-examination business process and related managementpractices, effectively improving the practical level of patentmanagement across various processes and stages.Patent Training Site

As of the end of the reporting periodHaier Biomedical's Patents and Software Copyrights

including newly applied invention patentsin 2024

1,595

Haier Biomedical hasaccumulate granted patents

invention patents

design patents

1,077

utility model patents

software copyrights

Lead the Industry DevelopmentAs an industry leader driving development through technological innovation, Haier Biomedical is committed tocollaborating with multiple stakeholders to advance the industry toward standardization, intelligence, and digitalization.We accelerate the implementation and application of innovative achievements, striving to maximize product value whilepromoting collaborative progress in life science and medical and health field.

Leveraging extensive expertise and practical experience, Haier Biomedical continues to contribute to industrystandardization. We actively lead or participate in the formulation of various national, industry, and group standards,accelerating the process of technological standardization and normalization in the industry, and providing strongsupport for innovative development in the biomedical field.Haier Biomedical's active involvement in standard development has been highly recognized by several authoritativeinstitutions. In 2024, significant progress and numerous honors were achieved in international, national, and industrystandardization initiatives.

Achievements and Honors in Standardization Work in 2024

Haier Biomedical made an appearance at the 2024 National Biosafety Academic ConferenceFrom November 8 to 10, 2024, Haier Biomedical presented its latest digital intelligence biosafety achievementsat the conference. As a corporate representative and industry benchmark in biosafety field, Haier Biomedicaldelivered a keynote report titled Innovation in

Industrialized Application of Core Technologies for High-endBiosafety Equipmentand demonstrated its full-scenario digital intelligence biosafety solutions. Through thesharing of forward-looking technological practices and industrialization experience, Haier Biomedical providedactionable guidance for the industry, accelerating the intelligent upgrade of the biosafety industry and theconstruction of a comprehensive ecosystem across all scenarios.

Haier Biomedical led or participated in the release of 8 National Industry Standards and 7 Group Standards; among

them, Haier Biomedical's third-time leadership in the development of the National Standard for Low-TemperatureStorage Cabinet has been approved and released. Haier Biomedical experts have been appointed as joint conveners of two working groups: the Medical Low-

Temperature Storage Equipment Performance Requirements and Testing Methods Working Group (WG3) and theTerminology and Classification Working Group (WG2).We led the proposal for the IEC international standardMedical Low-temperature Refrigeration and Freezers -Performance Requirements and Test Methods, which was successfully approved for project initiationWe were honored with the title of Advanced Unit in Standardization Work by the TC338/SC1 (National Measurement

Control and Laboratory Electrical Equipment Safety Standards Committee, Medical Devices Sub-TechnicalCommittee).We received the title of Advanced Unit in Standardization Work for the 10th anniversary of pharmaceutical logistics

standardization efforts.

Frontrunner Product: Low-Temperature RefrigeratorandFrontrunner Product: Medical Refrigeratorwererecognized as 2024 Corporate Standard "Frontrunners" by the China National Institute of Standardization

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

3637

Chairman's StatementAbout This Report

Standard No. Name Type

GB/T 20154-2024 Low-temperature Storage Cabinets National StandardsGB/T 42125.1-2024

Safety Requirements for Electrical Equipment for Measurement, Control andLaboratory Use - Part 1: General Requirements

National StandardsGB/T 42125.3-2024

Safety Requirements for Electrical Equipment for Measurement, Control andLaboratory Use - Part 3: Particular Requirements for Refrigerating Equipment

National StandardsGB/T 42125.4-2024

Safety Requirements for Electrical Equipment for Measurement, Control andLaboratory Use - Part 4: Particular Requirements for Climatic and EnvironmentalTesting and Other Temperature Conditioning Equipment

National StandardsGB 4793-2024

Safety Technical Specification for Electrical Equipment for Measurement, Controland Laboratory Use

National StandardsGB/T 42125.2-2024

Safety Requirements for Electrical Equipment for Measurement, Control andLaboratory Use - Part 2: Particular Requirements for Laboratory Equipment forthe Heating of Materials

National StandardsGB/T 42125.5-2024

Safety Requirements for Electrical Equipment for Measurement, Control andLaboratory Use - Part 5: Particular Requirements for Laboratory Centrifuges

National StandardsYY/T1902-2024 Medical Plasma Quick Freezing Machine Industry StandardsWB/T 1146-2024 Specifications for Online Retail Drug Delivery Services Industry StandardsT/CECC 027-2024 Compliance Guidelines for Data Application of Generative Artificial Intelligence Group StandardsT/SDAMDI 002-2024 Special Requirements for Humidity Controlled Medical Refrigerator Group StandardsT/CPPC 1080.3—2024

Guidelines for the Construction and Evaluation of Laboratory IntelligencePart 3: Biosafety Laboratory

Group StandardsT/CITS 162—2024 Specifications for Remote Intelligent Blood Management in Medical Institutions Group Standards

As of the end of the reporting period, we have led or participated in the formulation of 58 national, industry, andorganizational standards and technical specifications, including 1 international standard, 29 national industry standards,3 local standards, 23 group standards, and 2 CQC technical specifications. In addition, we hold positions in 15 industryassociations and actively contribute to the development of the industry.

Standards Led and Participated in by Haier Biomedical in 2024 (Partial)

Benefiting Healthby TechnologicalEmpowermentHaier Biomedical focuses on a comprehensive industrychain layout and diverse medical scenarios, targetingunmet needs in the global public health field. Withtechnological innovation as the core driving force,the company continuously empowers the efficientdevelopment of healthcare systems and the overallimprovement of health and wellbeing, contributingwisdom and strength to creating a global healthcommunity.

Supporting Cutting-edgeScienceHaier Biomedical actively explores cutting-edgescientific fields, integrating innovative technologies withscientific research to provide robust technical supportfor diverse scientific scenarios. This enables globalresearchers to break through scientific barriers.

In 2024, the National Demonstration Center forExperimental Marine Life science Education(Ocean University of China) adopted HaierBiomedical's smart laboratory managementplatform. This implementation enabled theintelligent, IoT-enabled, and shared upgradeof laboratory management, allowing for thecentralized control of laboratory operations,management, environment, and data through asingle screen. It effectively improved laboratorymanagement efficiency and supported thehigh-quality development of marine life scienceeducation and scientific research activities.

Haier Biomedical's smart laboratories management platform helps improve the quality and efficiency ofmarine life scientific research

In 2024, Haier Biomedical reached an important scientific research collaboration with the Botnar Institute forMusculoskeletal Sciences at University of Oxford. The company successfully delivered a large liquid nitrogen tankfor low-temperature storage, contributing China's technological strength to global multiple myeloma research.This equipment, equipped with precise monitoring capabilities, enables full-process digital traceability of sampleaccess, establishing a robust security system for biological samples and enhancing the reliability of critical diseaseresearch data.As a pioneer in the digital transformation of the life science field, Haier Biomedical, through its self-developedsmart biosafety solutions, helps top international scientific research institutions overcome technical bottlenecksin malignant tumor research. This highlights the mission of Chinese companies to safeguard human health andwellbeing through technological innovation.

Haier Biomedical supports the University of Oxford Research Center in deepening researchon multiple myelomaHaier Biomedical experts have been appointed as conveners of the International Standard WorkingGroup for Medical Low-temperature Storage Equipment

On September 26, 2024, the IEC PC130 Medical Low-Temperature Storage Equipment Project Committee held itsplenary meeting, during which Haier Biomedical's UK expertwas officially appointed as the joint convener of two workinggroups: the Medical Low-Temperature Storage EquipmentPerformance Requirements and Testing Methods WorkingGroup (WG3) and the Terminology and Classification WorkingGroup (WG2). This appointment will lead global industry effortsto develop international standards for medical low-temperaturestorage equipment, promote the unification of global standardsfor such equipment, and drive the international expansion ofChina's medical low-temperature storage equipment.

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

3839

Chairman's StatementAbout This Report

Empowering Public Health Construction

Haier Biomedical recognises that a robust public health infrastructure is vital for safeguarding human health andpromoting sustainable societal development. We are committed to advancing the modernization of global public healthsystems through technological innovation, fostering safer and more efficient health ecosystems.

Collaborates with Sangzhuzi District of Shigatse City to establish a Smart Medical Community Platform,leveraging digital intelligence in the public health system to benefit people's livelihoods

Haier Biomedical officially delivered a Mobile DR Diagnostic Vehicle to Kenya, contributing to thedevelopment of local public health construction

On November 6, 2024, Haier Biomedical partnered with Sangzhuzi District of Shigatse City to launch the SmartMedical Consortium Platform at the 7th China International Import Expo. Haier Biomedical has always focusedon addressing the urgent and difficult healthcare needs of residents. By integrating technologies such as 5Gand big data into the construction of the smart medical community platform, it has created a comprehensive"closed-loop" health management system covering the full lifecycle, including "prevention, screening, diagnosis,treatment, management, and rehabilitation". Through resource integration, the smart medical communityplatform achieves efficient coordination and integration of multiple systems. It truly helps to bring high-qualityhealthcare resource to grassroots, effectively improving the level of medical services and advancing theinformatization-based construction of the medical ecosystem in Sangzhuzi District to a new level.

During the reporting period, HaierBiomedical officially delivered itsinnovative Mobile DR Medical Vehicle- integrating mobile healthcare, DRimaging, and dental services - to ZuriHealth, a Kenyan medical group. Themobile DR diagnostic vehicle will serveas an important part of Kenya's publichealth service system, supportinglocal mobile clinics and public healthsectors, and providing more accessibleand convenient healthcare services tothe people of Kenya.

Integrated PIVAS center empowering partner hospitals to overcome the challengesDuring the reporting period, Haier Biomedical partnered withSuperiorMed and Perennial Hospital to jointly establish anintegrated PIVAS center, which has been completed and putinto use. The center addresses the "three high" challengesof high intensity, high risk, and high pressure in sterilepreparation work. Through innovative deployment of fullyautomated liquid dispensing robots, intelligent labeling anddrug dispensing machines, and other equipment, it achievesfully automated drug management. This not only reducesthe risk of drug contamination and healthcare workerexposure, but also significantly enhances the efficiency andaccuracy of medication preparation, ensuring the safety ofpatient medications.

Advancing Digital Intelligence HealthcareHaier Biomedical is committed to safeguarding human health, continuously strengthening life safety technologies inareas such as blood, vaccines, and medication. It aims to drive upgrades in medical scenarios through technologicalinnovation, ensuring the safety of the entire medical workflow with the power of technology and protecting the frontlineof human life.

Haier Biomedical built automated plasma and smart red blood cell storage systems

with Danyang Blood StationAmid growing demands for refined blood resource management, Haier Biomedical partnered with DanyangBlood Station in 2024 to develop an intelligent blood storage system. By integrating IoT technology with biosafetyprotocols, the system establishes end-to-end safety barriers from blood collection and storage to clinicalapplication, setting a new industry benchmark. The automated plasma storage facility is equipped with thecountry's first ultra-high-frequency plasma automation storage system, which is capable of locating plasmabags, greatly improving the efficiency and safety of blood management. Additionally, the smart blood storagesystem - a model project bridging storage systems and blood station operations - improves managementefficiency and offers an innovative framework for full lifecycle blood resource management.

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

LeadershipCreating an Intelligent Futurewith AI Empowerment

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendix

4041

Chairman's StatementAbout This Report

Haier Biomedical consistently regards compliant operations and qualitymanagement as the foundation of corporate development. Upholding highethical standards, the Company continuously improves its operationalmechanisms and internal management systems, strictly controls qualityacross all processes from procurement and production to sales andcustomer service, and builds a comprehensive risk prevention and controlsystem to deliver high-quality, reliable products and services that safeguardlife, health, and safety.

SDG-related responses in this Section

Percentage of female directors

33.3

%

Percentage of female seniormanagers

%Over Compliance education andtraining sessions

Anti-corruption education sessions formiddle and senior managers conducted

Supplier integrity agreementssigned

%Integrity education sessions for staff

%

Quality training sessionsconducted

Decrease in product defect rate

%

Customer satisfaction rate

99.96

%Rate of successful customercomplaint resolution

%

Performance Highlights in this Chapter :

Integrity:

Responsibility Assuming and

Sustainable Development

Integrity

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

EscortingGovernanceCornerstone withResponsibilityHaier Biomedical regards responsible governance asa core element of the Company's steady development.We adhere to business ethics standards, establish acomprehensive and efficient compliance managementsystem, continuously strengthen compliance cultureconstruction, and focus on enhancing corporategovernance transparency. We also work onstrengthening risk prevention and control capabilitiesand practising responsible marketing, ensuring the fullimplementation of responsible governance.

Sound Corporate Governance

Haier Biomedical ensures scientific, efficient, and forward-looking corporate governance and decision-making througheffective board operations. The Company also improvestransparency in investor communication to foster mutual trustand drive long-term development and value creation.

Board OperationHaier Biomedical strictly abides by theCompany Lawof the People's Republic of China, the Securities Law ofthe People's Republic of China, theCode of CorporateGovernance for Listed Companies,theRules Governing theListing of Stocks on the STAR Market of the Shanghai StockExchange and any other relevant laws and regulations. Wecontinuously improve our corporate governance structureand management systems, enhance corporate governanceefficiency, and standardize our operations while activelyprotecting our investors' legitimate rights and interests.Haier Biomedical has established a governance structureconsisting of the Shareholders' Meeting, the Board of Directors,and its special sub-committees and management. TheShareholders' Meeting elects all members of the Board ofDirectors. The Board of Directors oversees the Company'saffairs and makes operational decisions on behalf of theCompany. It has the right to appoint and remove the Company'ssenior management and to control major decisions in theCompany's daily operations.In addition, the Company has established the Board ofSupervisors and the Securities Department. The membersof the Board of Supervisors are democratically elected bythe Shareholders' Meeting and employees, and they performsupervisory duties on behalf of the shareholders. In 2024,Haier Biomedical actively responded to theAdministrativeMeasures for Independent Directors of Listed Companiesbyformulating and issuing theIndependent Directors' SpecializedMeeting Systemto further strengthen the alignment andoversight of independent directors' responsibilities.During the reporting period, we held 2 shareholders' meetings,8 board meetings, 6 special meetings of independentdirectors, 7 supervisory board meetings, 13 committeemeetings, and 2 meetings of employee representatives. Thesemeetings covered matters such as regular reports, profitdistribution, related-party transactions, leadership changes,share buybacks, stock incentive plans, and revisions to theCompany's articles of association and other systems.We are committed to implementing the board diversificationstrategy. When electing board members, we assess andappoint candidates based on diversification criteria to achievea balance in gender, age, cultural and educational background,professional qualifications, and industry and work experience.As of the end of the reporting period, female membersaccounted for 33.3% of our board of directors.

List of Board Members and Diverse Backgrounds

Position Name Gender Educational Background

Chairman Tan Lixia Female

Doctor of Professional Advanced Studies (DrAPS) in AppliedFinanceDirector Zhou Yunjie Male Ph.D. in Business AdministrationDirector Liu Zhanjie Male

PhD in Refrigeration and Cryogenic EngineeringMaster of Business AdministrationDirector Gong Wenwen Female Bachelor of Management and EconomicsDirector Wang Wenfu Male Bachelor of EngineeringDirector Chen Jie Female

Master of Business AdministrationBachelor of Applied Chemistry in CeramicsIndependentDirector

Huang Sheng Male

PhD in Economics, Washington University (St. Louis)Master of Economics, University of CambridgeDouble Bachelor in History and Economics, Peking UniversityIndependentDirector

Niu Jun Male

Doctor of Medicine, Shandong UniversityDoctor of Medicine, University of NewcastleIndependentDirector

Xu Ming Male

Postdoctoral Fellow in Strategic Management, Guanghua Schoolof Management, Peking UniversityPhD in Industrial Economics, Fudan University

Proportion of Female Executives

Total Executives Female Proportion (%)Board of Directors 9333.3Board of Supervisors 3266.7Senior Management 4375

Investor CommunicationBased on the principles of true, accurate, and comprehensive information disclosure, Haier Biomedical strictly adheres to the

Rules Governing the Listing of Stocks on the STAR Market of the Shanghai Stock Exchange, theMeasures for the Administrationof Information Disclosure by Listed Companies, and other relevant regulations. We have developed aWorking Memorandum onInformation Disclosure. Internally, Haier Biomedical implements prior notification for important matters. We continuously improve theinformation disclosure management system to ensure that related activities are legal and compliant.We value investor feedback and maintain positive interactions with investors through various channels, such as performance briefingsessions, investor days, the Shanghai Stock Exchange e-Interaction platform, investor hotlines, and investor relations columns.During the reporting period, we disclosed 31 investor relations records, responded to 36 Shanghai Stock Exchange e-Interactioninquiries, hosted 4 earnings briefings and regional investor events attracting nearly 780 participants, published 16 investor relationsarticles on our official account, and handled hundreds of investor hotline calls.In addition, we place great emphasis on protecting investor rights and interests. Since our listing, we have implemented a dividendpolicy for five consecutive years and launched a new round of share buyback plans in 2024, which were completed in January 2025.4445

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Adhering to Business Ethics

Haier Biomedical maintains a "zero tolerance" attitude toward business ethics violations, strictly adhering to the core principles ofanti-corruption, anti-unfair competition, and the prohibition of conflicts of interest. By improving internal systems, strengtheningintegrity training, and establishing supervision mechanisms, we ensure that employees and partners uphold honesty and integrityin business activities. At the same time, we place great importance on information security and privacy protection, establishinga comprehensive management system to effectively safeguard the legitimate rights and interests of our partners, users, andpatients, striving to create a transparent and open business environment.

Haier Biomedical strictly complies with theCompany Lawof the People's Republic of China, theInterim Provisionson Banning Commercial Bribery, and other relevant lawsand regulations. We have regularly updated internalmanagement systems, such as theHaier Group BusinessCode of Conduct and the Code of Conduct for Employees.In 2024, the Company developed the2024 Platform OwnerIntegral Value between Staff and Customers ("Rendanheyi")Responsibility Agreement, incorporating complianceperformance into the management assessment system,strengthening the construction of an integrity culture, andrigorously controlling corruption risks.We have established a comprehensive internal control andaudit platform. An independent auditing department plans,coordinates, and implements the Company's internal audit work.

Over the past year, we organized 4 anti-corruption education sessions for middle and senior management, covering departmentheads and key personnel. Additionally, we held dozens of warning case training sessions, covering 100% of employees, and allemployees signed aLetter of the Commitment to Integrity and Self-discipline. At the same time, we promoted and interpretedanti-corruption laws and regulations to all employees, strengthening awareness of compliance and legal business practices.During the reporting period, we irregularly provided mid-to-senior level personnel with documents related to the interpretationof compliance policies in the pharmaceutical and healthcare industries, as well as analysis of typical anti-corruption and anti-fraud cases. We enhanced the management team's compliance awareness and risk prevention capabilities through specialisedtraining and case discussions.In accordance with the Haier Group Code of Business Conduct, we strictly regulate the acceptance of gifts by employeesand partners in business cooperation, clearly requiring business personnel to consult the compliance officer in time andproactively report relevant situations. If fraudulent behaviour is discovered, we will handle it strictly in accordance with applicableregulations. Additionally, we have arranged for internal auditors to visit key suppliers and distributors, promoting complianceconcepts to ensure that all parties work together to maintain an honest and transparent business environment.

Relying on a comprehensive information security management system, we have achieved systematic and standardizedinformation security management, providing a solid guarantee for data security.

Anti-corruptionAnti-corruption Management

Employee Integrity Promotion

Information Security Management

The Company has established a whistleblowing website and compliance hotline, independently operated by a third-party serviceprovider. Dedicated personnel manage the whistleblower phone line and email. During the reporting period, we streamlinedanti-fraud reporting channels by setting up over 10 poster frames to promote the reporting pathways, ensuring the channelsremain open and accessible. We are committed to protecting the rights and interests of whistleblowers, strictly maintaining theconfidentiality of their personal information, and establishing a comprehensive mechanism to prevent and address retaliation. Weprovide clear channels for whistleblowers who have suffered retaliation to file complaints. After investigation and verification, if theclaims are found to be true, we will hold the responsible individuals accountable. In addition, we have established a dedicated fundto incentivise the reporting of misconduct under Haier Group'sWhistleblowing Reward System.

Reporting Mechanism

Haier Biomedical provides accessible whistleblowing channels for all employees within the Company andexternal partners such as suppliers

Information Security and Privacy ProtectionHaier Biomedical strictly adheres to theCybersecurity Law of the People's Republic of China, thePersonal InformationProtection Law of the People's Republic of China, and other relevant laws and regulations. We regularly update a seriesof internal systems, such as theCode of Conduct for Biomedical Information Security, to safeguard our stakeholders’information security and privacy.

Information Security Management System

Haier Biomedical has fully deployed the HUES endpoint security software to manage endpoint security policiesautonomously, providing comprehensive safeguards for corporate information security. This year, we initiated aspecial information security audit, identifying key issues such as information system access control and data assetmanagement. We also implemented measures to strengthen off-site disaster recovery and other control mechanisms,enhancing the overall protection capabilities of the Company's information security.

We have also established internal control and audit counterpartsin each division and subsidiary. They collaborate with theinternal control and audit platform. This partnership carriesout risk assessment and other compliance work to ensureefficient operation of the Company's control systems. Duringthe reporting period, we conducted 8 special anti-corruptioninspections and dealt with 5 individuals who violated regulations.

Report phone Compliance hotlineReport email Internal platform

137-3095-3132haierchina.ethicspoint.comhaierbiomedical@haierbiomedical.comjkjubao@haier.comjubao@haier.com

iHaier reporting channel forfraud reporting

Safeguard userinformation

Establish a robust userinformation protection

mechanism

Ensure information

security

Improve information security

managementEnhance risk mitigation

Implement networksecurity managementOptimize network constructionOptimize network security devicesMinimize network threats

During the reporting period

individuals whoviolated regulations

special anti-corruptioninspectionswe conducted and dealt with

4647

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

In 2024, Haier Biomedical updated and released thePrivacy Policy, further regulating the collection, use, storage,and protection of user personal information, ensuring transparency and security in data processing, and continuouslyproviding a solid guarantee for user rights and interests.During the reporting period, we irregularly issued documents to mid-to-senior level personnel on new regulations andcase analyses regarding personal information protection in the pharmaceutical and healthcare industries. This aimedto enhance the management team's understanding of personal information protection and ensure the Company'scompliance in this field. In 2024, our SAP system obtained the Level 3 certification from theClassified Protection ofInformation System Securityand has passed the ISO 27001 Information Security Management System Certification.There were no significant information security incidents in the Company during the reporting period.

We advocate for a fair global market environment, resolutely opposing unfair competition practices and strictly adheringto theAnti-Unfair Competition Law of the People's Republic of China.Guided by theCode of Conduct for Employees,we require all employees to maintain integrity and fairness toward competitors, customers, and suppliers in marketactivities, provide accurate product information, and avoid actions that undermine fair competition or consumer rightsand interests.

Haier Biomedical is committed to avoiding any form of conflict of interest. The Company regulates behaviours toprevent conflicts of interest in theCode of Conduct for Employees, ensuring fairness and justice in the operation of theCompany. Annually, all employees must complete a Conflict of Interest Disclosure Form to identify and mitigate potentialconflicts, safeguarding the Company from disputes and securing its long-term stability.

User Privacy Protection

Anti-unfair Competition

Prohibiting Conflicts of Interest

Implementing Risk ControlHaier Biomedical actively advances risk prevention and management by establishing internal regulations such as theComprehensive Risk Management System Operating Standardsand theMajor Operational Risk Incident Reporting andHandling Standards. The Company autonomously conducts risk identification, early warning, and assessment to ensure steadyoperations, leveraging a robust internal risk management framework.We have established a clear risk management framework, with the board of directors, supervisory board, management team,internal control team, and external auditing institutions each fulfilling their roles within the risk prevention and control system,ensuring that overall risks are kept within acceptable limits.In 2024, we established the Wanlian three-tier risk management system and the Wanlian three-level internal control managementsystem. We defined three categories of risks: field, operation, and execution. We identified over 1,400 risk points and establishedcorresponding risk prevention and control entities and strategies for each type of risk. Additionally, three-tier internal controlstrategies were formulated for field-level, industry platform-level, and chain group-level managers, ensuring coverage across thesmallest business units, all business types, and operational regions.Furthermore, the Company strengthened its Three-Check System (self-inspection, mutual inspection, and specializedinspection). Based on the PDCA (Plan-Do-Check-Act) and OODA (Observe-Orient-Decide-Act) cycle models, standardizedprocesses for internal control effectiveness verification were established across all nodes within the chain groups. This created acomprehensive risk control system featuring self-identification, self-remediation, self-resolution, and self-closing mechanisms.

In 2024, we conducted 5 major special audits, resulting in audit findings. We worked collaboratively with key departmentsto optimize and upgrade processes, addressing issues such as process gaps. Additionally, we further adjusted the riskassessment matrix, carried out 2 comprehensive risk assessments, and strengthened the verification and follow-up ofthe assessment results to ensure the adaptability and effectiveness of risk management measures. During the reportingperiod, we organized over 20 compliance education and training sessions for all employees, effectively enhancing theircompliance awareness and risk prevention capabilities.

Practicing Responsible MarketingHaier Biomedical rigorously implements responsible marketing practices, ensuring consumers receive truthful andreliable information to build a trustworthy brand image and foster a healthy market environment. We strictly comply withtheLaw of the People's Republic of China on the Protection of Consumer Rights and Interests, theProvisions on theAdministration of Instructions and Labels of Medical Devices(Decree No.6 of China Food and Drug Administration),and other laws and regulations. In 2024, we formulated and released theResponsible Marketing Policy, whichclarifies responsibilities and sets behavioural standards for honest advertising, advertising compliance, and brandcommunication, effectively safeguarding consumer rights and market order.Prior to product launch, Haier Biomedical's planning, R&D, and other teams collaborate to ensure that the product'shighlights and marketing content are legally compliant. We continue to standardize how we manage product labellingand provide clear boundaries in marketing, preventing noncompliance from the outset. We have also established a self-inspection system for random documentation of external markings on equipment, ensuring that all new products aremarketed with external product markings and service information that fully comply with regulatory requirements. Afterlaunching our products, our dedicated brand marketing team monitors customer comments and feedback on our officialwebsite and other platforms, monitors marketing compliance, and quickly addresses related risks.

Three Inspection System

By thoroughly understanding

business process standards,we conduct self-assessmentsand promptly correct issuesto ensure the quality of work

Execution gaps at other

nodes are promptlydetected and addressedwith corrective measuresto prevent escalation

Specialized inspections

are conducted to assignresponsibility and developresolution plans foridentified issues, ensuringclosed-loop remediation

Specialized inspection Mutual inspection Self-inspection

4849

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

EcologicalCoordination andExcellentCo-creation

We regard quality as the cornerstone of development,strengthening quality control throughout the full productlifecycle. We focus on building a comprehensive qualitymanagement system from raw material procurementand product manufacturing to customer service.Through an all-encompassing, multi-dimensionalquality assurance mechanism, we fully safeguard thewellbeing and health of life.

Joining Hands with IndustrialPartnersHaier Biomedical always regards supply chain managementas one of the key components of sustainable developmentmanagement. It is committed to building a standardized,stable, responsible, and sustainable supply chain system.Through a comprehensive supplier lifecycle managementsystem, a strict supplier review mechanism, and robustsupplier risk assessment and management measures,we steadily promote the high-quality development of theCompany's value chain, achieving mutual benefits for allparties involved.Supplier Full Lifecycle ManagementHaier Biomedical has established and continuouslyimproved theSupplier Evaluation Strategywhile furtheroptimizing the supplier environment and ensuring thecompetitiveness of suppliers based on this strategy toenhance the overall efficiency and stability of the supplychain. In 2024, we integrated supplier management intoHaier's quality management system and product launchquality assurance management system, establishing afull-link quality control from supplier entry to after-salesservice to ensure product quality stability.During the reporting period, we further improved thesupplier performance assessment standards across theirentire lifecycle, strengthened full-process managementfrom supplier entry to exit, and strictly reviewed supplierqualifications to effectively reduce supply chain risks. Inthe supplier entry phase, we conducted joint assessmentswith relevant functions such as procurement, quality,and R&D to ensure that new suppliers fully meet thestandards. In 2024, Haier Biomedical introduced 50new suppliers and eliminated 20 suppliers. Below is theregional distribution of suppliers in 2024.

In addition, we continuously optimize supplier performance evaluation standards and processes, conducting comprehensiveperformance assessments across multiple dimensions such as cost, delivery, technology, and quality, covering 100% ofsuppliers. Based on the assessment results, we accurately select and prioritize collaboration with high-quality suppliers thatmeet the Company's business upgrade needs, ensuring efficient collaboration and value enhancement in the supply chain.

During the reporting period, we continued to optimize the procurement platform, improving the level of informatizationmanagement in the supply chain. Suppliers' and components' quality review and risk control were significantly enhancedin efficiency and effectiveness.

Supplier Full-Cycle Management Process

Procurement Platform "Professional, Lean, Distinctive and Innovative" ModelDuring the reporting period, we also promoted compliance principles through visits to key suppliers and distributors,ensuring they strictly adhere to company policies and local laws and regulations. To ensure business continuity, weaccelerated the localization of procurement materials, driving the reduction of procurement costs, shortening deliverytimes, and improving quality. In 2024, we achieved the supply chain management goals set at the beginning of the year:

100% on-time delivery rate for product scenarios and a defect rate of less than 0.333% for the year.

In 2024

Suppliers from othercountries or regions

Domestic suppliers

Supplier sourcingIntegrate into new industries

in advanceUnderstand market demand

Supplier access

Improve the suppliermanagement systemSupplier management and

improvementQuantify supplier performance

by using the suppliermanagement mechanism

Supplier pricing

Establish a pricing modelPromote pricing standardisationSupplier review and evaluation

Implement dynamic partitioning

by following the supplierevaluation strategy

Identifying new supplier

productsImprove the identification

system for new parts

Order delivery by suppliers

Gradually build trust with

suppliers

ProfessionalInnovative

LeanDistinctive

Specialized industry suppliersNew industry procurementmodel and process

Supplier access authorizationDifferentiated and tailoredprocurement solutions

eliminated suppliers

Haier Biomedicalintroduced new suppliers

5051

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

Future

Gathering Talents

for Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Responsible Supply Chain Development

The Company has always regarded the construction of a responsible supply chain as an essential part of ESGmanagement practices. We are committed to building a responsible and sustainable supply chain ecosystem throughstrict quality control, integrity and green procurement, human rights protection, and conflict mineral management.During the reporting period, 100% of Haier Biomedical's suppliers signed theSupplier Code of Conduct, and 100% ofthem agreed to environmental protection, social responsibility, and integrity clauses.To ensure product quality, Haier Biomedical implements astrict review mechanism during the supplier entry process.We conduct a comprehensive assessment of suppliers' rawmaterial sources, production equipment, and processesto verify their authenticity and compliance. The Companysigns quality agreements with suppliers to clarify qualityrequirements and responsibilities, controlling the qualityof supplies from the source. Additionally, in accordancewith internal system requirements, we conduct an on-siteannual review of suppliers' quality qualification documents,providing a solid foundation for efficient quality control.Each year, we develop an annual review plan for keysuppliers. In 2024, we completed an annual review for 43suppliers. Through these reviews, we identified risks insuppliers' production processes and management, offeringguidance to enhance their process quality assurancecapabilities.We strengthened component inspection and increasedsupplier compatibility testing for components integratedinto new product scenarios to ensure that componentperformance aligns closely with new product requirements.Additionally, we implemented a three-tier componentcontrol review mechanism, reinforcing the supplier andcomponent risk assessment and full-process assuranceplans.Utilizing an informatization system, we assess suppliersonline based on various aspects such as on-site inspection,quality performance, and system capabilities. We also

During supplier onboarding, suppliers must provide certificates andqualification documents related to environmental protection, suchas ISO 14001, ROHS compliance, REACH-certified qualificationdocuments, etc. They must also sign an Environmental ProtectionCommitment Letter. For initial collaboration with suppliers, we inspecttheir materials' sources to assess their products' environmental impact.We regularly conduct random checks on bulk products throughoutthe collaboration with suppliers to ensure that their materials complywith environmental regulations. Additionally, we actively collaboratewith suppliers to co-develop and upgrade environmentally friendlymaterials, jointly creating a green, low-carbon supply chain ecosystem.Haier Biomedical requires suppliers to uphold laborrights and employ workers legally. Our procurementcontracts include clauses prohibiting child labor, forcedlabor, discrimination, and the use of labor from thosewith restricted freedom. We also advocate that suppliersprovide their employees with reasonable working hours,wages, and benefits to safeguard their legitimate rightsand interests.During on-site review of suppliers, we focus on evaluatingtheir labor management practices, including laborsystems, worker safety, and occupational health, aimingto safeguard their employees' human rights and otherlegal rights and interests.We also emphasize the health and safety rights andinterests of all supplier personnel who enter theCompany's operations. Such personnel must haveregular safety training and education and pass a testHaier Biomedical understands that managing conflict minerals is crucial to a responsible supply chain. We haveestablished a comprehensive management system and processes, with internal multi-departmental coordination, tocontrol conflict mineral risks systematically. We also collaborate closely with upstream and downstream partners inthe supply chain, conducting on-site reviews and regular investigations to ensure that supplier factories develop andenforce clear written procedures to prevent the procurement and use of conflict minerals.Additionally, we continue to advance the transparency of our supply chain, strictly tracing the source of minerals toensure they do not originate from conflict regions, and we take concrete actions to build a sustainable and responsiblesupply chain ecosystem.

Our company is dedicated to building an ecosystem of integrity incollaboration with our partners. We strictly adhere to national lawsand regulations, and require all suppliers to sign aSupplier IntegrityAgreement, which stipulates that suppliers must abide by the codeof business ethics and prohibit corruption, fraud, and other businessethics violations.As of the end of the reporting period, our suppliers had signed integrityagreements 100%.

Ensuring Procurement Quality

Promoting Environmentally Friendly and Green Procurement

Upholding Supplier Human Rights

Eliminating Conflict Minerals

Advocating for Transparent and Honest Procurement

Suppliers Quality Training and Exchanges

conduct annual reviews, periodic inspections, type testing,problem-solving, and supplier performance optimization aspart of routine monitoring. Based on assessment results,we implement classification management for suppliers. Wetake measures such as warnings and senior managementdiscussions for suppliers with poor quality performanceand require them to optimize independently. During thereporting period, we assessed a total of 598 suppliers usingthis system.In 2024, we provided special process certification trainingfor 6 suppliers to enhance their ability to ensure specialprocess quality. We also conducted quality and technicalexchange activities with 8 foreign suppliers to deepencooperation and communication. Additionally, we organizedquality improvement meetings with 7 wiring harnesssuppliers, summarizing process control methods andexperiences to strengthen the quality assurance capabilitiesof wiring harness suppliers.During the reporting period

we assessed a total of

suppliers using this system

before working onsite. This significantly enhances thesafety awareness of relevant personnel and effectivelyreduces health and safety risks for our partners. Duringthe reporting period, we conducted regular safety trainingfor suppliers, including three-tier safety education for newsuppliers, annual re-education, and specialized trainingsessions. A total of 107 participants attended, achieving100% coverage.During the reporting period

achieving

%

coverageA total of

participants attended

As of the end of the reporting period

our suppliers had signedintegrityagreements

%

5253

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Consolidating Product Quality

Haier Biomedical has always regarded quality as the lifeline of its products, and it is dedicated to providing users withsafe, efficient, and reliable products and solutions. We strive to create the best user experience, continuously improvingthe full-process quality management and assurance system, from product planning to market service. We fullyempower quality process management through digital intelligence and informatization technology, achieving refined andtransparent quality control and building a strong quality defense.

Haier Biomedical adheres to the "customer-first" quality managementphilosophy, focusing on key product issues and user pain points. We have clearlydefined a three-stage quality strategic goal: from "zero defects" in productsto "zero complaints" from users, and ultimately to "building the best customerreputation." This strategy provides a strong driving force for upgrading the qualitysystem and continuously improving quality performance.In recent years, we have adhered to a quality strategy that transitions from qualityinspection to process control and further to risk control and quality prevention.Through scientific and rigorous process methods and comprehensive riskthinking, we have achieved full-link closed-loop quality management before,during, and after production. To establish a global compliance system, we havebuilt a quality protection network covering the entire value chain, from R&D toproduction and service.We regard risk prevention and control as the cornerstone. Through the three-dimensional coordination mechanism ofquality planning, process control, and continuous improvement, we integrate customer needs, international compliancestandards, and ecological win-win goals into every stage of the value chain. This drives the constant optimization ofproduct quality performance throughout its entire lifecycle to build a reliable quality foundation for the global health andlife science sectors.

Haier Biomedical has established a quality management system centered on core documents such as theRiskManagement Control ProcedureandDesign and Development Management Control Procedure, along with highstandards for internal quality regulations, ensuring that all quality management processes and stages consistently meetinternal and external requirements. In 2024, we optimized 66 process documents in accordance with the requirementsof theEU Medical Device Regulation (MDR)and the nationalGood Manufacturing Practice (GMP)standards, furtherensuring the systematic and standardized nature of our quality management.We have always focused on customer needs, continuously exploring innovative models for quality improvement andempowerment in digital transformation. Leveraging digital intelligence capabilities, we constantly upgrade our qualitymanagement system.

Haier Biomedical has established a quality management system covering the full product lifecycle, enabling detailedquality control over product R&D, procurement, production, and market services. Through a three-stage managementmodel of "prevention before, control during, and improvement after", we ensure that each step and procedureundergoes rigorous scrutiny, laying a solid foundation for creating "zero-defect" products.We also set annual quality objectives, including key indicators such as product defect rates and model achievementrates, and use these as guidelines to promote product quality improvement steadily. During the reporting period, weexceeded our annual quality goals, with the product defect rate decreasing by 8% year over year.

Enhanced Quality SystemQuality Strategic Objectives

Quality Management System

Haier Biomedical Quality StrategicObjectives and Preventive System

Haier Biomedical Full-Chain Quality Management Strategy

Processes and

methodsFirst-timecorrectness Rapid response

Risk thinking

Q

u

a

lit

y

i

m

p

ro

v

e

m

e

n

t

A

fte

r-

s

a

le

s

M

ark

et

C

o

rp

o

ra

t

e

planning

R&D

Purchasing

Usersatisfaction

Quality

planning

QualitycontrolQualityimprovement

P

ro

d

uct

q

ualific

a

t

io

n

S

ystem

conformity

P

r

o

c

es

s

efficiency

Create the foremostuser reputation andbecome the globalleader in life sciencequality

Interaction

risks

Design

risksImprove-mentrisks

Deliveryrisks

Processrisks

Log

istics

Quality inspection

Manufacturing

M

an

agement

right

brain

syste

m

U

ser

reputation

DNA

Digital-intelligent

left

brain

technologies

F

u

l

l-

c

h

a

i

n

q

u

a

lit

y

n

e

u

ra

l

no

d

es

Target systemguidance via platform

Standardcomplianceenforcementvia platform

Process/

reputation

sensitivity

via platformKnowledge accumulation

and empowerment viaplatform

Risk early-warningintelligencevia platform

Work scenarioimplementationvia platform

TractionImplementation

Empowerment

EnforcementCorporateplanning

R&D

PurchasingManufac-

turingDetectServicesServices

Best userexperience

Sensitivity Early

Continuo

us

imp

rove

ment

thro

u

gh

fu

ll

a

c

c

e

ss

ib

i

li

t

y

5455

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Quality Assurance System

At Haier Biomedical, our strong quality assurance capability is crucial for creating high-quality products and maintainingour core competitive advantages. For newly launched products, we integrate quality requirements at each stagebefore and after the product launch and implement a series of quality assurance projects. This ensures full-processparticipation in quality management, and through key milestones such as user research, risk assessment and mitigation,and user trials, we ensure that the product meets user needs and pain points from design to delivery. By continuouslyenhancing our quality capabilities, we improve the user experience.

We have established clear quality assurance mechanisms for critical stages, including design, manufacturing, andprocurement, to achieve the Company's long-term quality strategic objectives and ensure products consistentlymeet "zero-defect" standards throughout their lifecycle. Through integrated digital platforms such as the productlifecycle management system, quality informatization platform, and after-sales service system, we have constructed acomprehensive "zero-defect" quality assurance framework.

Manufacturing

Purchasing

Hygienic-style factory

management

Design

Scenario integration

and margin design

Supplier onlineevaluationComponent control

and review

Product lifecycle management system100% control of quality checkpoints fornew products/changesQuality-oriented information platform100% transparent traceability of marketquality data to serial numbersAfter-sales service system100% closed-loop market quality information

Quality Management System Certificate

We continuously promote internal and external product qualitycertifications with high standards and strict requirements to ensurethat our products meet the performance, safety, environmental,and other requirements outlined in relevant laws, regulations,and standards. We also continuously expand the dimensions andcontent assessed by our internal quality certifications, focusingon areas such as user experience and product reliability to morecomprehensively and deeply control product quality. As of the end ofthe reporting period, Haier Biomedical has obtained several qualitysystem certifications, including ISO 9001, ISO 13485, and the U.S.FDA QSR 820. In 2024, we also obtained the EU Medical DeviceRegulation (MDR) certification.

Haier Biomedical Product Launch Quality Assurance System

Haier Biomedical's "Zero-Defect" Quality Assurance System

Haier Biomedical places great importance on the potential quality risks at each stage of the full product lifecycle.Through a well-established quality risk control mechanism, we continuously transform quality management frominspection and process management to preventive management, fully ensuring product delivery quality.

Planning: Ensuring productfunctionality and scenariosolutions meet user needs

Design: Zero defects instructures and modules

Knowledge reuse: Qualityknowledge retrieval/reuseand risk zone elimination

Haier Biomedical Full-process Quality Management System

Entering factory: Supplierpre-inspection with visibleonline inspection plans andresults

In factory: Implementedautomated inspectionsand launched a qualitydigitization platform

Leaving factory: Achievedthe integration of standards,platforms, and processes,focusing on overcomingpersistent challenges

Consultation: Throughintelligent assistance, weproactively serve users andleverage digital technologiesto enhance problem-solvingcapabilities

Services: Timely response,on-site service asscheduled, real-time userfeedback to achieve zerocomplaints

Improvement: Ensuringroot-cause resolution whileadvancing standards andsystem upgrades

User participation inrisk elimination

No inflow, no occurrence,

no outflow

Information-to-person andclosed-loop optimizationBeforeDuringAfter

Haier Biomedical Undergoes ISO9001 Quality Review by PQS Team, Demonstrating Exceptional QualityManagement and Practices

In May 2024, experts from the World Health Organization (WHO)'s PQS (Performance, Quality, and Safety)team conducted an on-site ISO9001 quality review for PQS vaccine refrigerators at Haier Biomedical. Duringthis review, the experts spoke positively of Haier Biomedical's quality management system, compliancemanagement, and other related efforts. Up to now, 23 products of Haier Biomedical have met the PQS productrequirements.

Our quality management level and practices have also received widespread recognition from the industry and society.In 2024, Haier Biomedical underwent a PQS (Performance, Quality, and Safety) on-site assessment conducted byexperts and received positive feedback. To date, Haier Biomedical has won a number of quality awards, including theNational Leading Quality Brand in the Medical Device Industry and the National Leading Quality Enterprise in the MedicalEquipment Industry.User research andmaster sample analysis

Model risk elimination

Riskassessment

Manufacturing riskelimination

Component risk

eliminationExperimental risk elimination User trial use Product release Deliver to users

Product

5657

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Quality Digitization - Quality Management Platform

Manufacturing Intelligence - IoT Factory

Supply Chain Informatization - Integrated Supply Chain Management Platform

In the context of global competition and deep IoT technology integration, Haier Biomedical, guided by itsecological brand strategy, has implemented a dual-platform digital procurement system with global coverage,achieving full-link quality control upgrade of the supply chain.This system is centered on a modular quality visualization cloud platform that integrates supplier productiondata and user evaluations in real time, forming a closed loop of dynamic quality optimization. Concurrently,it establishes a preferred materials repository based on multi-dimensional rules, complemented byblockchain technology to enhance full lifecycle traceability from design to delivery, ensuring transparencyand controllability of quality from the source. Through systematic innovation, this digital system effectivelyenhances cross-regional collaboration efficiency, fosters supplier ecosystem co-development, and deeplyintegrates quality control with green development, establishing the foundation for efficient and sustainablesupply chain management.

To strengthen the closed-loop management effectiveness of quality issues, Haier Biomedical has constructeda digital quality platform encompassing quality planning, inspection task management, and process monitoring,leveraging big data analysis technology. Through comprehensive collection, real-time feedback, and efficientprocessing of quality data, this platform achieves product quality that is "foreseeable, controllable, manageableand plannable", while providing a high-efficient collaboration platform for quality management personnel at alllevels. This simultaneously enhances quality management efficiency and continuously strengthens productquality assurance capabilities.

Haier Biomedical's smart IoT factory uses automation, intelligence, information and other technologies toachieve precise control throughout the production process and dynamic monitoring of production and qualityinformation, significantly mitigating quality risks during manufacturing. It further advances medical intelligentfactories to realize equipment interconnection, data integration, and intelligent management and control,establishing a new production mode for full product lifecycle management.

Haier Biomedical's Quality Management System of Digital Intelligence

Quality Digitization

Manufacturing Intelligence

Through internet-based information technology, we systematically display orders, incoming materials,processes, sampling inspections, and shipping status, achieving comprehensive informatization of datathroughout all processes and ensuring information sharing and efficiency.

The implementation of quality information and data collection and feedback mechanisms enables high-efficiencycollaboration in quality management.

100% informatization monitoring of operational parameters is conducted with automated facial recognition atcritical procedure points.

Real-time monitoring and dynamic optimization through big data analysis (SPC) are implemented.

Real-time visualization of production indicators is accessible for real-time access to production, quality,equipment, and logistics information, among others.

Supply Chain Informatization

The combination of advanced information integration (CRM+SRM+Supplier Evaluation System), comprehensivesupply chain resources, and mature Just-In-Time (JIT) management mode constitutes supply chain capabilitieswith core competitive advantages, establishing the foundation for robust quality control at the source of materials.

Strengthening Quality Control CapabilitiesDigital Intelligence in Quality ManagementHaier Biomedical responded to the national strategic requirements of "informatization and industrialization integration"and "digital transformation" by advancing new-quality productive forces. Leveraging digital and information technologiesas key enablers, the Company is comprehensively promoting digital intelligence upgrades in product manufacturing andquality management, propelling quality management toward more intelligent and efficient modalities.In recent years, we have consistently pursued the deep integration of digital innovation with product manufacturingand process management. Through the deployment of internet-based information technology, we have establisheda comprehensive quality management system of digital intelligence, achieving a full-process digital managementand control from raw material receipt to product delivery, thereby substantively enhancing quality managementeffectiveness.

Precision Quality TraceabilityBased on the Quality Management System (QMS), Haier Biomedical has established a quality information traceabilitymechanism that encompasses the entire product lifecycle to ensure accurate positioning of quality information and aswift response to quality issues. Through this mechanism, we achieve information interconnection from order issuanceto production processes and logistics transportation, facilitating collaboration among multiple stakeholders on qualityinformation across users, equipment, production, logistics, and other interfaces. This enables both forward and reversequality information traceability and supports timely improvement initiatives for quality issues.

Full Lifecycle Quality Information Traceability System

Supplier factory test Acceptance test Contract assessment

Production process Factory inspection Market service diagnosis

5859

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Laboratory Quality Control SeminarSpecial Process and Key Procedure

Verification Training

Advanced Study in Supplier QualityManagement

Collaborative Quality ImprovementBased on a comprehensive quality management and assurance system, Haier Biomedical consistently promotesproduct quality improvement by implementing routine management and control measures for actual or potential qualityissues throughout the product lifecycle. This ensures that every quality issue is promptly addressed with closed-loophandling. We have established a thorough closed-loop system for quality issues, focusing on four major aspects: qualityinformation collection, quality issue improvement, persistent problem resolution, and system solidification. This clearlydefines the management mechanism for quality issues from source to continuous improvement while striving to createhigh-quality products with a "zero tolerance" attitude.

Collecting quality issue information through marketfeedback, data analysis, defective product/partanalysis, public opinion monitoring, etc.

Identifying issues immediately after informationcollection to prevent quality issues from escalating

System Solidification

Information Collection Issue Improvement

Persistent Problem Resolution

Direct on-site analysis and handling of immediateissues at user locations

Organizing TOP issue lists with 100% closed-loopimplementation

Conducting improvement evaluations throughdaily quality improvement meetings, weekly andmonthly analysis meetings

Identifying persistent quality issues and signingperformance agreements with chain groups

Promoting organization-wide quality improvementthrough monthly quality star evaluationsand quarterly quality improvement projectannouncements

Improving key checkpoint lists to achieve errorprevention in high-risk areas

Conducting long-term reliability testing and analysis

Haier Biomedical Closed-Loop Quality Issue System

Four Main Quality Training Themes

Quality system

Quality regulationsQuality tools

Components technology (suppliers)

During the reporting period, we implemented more than 200 quality improvement projects, further enhancing productquality control capabilities and striving to provide users with products and experiences of higher standards, higherperformance, and superior quality.Haier Biomedical considers the enhancement of the quality awareness of employees as a key component of productquality management and improvement. Through various formats, including internal discussions, case sharing,experience summaries, practical exercises, and external expert lectures, we conduct quality training for employees,suppliers, and other relevant parties on an ad hoc basis. This promotes the effective transformation of quality knowledgeinto practical capabilities, encouraging all personnel to proactively identify risks and precisely solve problems in R&D,production, and service processes, preventing quality risks at the source. During the reporting period, we conducted atotal of 8 quality-related training sessions with 98 participants.

6061

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Product Recall

Promoting a Culture of Quality

To promptly respond to and effectively address potential quality incidents, we strictly implement full-process qualityrisk control and have established a comprehensive global major incident early warning system. We have formulatedtheAdverse Event Reporting, Recall, and Information Notification Control Procedures, recalling medical products withsafety hazards when necessary to minimize adverse impacts on users due to product quality factors.During the reporting period, Haier Biomedical had no major quality and safety incidents or product recalls.

Haier Biomedical proactively advocates the quality concept of "reverence for life and quality", continuouslystrengthening quality awareness and quality culture throughout all aspects of production and operations. Through multi-channel quality culture promotion and diverse quality culture activities, we have created an atmosphere of quality cultureparticipation across all personnel and processes.

To fully stimulate employees' initiative in participating in quality management and enhancing quality awareness, everyyear, Haier Biomedical organizes a series of themed activities, such as "Quality Month", for all our employees. Throughvarious activities such as assembly skills competitions, "Military Order" competitions, and quality skills training, weintegrate theoretical knowledge with practical scenarios, strengthen the inheritance of craftsmanship spirit throughcompetitions and learning, and facilitate the resolution of quality challenges through innovative vitality. In 2024, wesuccessfully held "Quality Month" activities, comprehensively reinforcing employees' quality knowledge reserves,improving practical quality skill levels, and building a solid first line of defence against quality risks.

Forms of Quality Culture Promotion

Quality Integrity System Construction

At Haier Biomedical, we embrace values of righteousness, integrity, and collaborative value creation. We've establisheda robust quality integrity system with legal compliance as its foundation. We strictly implement internal and externalquality management requirements with a rigorous and pragmatic attitude. Through cross-departmental collaborativemechanisms, we achieve standardized control across the full lifecycle, including R&D, production, and service, ensuringeffective implementation of quality responsibilities.We have formulated theHaier Biomedical Quality Red Line, clearly defining our quality integrity rules and making explicitprovisions for quality dishonesty behaviors and their penalties, constantly reinforcing our quality bottom line.

Setting benchmarksWe regularly organize "ZBB Talent ChainCelebrity List", "Haier Group Monthly Awards","Wanlian Monthly Customer Stars", "MonthlyQuality Stars" and other assessmentcompetitions and announce the resultsvia emails, ihaier and other channels to allemployees to commend those who have madeoutstanding contributions.

Official account postsOur official WeChat accounts, such as WalianMaker Home and Haier Biomedical, regularlyshare our latest products, trends and qualitymanagement concepts to relevant parties suchas our customers.

We-media operationWe showcase outstanding company personnelachievements and excellent cases through we-media platforms such as "Most Beautiful HaierPeople" and "Haier Integrated Media" for allemployees to learn from.

Advertising slogansQuality slogans, red lines, warnings and othercontent are placed at prominent locations inproduction workshops and office buildingsto continuously enhance employees' qualityawareness.Makers' speech competitions

Themed activities on quality culture building and quality management are held regularly to enrich ouremployees' lives.

Haier Biomedical's Product Recall Process

RecallrecordsfilingRecalleffectivenessassessmentIssueinformationcollection

Recall planpreparation

Recallexecution

Recallreportsubmission

6263

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Haier Biomedical adheres to theLaw of the People's Republic of China on the Protection of Consumer Rights andInterestsby formulating and implementing internal service management systems, including theAfter-sales ServiceManagement System, theAfter-sales Defective Product Return Management System, theAfter-sales TrainingManagement Provisions, and theUser Satisfaction Return Management Provisions, to ensure standardized customerservice processes.We also continually enhance the optimization of our service assurance system by establishing global high-end seven-star service standards to promote standardized services in new industries and upgrade user experiences. During thereporting period, leveraging 6 support nodes and the biomedical service platform, we developed a comprehensiveservice ecosystem encompassing 5 major industry clusters. Based on a robust assurance mechanism and servicestandards, we deliver customers high-quality, integrated solutions, continuously empowering the industry development.

Service Systems and Frameworks

Assessment SystemNational Commodity After-Sales Service Conformity Certification Evaluation Committee DatabaseChina Electronics Standardization AssociationISO 13485/ISO 9001/ISO 14001/ISO 45001/ISO 27001 System Certification

Haier Biomedical Service Assurance System

In 2024, Haier Biomedical received multiple certifications including CTEAS After-sales Service System Seven-star(Excellence) Certification and National Product After-sales Service Five-star Certification, reflecting the Company'soutstanding performance in after-sales service.

Haier Biomedical After-sales Service Related Certification CertificatesScenario Service Ecosystem ConstructionIn 2024, Haier Biomedical continued to advance the transformation of its service model from single product service to ascenario service ecosystem, building comprehensive lifetime user profiles with user needs at the core and creating one-stop laboratory scenario solutions to fully meet multi-scenario user requirements. As of the end of the reporting period,we had launched 13 categories of value-added service products, including 2 types of scenario service ecosystems,established 256 lifetime user profiles, completed over 1,500 service ecosystem orders, and served 225 users,significantly enhancing user stickiness and service value, and setting a benchmark for service model innovation in theindustry.

Service System UpgradeHaier Biomedical upholds the service philosophy of "heartwarming service, creating worry-free experiences". With thegoal of "best user experience", we are committed to resolving customer pain points and enhancing user experiencethrough professional, efficient, and attentive service. During the reporting period, Haier Biomedical formulated a qualitystrategy plan centered on improving user satisfaction, deeply integrating customer service management into thequality management system, continuously optimizing the customer service assurance system, and comprehensivelyenhancing the full product lifecycle service and quality assurance.

Digital IntelligenceBiobank Industry

Digital IntelligenceLaboratory Industry

Digital Intelligence

Medical Industry

Digital IntelligencePublic Health Industry

Digital Intelligence

Blood Industry

365 days a year,

24-hour hotlineresponseResponse within

2 hours afterdispatch, on-sitewithin 24 hours

Response within

30 minutes duringworking hours, andapproximately 12-hour response intime-differenceregions

Second-level

response, 100%issue processing onthe platform

100% delivery

issue processingon the platform100% on-time

delivery withinbudget

Multiple categories

of value-addedservice productsDomestic Services Overseas Services Automated Services Major Project Delivery Value-added Services

Biomedical Service Platform

"Seven Star Exquisite" Service

Optimizing User ExperienceHaier Biomedical strongly emphasises "user-centricity" by continually refining service processes and enhancing closed-loop capabilities. We establish responsive mechanisms for customer feedback to promptly address issues. At the sametime, we integrate customer service management into both our product lifecycle management and comprehensivequality management systems, consistently enhancing product performance and service quality to deliver greater valueto our customers.

6465

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Optimizing User ExperienceHaier Biomedical continuously promotes service process upgrades covering the full product lifecycle and multiplebusiness scenarios, including installation and commissioning, performance testing, defective product returns andexchanges, and telephone consultations, to all meet customer needs.The Company continuously optimizes service quality management with the goal of achieving "0 complaints". We haveestablished an efficient product complaint handling process, quickly responding to user feedback through the valueinformation system for analysis and verification by the quality department, with solutions implemented by the after-sales service department. Concurrently, we further optimize the user satisfaction follow-up management regulationsto ensure continuous service quality improvement. During the reporting period, we handled 44 customer complaintincidents with response times, all within 24 hours, achieving a customer satisfaction rate of 99.96%.

In 2024, we comprehensively improved customer service response efficiency and service closed-loop capabilitiesby upgrading service processes, conducting "Heartwarming Winter Service" activities, and building a digital serviceplatform, providing users with all-weather, comprehensive quality service experiences.

We continue to advance foundational service digitalization,providing 24-hour online instant second-level responseservices. For after-sales service personnel, weimplement a 72-hour resolution deadline assessmentmechanism, continuously enhancing product after-salesservice processing speed. During the reporting period,we improved customer service response time from 13seconds to 9.6 seconds, significantly enhancing serviceefficiency and user experience.

Haier Biomedical has established the Haier BiomedicalAfter-sales Service System (ASSS), which comprehensivelycovers the entire process management from informationcollection to user service and issue resolution. By leveragingmulti-level warning mechanisms and information closuresystems, we achieve zero-delay user service, ensuring thatissues reach the responsible departments and personneldirectly. This forms an efficient, transparent, information-based, fully closed-loop service system that providescustomers with timely and precise after-sales support.

Service Capacity Building

Digital Platform Construction

In 2024, Haier Biomedical's caring service team consistentlypracticed the service concept of "Sincerity Forever", organizingover 13,000 Heartwarming Winter Services activities coveringmore than 420 users, aimed at deeply understanding and promptlyresponding to user needs, and providing professional and reliableservice.We visited Qinghai University to understand users' product

usage, reconfirm equipment disposal times, and collect newequipment needs, providing equipment trade-in services. Thesecaring service activities, as a carrier, greatly improved userexperience and ensured equipment safety.During severe weather warnings, we received an urgent medical

equipment delivery and installation request from Shanxi ProvincialCenter for Disease Control and Prevention. The service teamof Haier Biomedical responded immediately to customer needs,efficiently completing delivery and installation, and providingreliable support to users with professional spirit and efficientaction.

Conducting Heartwarming Winter Service Activities

During the reporting period

achieving a customer satisfaction rate of

99.96

%we handled

customer complaint incidents

with response times all within

hours

Haier Biomedical After-sales Service System (ASSS)

Information Collection Process

User Service Process

Closed-loop Issue Resolution Process

400 work order information Cloud platform information Remote monitoring information

Satisfaction

follow-up visitsOn-site visits

Service center receives order → Service centerschedules appointment with user → Service centerprovides on-site service

Service center closes order → Telephone follow-up→ Work order completion

Customer service access:

Consultation-type work orders: concluded after

customer service consultationOn-site service work orders: generate work orders and

dispatch

After-sales manager → Service support

Service center closes order → System automaticallyidentifies issue and responsible personnel → Issueassigned to individual (design, manufacturing, components,logistics, after-sales) → Rendanheyi mechanism driving →Information-based closed-loop resolution

Conducting Specialized Training to Enhance Team Service Capabilities

In March 2024, Haier Biomedical conducted closed specializedtraining for 31 provincial after-sales service directorsnationwide. The training focused on core areas such as ultra-low temperature storage and automated sample managementplatforms, providing service personnel with in-depth analysis oftechnical specifications, and conducting theoretical training andpractical exercises centered on scenarios such as maintenanceof ultra-low temperature equipment in biopharmaceuticalenterprises. This training program was designed with a 3Dempowerment framework of "product technology iteration +service standard enhancement + scenario-based practicaltraining", deepening participants' product knowledge,enhancing their operational capabilities, and effectivelyimproving service quality across the national service network.

6667

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

SDG-related responses in this Section

Obtained the ISO 45001 certification for the occupational health and safetymanagement system

Average training hours

35.26

Number of employees2,807

worth of public welfare donations in totalRMB502,000

Training coverage

%Working days due to workinjuries

Performance highlights in this chapter:

Future:

Gathering Talents for

Healthy Life

FutureHaier Biomedical firmly believes that employees are the core driving forcebehind enterprise development, while enhancing human health and wellbeingremains our unwavering mission. Through innovative talent developmentsystems, we promote employee growth, share enterprise achievements,and enable the realisation of higher professional value. At the same time,we continue to strengthen the development of the public health system,working to improve population health standards, promote equitable accessto healthcare resources, and contribute to building a community focused onhuman health.

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Diverse and InclusiveWorkplace

The Company strictly adheres to compliant employmentregulations, ensuring an open, fair, and transparentrecruitment process, committed to providing equalopportunities and support for all employees, fostering adiverse and inclusive corporate culture, respecting andprotecting the fundamental rights of each employee.

Labor Rights and InterestsHaier Biomedical strictly adheres to theLabor Law of thePeople's Republic of China, theLabor Contract Law of thePeople's Republic of China, and other relevant laws andregulations. We utilize theHaier Biomedical Recruitmentand Employment Policyas our governing standard tosystematically regulate the entire recruitment process,implementing the principles of "fair, just, and open" in ourtalent acquisition initiatives.We have established protocols in our onboarding system torigorously review candidates' identity and age information,thereby eliminating child labor employment. Concurrently,Haier Biomedical's recruitment procedures maintaincomplete transparency, precluding any form of forcedlabor. Haier Biomedical implements the philosophy of "noovertime if not necessary" through process optimizationand efficiency enhancement, directing employeesto increase work productivity, appropriately arrangeworking hours, and further elevate job satisfaction andwellbeing. We rigorously regulate overtime management,systematically monitor overtime hours, and remunerateovertime compensation in full accordance with statutoryrequirements to substantively safeguard employees'legal rights and interests. Furthermore, at the 8th Meetingof Employee Representatives in 2024, we promulgatedpolicies to eliminate ineffective overtime and facilitate theimplementation of two-day weekends, further cultivatingan optimal working environment for personnel.Haier Biomedical has instituted stringent proceduresto address child labor recruitment and forced laborinfractions. Upon identification of relevant circumstances,the Company will expeditiously implement actions pursuantto established protocols to ensure the preservation ofemployee rights and interests. For incidents involving childlabor, Haier Biomedical has formulated supplementaryrights and interests protection measures to safeguard thephysical and psychological welfare of minors.

People-centered,Unlocking PotentialHaier Biomedical empowers employee growthand facilitates self-actualization through scientificrecruitment mechanisms, comprehensive Rights andInterests protection systems, and systematic trainingand development plans. We are committed to creatingan Integral Value between Staff and Customers("Rendanheyi"). We start by "finding the right people,helping them succeed, and finally supporting them"to establish a clear career development pathway.Additionally, we prioritize occupational health and safety,providing employees with an equitable, inclusive, andhealthy work environment, continuously enhancingemployees' sense of belonging and happiness.

We continuously refine our talent acquisition mechanisms,with "finding the right people" as our fundamental objectiveto sustain corporate development. Through talentstructure optimization, during the reporting period, wesuccessfully integrated 31 core talents in critical positions,with substantial increases in technological innovationspecialists, advanced degree holders (master's andabove), and industry authorities, effectively supportingthe Company's strategic imperatives for technologicaladvancement and market penetration.

Concurrently, we have enhanced talent recruitment andinternal personnel transfer governance frameworks,facilitating internal employee mobility and promotingjudicious allocation and maximum utilization of humancapital resources. In 2024, Haier Biomedical hired 462new employees; at the same time, 30.73% of internalemployees filled internal vacancies.

Child Labor Incident Rights and Interest Protection Measures

Mandate

workcessation

Conducthealthexaminations

Ensure securerepatriationof affectedemployees

EnhancepreventativeprotocolsCompletesettlement ofremunerationand benefits

Child Labor and Forced Labor Incident Handling Process

StrengthentrainingImmediatelyceaseviolations

Identifychild laborand forcedlaborincidents

Identifychild labor

incidents

Conductinvestigation and

verification

Executereporting andcommunication

Implementremedialmeasures and

corrections

Provideemployee careand supportservices

Carry outresponsibilityinvestigation

Haier Biomedical's Approach to Talent Attraction

Identify the talent profile

Through comprehensiveanalysis of operationalrequirements and positionspecifications, identify essentialcompetencies and contributionsfor distinct roles

Secure talent layout

Predicated on industrytrajectories and labormarket dynamics, establisha comprehensive candidaterepository encompassing criticaldomains to secure key talentresources

Accurate talent reservematching systemOptimize personnel reservesand position compatibilitymechanisms through methodicalpreparation strategies andselection procedures to fosteremployee development

7071

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

2,762，98%693，25%110，4%

At Haier Biomedical, we uphold the management philosophy of providing equal opportunities to every employee andactively safeguard employees' fundamental rights. We have established multiple reporting and communication channelsto ensure employees can promptly report situations where their rights have been compromised, including harassment,discrimination, forced overtime, etc.

As of the end of the reporting period, Haier Biomedical's total number of on-the-job employees is 2,807. The employeestructure of Haier Biomedical is as follows:

On-the-job EmployeeNumbers and PercentagesCategorized by Gender

On-the-job Employee Numbersand Percentages Categorized byGeographical Region

On-the-job EmployeeNumbers and PercentagesCategorized by Age Group

On-the-job EmployeeNumbers and PercentagesCategorized by Function

On-the-job EmployeeNumbers and PercentagesCategorized by Ethnic Group

Equality and DiversityHaier Biomedical remains consistently committed to fostering a diverse, equitable, and inclusive work environment,resolutely opposing any form of discrimination, and ensuring all employees enjoy equal opportunities and treatment.We explicitly prohibit discriminatory practices in recruitment and promotion processes based on dimensions such asgender, age, ethnicity, geographical origin, marital status, and religious beliefs, while promoting equal pay for equal workregardless of gender. Haier Biomedical maintains a zero-tolerance stance toward behaviors involving infringement,harassment, and retaliation, and provides legal support and assistance to employees when necessary.

Human Resource Management Concept of "Non-discrimination, Diversity, Equal Opportunities"

Non-discrimination

Strictly adhering to principles of "fair, just, and open" toensure the absence of any discriminatory practices inrecruitment, promotion, and incentivizationProhibiting any discrimination based on factors such asgender, age, race, religious beliefs, ensuring employeesreceive equal opportunities within the Company

Equal Opportunities

Promotion mechanism: Establishing equitable promotion mechanism to ensure that employees receive equal promotionopportunities based on capabilities and performanceEqual rights and interests: Ensuring all employees receive equal treatment regarding remuneration, benefits, leave entitlements,etc., unaffected by factors such as gender, age, race

Diversity

Promoting multicultural integration, encouragingemployee communication and collaboration in cross-cultural environmentsProviding diversified training and cultural activities toenhance employees' cross-cultural awareness andcommunication capabilities

Email: Public Reporting Email -Maker's Voice MailboxReporting and Communication Channels

Supporting Talent Development

Haier Biomedical consistently regards employees as the Company's valuable assets, committed to providing allemployees with extensive development platforms and growth opportunities. Through our systematic training framework,clear career advancement pathways, and competitive remuneration incentive mechanisms, we comprehensivelyempower employee capability enhancement and professional development.Haier Biomedical consistently views employee growth as the core driving force for corporate sustainable development.Haier Biomedical has constructed a complete talent development support system to promote comprehensive employeedevelopment and enhance organisational effectiveness.

We have constructed a talent core competency model that scientifically and systematically facilitates employeecareer growth by continuously enhancing their leadership, professional competence, and general skills, empoweringemployees to achieve synergistic development between personal value and corporate strategic objectives.

Employee Training

Talent Development Support System

Implement specialized training instrategic thinking enhancementand organizational managementinnovation, and strengthendecision-making capabilities andholistic perspective in combinationwith practical simulations andcross-departmental collaborativeprojects

Leadership

Design industry cutting-edge technology training,skills certification, and projectimplementation plans for keypositions such as technical R&Dand production operations,ensuring dynamic alignmentbetween professional capabilitiesand business requirements

Professional Competence

Comprehensively enhancethe comprehensive qualitiesof employees through digitaltool application, cross-culturalcommunication, professionalquality improvement, and othercourses, cultivating versatiletalents adaptable to diversebusiness scenarios

General SkillsCore Capability Development Mechanisms

Talent assessment systemPrecisely identify talent potential and adaptabilitybased on three dimensions: performance,capability, and values

Career development channelPerfect dual-channel promotion mechanisms,establish internal rotation and competitiveselection systems, and stimulating employeevitality and organizational innovation momentum

Mentorship and learning platformsConstruct internal mentor networks and digital learning platforms, providing personalized development resources,supporting the continuous learning and career advancement of employees

840，30%36，1%

793，28%

1,904，68%

990，35%

835，30%

41，1%248，9%45，2%

2,771，99%1,967，70%China Technical MaleFemale Other countries or regions

Sales Minority

Non-minorityUnder 3030-50Over 50

Finance AdministrationProduction

Online platforms: Haier Community,Cultural Discussion Community,Maker's Voice Anonymous Platform

Tel.: Haier BiomedicalCompliance Hotline

7273

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Haier Biomedical profoundly recognizes that the long-term development of the Company is inseparable fromestablishing a mature and comprehensive talent team. Through implementing training programs targeted at employeesat different career stages, we continuously cultivate future leaders possessing holistic perspectives and innovativecapabilities, strengthening talent echelon construction.

Haier Biomedical is committed to encouraging employees to start businesses and innovate, striving to realize their self-

worth, and refers to employees as "makers"

Haier Biomedical places a high value on cultivating and developing a new generation of talent. For recent graduates andnew employees, we customize development pathways and offer comprehensive growth support through systematicintegration programs. We are committed to helping emerging talent quickly adapt to the workplace environment, fullyrealize their potential, and achieve professional value.

During the reporting period, we customized multiple specialized training programs for recent campus recruits,management personnel, and other categories of makers, aiming to help makers quickly adapt to the workplaceenvironment and systematically enhance their professional capabilities and management qualities.

Reserve Talent Echelon ConstructionGeneral Manager Reserve TalentPoolImplement the "AcceleratedDevelopment Program of FutureBusiness Leaders", cultivatingleaders with holistic perspectiveand innovative capabilities throughrotational assignments, strategictopic research, and executivementor guidance

Young High-potential Maker

Reserve ProgramInitiate the "Spark ProgramAccelerated Training Plan",expediting the rapid growthand value realization of high-potential talent through cross-boundary learning and resourceempowerment

Chain Group Leader ReserveTalent PoolLaunch the "AcceleratedTraining Program of FutureExcellence Managers", focusingon supply chain and businesschain collaborative capabilities,and strengthening end-to-endmanagement abilities throughcombined warfare-training models

Campus Maker Development New Maker Development

The company has launched the "Future Partner Long-termDevelopment Program", which establishes a customized3-year development pathway. Through rotational practicalexperience, professional specialization, and innovationchallenges, the program accelerates the career growthof fresh graduates, cultivating next-generation industryleadership talent for the Company.

For new employees, the Company has designed a 6-month"New Employee Integration Development Program",encompassing corporate culture orientation, positionskill enhancement, and team collaboration capabilitydevelopment. The Company has established a mentorshipmechanism, providing diverse learning opportunitiesincluding scenario simulations and team projects, helpingnew makers rapidly adapt to the work environment, mastercore position skills, and integrate into the organizationalculture.

During the reporting period, Haier Biomedical employees spent 98,974 hours on training. The average employee learntfor 35.26 hours and 100% of our staff participated in a training of some kind. Among these, the percentage of trainedemployees and average training hours by employee gender are as follows:

Project Management (PMP) Training and Support Plan - Management Training

Project Management Training and Support PlanHaier Biomedical continuously strengthens project management talent cultivation, supporting employees inobtaining professional project management qualifications and reimbursing examination fees according toregulations. In 2024, the Company conducted 4 PMP training sessions covering the project managementknowledge system and examination techniques, utilizing combined online and offline approaches. During thereporting period, 55 employees participated in the examination, achieving a pass rate of 83.6%.

Targetcandidates

Training and

learningExamregistration

Examination

Expensereimbursement

Receivecertification

New-New Maker Project - Developing Future Partners

To promote digital transformation and innovative talent development, Haier Biomedical actively participatedin the 2024 New-New Maker Project. This project helps new employees rapidly integrate into the companyculture through diversified activities and training, utilizing ice-breaking games, company culture exhibitions,small group presentation competitions, etc. to promote team cooperation and cultural identification.Additionally, the project arranges safety and CPR first aid training, goal management and effectivecommunication courses, and among others, combined with factory visits and user scenario simulations,helping employees enhance professional skills and deeply understand company products and applicationscenarios. Through a combination of online and offline courses with practical operations, new employees canquickly adapt to company culture, achieving role transformation and capability enhancement.

Percentage of TrainedEmployees by Gender

Average Training Hours by Gender

Male FemaleMaleFemale

70%

30%

35.58

34.52

7475

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Employee Promotion

Remuneration Incentives

Haier Biomedical continuously perfects employee growth and development mechanisms, providing clear careerpaths and supporting fair promotion opportunities for employees. We have formulated theHaier Biomedical MakerDevelopment Policy, constructing a dual-channel career development pathway, supporting employees' verticaldevelopment within professional and management channels as well as horizontal transitions across channels.During the reporting period, we updated the maker development evaluation criteria by precisely assessing employeecapabilities, taking inventory of the talent structure, and ensuring that organizational talent aligns with the requirementsof corporate strategy.

Haier Biomedical is committed to offering employees competitive remuneration and benefits, and through continuousoptimization of incentive mechanisms, it achieves a high level of unification. between employee value and enterprisedevelopment. With the user-paid mechanism as our core, we establish a model combining long-term and short-termincentives, constructing a comprehensive and diversified remuneration incentive system that fully stimulates employee workenthusiasm.

Remuneration Incentive System

Short-term Incentive

Annual Salary Adjustment and BonusIncentives: Establishing annual salary adjustmentwindows, combined with diversified bonusincentives including performance bonuses andproject bonuses, promptly converting employeevalue contributions, enhancing the flexibility andcompetitiveness of remuneration incentives

Long-term Incentive

Business Partnership Incentives: Constructinga performance self-evaluation system, andmotivating employees to engage in work withan entrepreneurial mindset, achieving mutualgrowth between individuals and the enterpriseEmployee Stock Ownership Plan (ESOP):

Implementing a Type II Restricted Stock IncentivePlan, granting 3.42 million A-share ordinary sharesto 262 employees, sharing enterprise developmentachievements with core talent through equity

Haier Biomedical Promotion Pathways

Haier Biomedical consistently advocates the management concept of "Integral Value between Staff and Customers(Rendanheyi)", establishing a scientific performance evaluation system focused on four dimensions: "comprehensiveassessment, objective management, value realization, and career development", closely combining employeeperformance with value creation. For employees at different levels, we implement differentiated performance evaluationstandards, and in combination with customized incentive programs, we comprehensively stimulate employee potentialand promote mutual growth between individuals and the organization.

Haier Biomedical Performance Evaluation SystemCaring for Employee WellbeingHaier Biomedical consistently strives to create a warm and caring work environment. Through diversified employeebenefits, enriched cultural activities, and unimpeded democratic communication mechanisms, we build a workplacefilled with respect and warmth, protecting employees' physical and mental health and enhancing their workplacebelonging and happiness.

We consistently uphold a people-oriented philosophy, strictly comply with national laws and regulations, and ensurethe full contribution of pension, unemployment, work injury, medical, maternity insurance, and housing provident fundsfor all employees. We also continuously optimize and expand the employee benefits system, and we are committed toenhancing employees' overall wellbeing and job satisfaction. In 2024, the social insurance and physical examinationcoverage rates for Haier Biomedical employees reached 100%.

Employee Benefits

Value realizationValue evaluation and distribution based ontalent classification: Refining rank developmentevaluation standards, precisely assessing allemployees' capabilities, and ensuring alignmentwith enterprise strategy direction

Comprehensive Assessment360-degree assessment mechanism: Employeesevaluate their direct supervisors and givefeedback on a monthly basis through the system,promoting bilateral communication and continuousimprovement

Objective managementPerformance coaching mechanism: Directmanagers conduct monthly performanceinterviews and coaching for employees, helpingemployees clarify improvement directions

Career developmentConducting work based on performanceobjectives, clarifying direction, continuouslyimproving, and facilitating career growth and self-breakthrough

In 2024

%the social insurance and physical examination coverage rates for Haier Biomedical employeesreached

Platform OwnerSub-platform Owner/Deputy ManagerChain Group Owner/WeChat OwnerSub-chain Group Owner/Interface

PersonnelManagement (M) Pathway

Chief ExpertChief EngineerVeteran Engineer

Senior EngineerIntermediate Engineer

Junior EngineerAssistant EngineerProfessional (P) Pathway

7677

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

We regularly organize employee care activities such as Mid-Autumn Festival benefit distributions, shuttlecockcompetitions, "National Science and Technology Workers' Day" events, free two-cancer(cervical cancer and breastcancer) screening clinics for women, and food festivals to enhance employees' sense of belonging and satisfaction.Additionally, we have established a comprehensive assistance mechanism for employees in difficulty, mobilizingemployee support to raise funds for colleagues in need through public fundraising platforms, effectively helping themovercome challenges. The Company also regularly organizes sympathy visits to employees suffering from illness,ensuring they receive timely care and support when needed, allowing every employee to feel the warmth and strength ofthe collective.

Mid-Autumn Festival Benefits Shuttlecock Competitions "National Science and Technology

Workers' Day" Activities

Employee BenefitsSix Insurances and Two FundsBesides the statutory five insurances and one fund, the Company providesenterprise annuities for employees to enhance economic security after retirement.We also purchase supplementary commercial insurance for employees to furtherimprove their medical and accident protection levels.

Paid Leave

Besides statutory holidays, theCompany also provides paid annualleave, leave for parent-teachermeetings, employee children'sentrance exams for senior highschool and university, parentalleave, parent-care leave, etc.We also provide three days ofmaker's leave and two days ofspring break for fresh graduates.Meal Stipend

The canteen offers diversedining options with mealsubsidies;There are food festivalactivities from time to timeto enrich employees' diningexperiences.

Physical Examination

We provide free annual health examinationopportunities for employees.

Talent HousingWe provide rental talent housing application opportunitiesfor qualifying employees.

Women's Care

We establish lactation rooms in factories and officebuildings.

Diverse Benefits

We provide allowances for high temperatures in the summer, heating in the winter, andclothing. We also provide a business anniversary bonus, birthday gifts and correspondingholiday benefits.

2024 Women's Day free screening for cervical and breast cancer

Free Two-cancer Screening Clinic Activity

To improve women's health levels and facilitate early prevention, earlydetection, and early treatment of cervical cancer and breast cancer, welaunched the "Walking with Glowing Love" women's health care seriesof activities on March 8. To facilitate female employees' participation, wespecially arranged professional two-cancer screening vehicles to enterthe park, providing "door-to-door" free screening services. The activity notonly effectively raised health awareness among Haier Biomedical's femaleemployees but also built a health protection line for them through practicalaction, fully demonstrating the Company's deep concern for employees'physical and mental health, as well as its firm commitment to actively fulfillingsocial responsibilities and supporting employee development.

Democratic CommunicationHaier Biomedical actively enhances various democratic communication channels, values and considers all employeefeedback, works to create an open and transparent communication environment, and fosters the deepening andexecution of democratic management.

Food Festival activities

Food Festival Activities

To enrich employees' lives, enhance happiness, and promotecommunication, Haier Biomedical regularly holds food festivalactivities in the canteens, where employees actively offersuggestions for canteen improvements while enjoying deliciousfood. The activities convey the Company's care for employees'lives and also enhance employees' sense of belonging andhappiness.

We regularly conduct company-wide satisfaction and engagement surveys, developing solution plans for feedbackissues and clarifying the management period to ensure the effective implementation of these solutions. The 2024 surveyresults show an overall score of 4.49 (out of 5), with engagement, satisfaction, and cultural atmosphere reaching 4.47,

4.43, and 4.54 points, respectively. Approximately 600 employees participated in the survey, and the positive feedback

reflects employees' recognition and trust in the company.

Employee Satisfaction and Engagement Survey in 2024

Democratic Communication Channels

Maker's Voice Public MailboxThe Company establishes the Maker's Voice public mailbox (chuangkexinsheng@haierbiomedical.com), encouraging employeesto actively provide feedback on needs and suggestions regarding platforms, work, and life. mailto:chuangkexinsheng@haierbiomedical.comThe Company strictly maintains the confidentiality of employee information and actively resolves problems, committed to creating agood environment for entrepreneurship and innovation.After receiving emails, the public mailbox transfers issues to relevant responsible departments within 24 hours, and the responsibledepartments must respond within 24 hours, resolving issues raised by employees as much as possible through bilateralcommunication.At the beginning of each month, the Maker's Voice mailbox publicizes to all employees the issues collected in the previous month,responsible department responses, issue closure progress, and other information.Democratic EvaluationHaier Biomedical has semi-annual democratic evaluation among divisions to promote the normalization of democraticmanagement.Cultural Discussion

Through "Cultural Discussion" activities, we encourage employees to reflect on problems in the work and workplaceenvironment, with timely feedback and improvements on major concerns.Employee Self-governance CommitteeCommittee members actively work to build a good workplace environment, listen to employee needs, feedback, andsuggestions, and help employees resolve problems promptly.

4.47

Engagement

4.43

Satisfaction

4.54

Cultural atmosphere

7879

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Occupational Health and SafetyHaier Biomedical has always viewed employee health and safety as the cornerstone of sustainable corporate development. Wehave established a comprehensive safety management system, scientific accident prevention mechanisms, and rigorous safetymanagement measures to enhance our safety management capabilities, thereby fostering a safe, healthy, and dependableworking environment for employees, ensuring the health and wellbeing of each employee and the long-term growth of theCompany.

Haier Biomedical strictly complies with theWork Safety Law of the People's Republic ofChinaand other relevant laws and regulationsto ensure all production activities meet safetyproduction standards. We have establishedthe "139 safety management system", aimingat zero accidents and emphasizing themanagement principles of zero negligence,zero hazards and zero violations.We implement a model of "full participation, fullcoverage, and whole process" combined witha management mechanism of "prevention, in-process control, and post-incident summary"to ensure safety hazards can be "timelyidentified, timely addressed, and swiftly andcomprehensively managed". During thereporting period, the Company had no majorsafety accidents and lost no working days dueto work injuries.

Health and Safety System Development

ISO 45001 certification for the occupationalhealth and safety management system

As of the end of the reporting period,Haier Biomedical has obtained ISO 45001certification for the occupational healthand safety management system.

139 Safety Management System

Whole

p

r

o

c

e

ss

Timely

identification

Timely

identification

Full

coverage

Full

coverage

Swift,

comprehensive

Swift,

comprehensive

Zero

negligence

Zero

negligence

Ze

ro

hazards

Ze

ro

hazards

Full

participation

Full

participation

comprehensive

comprehensive

Po

st-incident

Po

st-incidentPrevention

Prevention

In-process

control

In-process

control

Zero

violations

Zero

violations

No

occurrence

Zero accidents

Haier Biomedical strictly follows theGuidelines for thePreparation of Emergency Plans for Production SafetyAccidents of Production and Operation Units, Measuresfor Management of Emergency Plans for ProductionSafety Accidents, Regulations on Emergency Response toProduction Safety Accidents, Shandong Province Measuresfor Emergency Response to Production Safety Accidents,and other relevant laws and regulations on production safety.We have established a comprehensive safety productionmanagement system to enhance enterprise safety productionlevels and emergency response capabilities, effectivelyprotecting employees' lives and property safety and ensuringstable business operations.During the reporting period, Haier Biomedical updated internalregulations such as theQingdao Haier Biomedical Co.,Ltd. Hazardous Chemicals Management Systemto furtherstandardize hazardous chemicals' storage, use, and disposalprocesses, ensuring continuous improvement of laboratorysafety management.

Haier Biomedical has always regarded hazard identificationand prevention as the core element of safety management,thoroughly investigating potential safety hazards andadopting targeted measures to ensure controllable risks. TheCompany has introduced professional manufacturers andproven solutions through open bidding, deploying networkedcombustible gas detection and alarm systems in key areasfor flammable and explosive gases such as natural gas andisobutane. These systems cover a total of 13 locations, includingall factory welding points and kitchen gas facilities, achievingreal-time monitoring and early warning, effectively reducingsafety risks.Concurrently, Haier Biomedical places great emphasis onequipment safety management, ensuring safe equipmentoperation and effective identification and control of potentialhazards through a management system with full employeeparticipation and advanced technical means. The Company hasformed a comprehensive safety prevention and control systemby continuously optimizing equipment management processesand strengthening employee involvement.

Equipment Safety Management and Risk Assessment: Haier Biomedical implements a specialized equipmentmanagement system with full employee participation. Through regular safety inspections and equipment identificationmanagement, we ensure safe equipment operation. All equipment must undergo strict risk assessment before use toidentify potential hazards and implement preventive measures.Electronic Monitoring and Real-time Data Analysis: The Company monitors equipment operating status in real-timethrough electronic systems and conducts safety assessments based on data analysis to ensure timely identificationand handling of issues during equipment operation.Five-prevention Management and Operating Standards: By developing and strictly implementing the "TenRequirements and Five Musts" operating standards, we ensure proper equipment use and regular maintenance tominimize equipment failures and operational risks.

Safety Production

Fire safety month campaignOn October 28, 2024, Haier Biomedical launched a fire safety month campaign with the theme "Prevention First, Lives First".We comprehensively enhanced fire safety management and employee emergency response capabilities through systematictraining, drills, and hazard identification. We organized 38 safety management personnel for training in basic fire safetyknowledge and emergency skills, and held a firefighting skills contest and company-wide emergency evacuation drills. Duringthis period, we inspected fire water systems, technical prevention facilities, hazardous chemical storage points, and hot workoperations, and issue 5 hazard rectification orders, ensuring that safety measures were properly implemented. Concurrently,we actively promoted a company-wide smoking ban. This campaign strengthened all employees' safety awareness, effectivelyimproving the Company's fire safety management level, and creating a favorable environment for ensuring employee safety.

Fire Safety Month LaunchCeremony

Firefighting Skills ContestComprehensive Safety

Testing of Electrical Areas

Hot Work OperationsInspection

No

occurrence

manag

e

m

e

n

t

8081

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Occupational Disease Prevention

Haier Biomedical comprehensively safeguardsemployees' occupational health and safety bycontinuously strengthening occupational hazardidentification and prevention. Haier Biomedical hasestablishedOccupational Health Recordsand promptlyreports theOccupational Hazard Project DeclarationFormto health administrative departments as required,taking responsibility for all employees' occupationalhealth and safety.The Company organizes annual occupational hazardfactor testing by third-party institutions. It conductsoccupational hazard status evaluations every threeyears to protect employees' health in high-risk positions

effectively. Haier Biomedical regularly organizesoccupational health examinations for employees inpositions involving occupational hazards. It makesnecessary job adjustments or follow-up arrangementsbased on examination results to protect employeehealth.To strengthen occupational health and safetyawareness among all employees, Haier Biomedicalregularly conducts employee training to enhanceoccupational safety protection capabilities. We alsorequire all employees to pass annual safety training andobtain relevant certificates.

Heat stroke emergency response training

On May 28, 2024, Haier Biomedical organizedspecialized heat stroke emergency response trainingfor employees. The training covered heat strokesymptom identification, first aid measures, medicationusage, etc. to enhance employees' emergencyresponse capabilities and self-protection awareness,providing strong safeguards against health risks duringhot weather. Concurrently, Haier Biomedical equippedfacilities with heat stroke emergency medicationsto ensure employees receive timely and effectiveassistance in case of heat stroke.

Heat Stroke Emergency Response Training

Hazardous Chemical Spill EmergencyResponse Drill

On October 16, 2024, Haier Biomedical organizeda specialized drill for on-site hazardous chemicalspill response. This training focused on emergencyresponse procedures, emergency suppliespreparation, and among others. Through courselearning, employees improved their emergencyresponse skills for hazardous chemical spillincidents, ensuring they can quickly organizerescue efforts when facing emergencies, therebyreducing accident losses for the Company.

Hazardous Chemical Spill Emergency Response Drill

Red Cross emergency rescue trainingIn 2024, Haier Biomedical organized Red Cross emergency rescue training covering first aid skills, AEDequipment use, CPR, and emergency bandaging. Through a combination of theoretical learning andpractical operations, employees mastered basic first aid methods. To further enhance emergency responsecapabilities, we introduced AED equipment in office buildings during the reporting period to ensure timelyrescue in emergency situations. A total of 143 employees participated in this training, greatly enhancingemployees' self-rescue and mutual aid capabilities while also improving the Company's emergency responselevel for unexpected incidents.

Universal HealthcareHaier Biomedical is deeply rooted in the healthcare industry. Leveraging advanced technology, experiential advantages,and a profound understanding of smart digital scenario solutions, we persistently promote global universal healthcare. Weare committed to making high-quality medical services more universal and accessible. As a long-term partner of the GlobalAlliance for Vaccines and Immunization (GAVI), Haier Biomedical supports global immunization health with its productsand technology. GAVI served 1.1 billion children worldwide from 2000 to 2023,

effectively enhancing children's health andwellbeing globally.

Sharing Health andCo-constructingCommunity

As an enterprise with a sense of mission andresponsibility, Haier Biomedical leverages its capabilitiesand advantages to fulfil social responsibilitiesalongside government agencies, non-governmentalorganizations, universities, and other global ecologicalpartners, promoting the development of global universalhealthcare. We consistently collaborate closelywith global public welfare organizations, supportingcommunity development through cash and productdonations, with total donations of cash and materialsreaching RMB 502,000 in 2024.

Promoting the flow of quality

healthcare resources to grassrootslevel, vulnerable groups, andeconomically less developed areasReducing medical access costs,

and ensuring fair and accessiblehealthcare resources

Spreading medical knowledge,

enhancing partners' professionalcapabilities and improving theoverall quality of medical servicesthrough professional products andtechnical training and educationalresources

Upgrading medical facilities,

implementing digital and intelligentsolutions, strengthening publichealth system construction, andenhancing the overall servicecapability and technical level of themedical industryHaier Biomedical Universal Healthcare System

Medical accessibility development Medical ecological empowerment

Medical and public health

upgrades

Our Principles of Public Welfare and Focus Fields

Respond to stakeholderrequirements to build acommunity of common health

for mankind

Fulfill the responsibilities as acorporate citizen based on our

core strengths

Medicalaccessibilitydevelopment

Medicalecologicalempowerment

Medical andpublic health

upgrades

Principlesof PublicWelfare

Focusfields

Materialdonation

Communityempowerment

Employeepublic welfare

Data source: https://www.gavi.org/, the ocial website of GAVI8283

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

Leadership

Creating an Intelligent Future

with AI Empowerment

Medical accessibility development Medical Ecological Empowerment

Haier Biomedical is committed to delivering advanced medical supplies to the grassroots level and developing countries,helping popularize quality healthcare resources in economically less developed areas. Our services have reached morethan 80 countries and regions, including those along the "Belt and Road" initiative. Concurrently, we focus on the healthneeds of specific populations, and increase the accessibility of medical services through actively organizing communityhealth screening activities and other approaches, ensuring more people globally can conveniently access high-qualitymedical services.

By strengthening the training, education, and promotion of medical products and technologies, Haier Biomedicalempowers its partners in the medical ecosystem and promotes the coordinated development of the industry. It aimsto build a sustainable universal healthcare ecosystem and facilitate the efficient allocation and sharing of healthcareresources, injecting impetus into the innovation and sustainable development of the industry.

Contribution to Malaria Eradication with Cold Chain Technology - Haier Biomedical Provides Solar-powered Vaccine Refrigerators for Rural and Remote Areas in Africa

Medical Knowledge Popularization - Haier Biomedical Holds the Haier Week Event in Senegal

Supporting the Enhancement of Healthcare Professionals' Capabilities - Haier Biomedical ProvidesCentralized Training on Solar-powered Vaccine Refrigerators for the Syrian Ministry of Health

Caring for Women's Life and Health - Haier Biomedical Contributes to the Early Diagnosis and Treatmentof "Two Cancers" (Cervical Cancer and Breast Cancer).

In addressing the challenges posed by inadequate electricity andinfrastructure in regions such as Cameroon and other parts of Africa, HaierBiomedical, in collaboration with international organizations, initiated themedical inclusive projects. This initiative specifically targets the uniqueneeds of rural and remote areas in Africa by developing and supplyingsolar-powered vaccine refrigerators HTC-110 and HTC-120. Leveragingsolar direct-drive technology and a microelectronic temperature controlsystem, this solution guarantees the constant low-temperature storage ofvaccines under extreme conditions. Even in the absence of power supply,it ensures a stable temperature of 8°C, maintaining this temperature forup to five days, thereby significantly safeguarding the quality, safety, andefficacy of the vaccines. Through this innovative solution, Haier Biomedical has effectively helped the local peoplesolve the safety issues of vaccine storage and transportation, contributing to the cause of fighting malaria in Africa.

In December 2024, Haier Biomedical, in conjunction with its agent in Senegal, jointly organized the secondHaier Week event, attracting more than 200 users to participate. At the event site, Haier Biomedical showcasedlaboratory products such as floor-standing centrifuges and provided professional product explanations andtraining, popularizing product and medical knowledge for important industrial partners. In addition, multiplevisits and seminars were organized at the event site. Haier Biomedical and its ecological partners engaged inheated discussions on issues such as industry development trends and scientific research product planning.This promoted in-depth discussions among global practitioners about emerging scientific research tools andsolutions, and contributed to the development of medical scientific research work.

In August 2024, Haier Biomedical carried out training on the operation and maintenance of the HTCD-160 solar-powered vaccine refrigerator for the Syrian Ministry of Health in Dubai. This training aims to improve the abilityof healthcare professionals to manage vaccine storage under challenging conditions. This training helps toenhance the level of vaccine cold chain management in Syria and achieve public health goals. It also sets anexample in supporting developing countries in dealing with infectious diseases and increasing the immunizationrate.

Haier Biomedical has been continuously making efforts to increasethe rates of early diagnosis and treatment of the "two cancers",safeguarding the health and safety of women. In response to theproblems such as insufficient healthcare resources in rural and remoteareas, weak health awareness among women, and the difficulty inpopularizing the regular "two cancers" screening services, HaierBiomedical's intelligent screening vehicles for the "two cancers" havesuccessively entered the townships, villages, residential communities,and enterprise parks in Yuncheng City and Hohhot City, providing"one-stop" on-site two-cancer screening services for women of theappropriate age groups as well as popularizing health knowledge.Haier Biomedical's intelligent screening vehicles for the "two cancers" bring advanced detection technologiesand convenient services to the grassroots level. The vehicles are equipped with professional screeningequipment, 5G networks, digital platforms and other facilities, and are divided into multiple functional areas.They support mobile phone appointments, ID card scanning for registration, and real-time data uploading.The screening results are fed back through mobile terminals, ensuring the professionalism and privacy ofthe screening. The convenient and professional screening services and health popularization activities haveeffectively enhanced women's relevant awareness and the coverage rate of the "two cancers" screening. Ourpromotion activities will continue to make important contributions to reducing the disease risks and promotingthe equalization of public health services.

8485

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Construction of Medical and Public Health

To improve the global public health level, Haier Biomedical is committed to building a disease prevention network,perfecting the emergency response mechanism, and promoting the construction of a data-sharing platform. It helps toenhance the level of public medical supply chains in various countries around the world, promotes the digital intelligencedevelopment of healthcare, and strives to contribute to the long-term development of the public and medical healthsectors in the international community.

Public Welfare and CharityHaier Biomedical actively participates in community public welfare activities, donates medical devices to multipleregions, and enhances public health capabilities. We also continuously strengthen cooperation with universitiesand scientific research institutions to support the growth of talents in the healthcare industry. We are committed tocontributing to the global healthcare sector with our own strength, demonstrating social responsibility and reflectingindustry leadership.Donation of Medical SuppliesAs a global corporate citizen, Haier Biomedical actively fulfills its social responsibilities and provides material assistanceto regions in need around the world. Leveraging our core advantages, we promote our products and advanced solutionsin areas with medical needs and support the enhancement of the public health system, contributing to the creation of amore equitable and inclusive global healthcare environment.

Promoting the Establishment of Nepal's Public Health Service System - Haier Biomedical establishes aMicrowave Medical Waste Treatment Workstation in Nepal

Supporting the Public Health Construction in Turkey - Haier Biomedical Donates Laboratory and MedicalDevice to Turkey

Helping Upgrade the Immunization Planning System in Rural and Remote Areas - Haier BiomedicalDonates Vaccination Vehicles to Diqing Tibetan Autonomous Prefecture

Assisting in the Upgrading of Brazil's Medical Service System - Haier Biomedical's "Smart Blood CityNetwork" Lands in Brazil

Haier Biomedical adheres to the mission of"Making Life Better" and focuses on innovation andservices in the medical and health field. During thereporting period, the microwave medical wastetreatment workstation innovatively developed byHaier Biomedical was officially delivered to a localhospital in Nepal. This microwave medical wastetreatment workstation provides strong support fortechnological model innovation and environmentalrisk prevention and control in the local medical wastefield. It will become an important part of Nepal'spublic safety and health service system, whichis conducive to improving the local public healthand safety conditions. It also demonstrates HaierBiomedical's corporate contribution in promotingmedical technological progress and healthimprovement in less developed areas.

Haier Biomedical has reached a cooperation withthe Turkish health department to help it createpublic health solutions and ensure the health andwellbeing of local residents. During the reportingperiod, Haier Biomedical donated devices such asultra-low temperature refrigerators, carbon dioxideincubators, sterilizers, and consumables to Turkey.These devices will be applied in various public healthlaboratories in Turkey, providing a solid guaranteefor local disease prevention, vaccine R&D, andmedical research in Turkey.

In 2024, Haier Biomedical, in collaboration with theRed Cross Society of China Diqing Zangzu ZizhiBranch in Yunnan Province, donated intelligentvaccination vehicles to Diqing Prefecture, helpingDiqing Prefecture create a more convenient andintelligent mobile vaccination model. This enablespastoral residents in remote mountainous areasto receive vaccines safely and efficiently at their"doorsteps", promoting the further upgrading ofthe immunization planning system in the wholeprefecture and contributing to the development ofthe public health sector in Diqing Prefecture.

Haier Biomedical accurately grasped the intelligenttrend of the Brazilian medical market, successfullyconstructed the Smart Blood City Network, andachieved seamless connection with the local bloodstation system, thus improving the level of medicalservices in Brazil. By focusing on the safe supplyof blood, Haier Biomedical has created a SmartBlood City Network "linked on the same network".Utilizing intelligent Internet of Things (IoT) technology,it realizes full-process traceability from bloodcollection to blood use and cold chain supervision. Byestablishing a refined and intelligent integrated bloodmanagement service platform, we have promoted thetransformation of urban blood management in Brazilfrom an emergency response mode to a scientificgovernance mode. The successful application of theSmart Blood City Network in the Central Blood Stationof Rio de Janeiro, Brazil, is expected to serve as areplicable model for approximately 7,000 hospitalsacross the country, contributing to the efficientutilization of healthcare resources in Brazil.

8687

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Empowering Community Construction

Haier Biomedical is committed to promoting high-quality development in the fields of scientific research safety andmedical health. Through practical actions such as helping improve laboratory safety management levels, deepeningcooperation in the field of medical health, providing scientific support for sports health, and supporting the cultivationof young talents through educational public welfare, it comprehensively aids social safety and health development,showcasing the Company's social responsibility and innovative value.

Ensuring the Safety of University Laboratories - Haier Biomedical Assists Multiple Universities inConducting Laboratory Safety Training and Emergency DrillsWith its exploration and practice in the field of safe use and management of hazardous chemicals, HaierBiomedical provided services such as laboratory safety education and training, and the design, process follow-up, and experience summary of emergency plans for hazardous chemical leakage and fire accidents in 2024 formultiple universities, including North China University of Science and Technology, Southwest Jiaotong University,Hebei Normal University, Shandong University of Science and Technology, University of Jinan, China AgriculturalUniversity, and Qingdao University of Science and Technology. It helps university laboratory safety emergencydrills achieve the dual goals of inspection and demonstration, and effectively improves laboratory safetymanagement levels and emergency response capabilities, providing a strong guarantee for the smooth progressof scientific research work in universities and the safety of teachers and students.

Encouraging Public Welfare Work among Employees

We advocate that employees actively participate in public welfare activities and contribute to community construction.The Company regularly organizes employees to participate in community service, environmental protection activities,assistance to vulnerable groups and other projects, enabling employees to spread care and dedication to every cornerof the community in their spare time. Every little act of kindness can converge into a river, which will surely inject a strongdriving force into the harmonious development of society and jointly create a better future.

Haier Biomedical Organizes an Employee Voluntary Blood Donation Activity

Supporting the Cultivation of Life science Young Talents - Continuously Promoting the "Haier BiomedicalStrong Foundation for Education Assistance Program"

Promoting "Belt and Road" Cooperation and Marine Biological Resources Protection - Haier BiomedicalEstablishes a Joint Laboratory in Collaboration with the Universiti Malaya

In 2024, Haier Biomedical, in collaboration with the Qingdao BloodStation, carried out a voluntary blood donation activity. Employeesfrom various departments of Haier Biomedical actively respondedand fulfilled their social responsibilities with practical actions. A totalof 44 employees successfully donated blood in this blood donationactivity, with a blood donation volume of 15,600ml, demonstrating theenthusiastic public welfare spirit and willingness to contribute of theCompany's employees.

Since 2022, Haier Biomedical has continuously supported youthentrepreneurship and employment through a public welfare fund, helpingcultivate young talents. In 2024, Haier Biomedical continued to implementthe "Haier Biomedical Strong Foundation for Education AssistanceProgram" in accordance with the strategic cooperation agreement, and helda funding ceremony at the College of Life science, Hebei Normal University,awarding funding to 9 students. In this year, the Company added the fundingplaces for the "Outstanding Research and Application Star of Life ScienceInstruments" on the basis of the original education assistance project. Theaim is to support master's students who have performed excellently in thefield of life science research, stimulate their innovative spirit and practicalability, and at the same time accelerate the transformation of scientificresearch achievements, injecting new driving force into the sustainabledevelopment of the life science field.

In March 2024, as an important co-constructing unit of the "Belt andRoad" Joint Laboratory of China-ASEAN Mariculture Technology,Haier Biomedical held a signing ceremony for the donation oflaboratory equipment and the unveiling ceremony of the jointlaboratory with the University of Malaya at the site of the 2024 HongKong-Zhuhai-Macao Marine Industry Development Forum & China-ASEAN Mariculture Industry Development Forum. It jointly promotesmarine scientific and technological innovation and coordinatedindustrial development, and contributes to the conservation andsustainable utilization of global marine biological resources.

Helping Athletes Protect Their Health with "Oxygen" - Haier Biomedical's Micro-pressure OxygenChamber Debuts at the Qingdao Marathon Expo

In April 2024, the Haier·2024 Qingdao MarathonExpo was held at the Qingdao International ConventionCenter. At the expo site, Haier Biomedical provideda series of products such as micro-pressure oxygenchambers for the athletes of this Qingdao Marathon,aiming to provide scientific and safe pre-race oxygensupplementation services for the athletes and help themmeet the challenges of the race in the best physical andmental state.

8889

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Sharing Sunshinealong Belt and Road

Haier Biomedical actively engages with the "Belt and Road"initiative, delivering global green, low-carbon, and efficientlife science solutions. We have formed strong partnershipswith numerous countries' governments and internationalorganizations, consistently contributing Chinese expertise inmedical devices, cold chain logistics, laboratory construction,and more, while promoting sustainable and universal healthcareglobally. By the end of the reporting period, Haier Biomedical'sintelligent solutions had reached over 80 countries and regionsinvolved in the "Belt and Road" initiative, establishing long-termcollaborations with nearly 80 international organizations.In 2024, we actively promoted the widespread application ofinnovative green products in regions such as Africa, helping improvelocal public health conditions and the construction of scientificresearch capabilities. In Africa, Haier Biomedical has acceleratedthe promotion of the application of environmentally friendlyhydrocarbon refrigerant series products in medical and health andscientific research institutions. Among them, the energy-conservingand consumption-reducing effect of the energy-saving core seriesultra-low temperature refrigerators has reached 50%, and each unitcan reduce carbon emissions by 2 tons per year.

Promoting the Development of Localized PrecisionMedicine in Africa - Haier Biomedical Assists in theConstruction of Africa's First Pan-Continental Genebank

Africa's first transnational genebank, 54GENE, is ledby the US medical technology company 54gene. Its aimis to promote local drug R&D in Africa and improve theglobal diagnosis and treatment level through genomicsequencing, target R&D, and precision medicine clinicaltrials. This genebank mainly uses core equipment such asHaier Biomedical's ultra-low temperature refrigerators,medicine cabinets, and remote monitoring systems,providing key technical support for the safe storage andintelligent management of gene samples, highlightingthe important role of Chinese enterprises in supportingthe construction of scientific research infrastructure inAfrica.

In 2024, Haier Biomedical promoted the sharing of sunshineand the accessibility of health with actions.

JanuaryThe Ministry of Environment andSustainable Development of C?ted'Ivoire introduced Haier Biomedical'smobile environmental detectionvehicle.

AprilProvided a complete set of medicaldevices and laboratory instruments,totalling 220 categories, to theTadjoura Hospital in Djibouti, andundertook the subsequent qualityassurance and maintenance.

SeptemberProvided medical devices, laboratoryinstruments and related consumables forall departments of the Bobo-DioulassoHospital in Burkina Faso and undertookthe subsequent quality assurance andmaintenance and training of medical staff.

NovemberTrained users such as the Ministry of Healthof Senegal, public/private hospitals, scientificresearch institutions and universities onlaboratory product usage and maintenanceknowledge.OctoberTrained technicians of the ImmunizationProgram Department of the Ministry ofHealth of Madagascar and the medicalstaff at vaccination stations on the basicusage and maintenance knowledge of thevaccine cold chain

2025 Outlook

In the future, Haier Biomedical will continue to comprehensively deepen its layout in the countries and regions along the "Beltand Road" initiative, accurately grasp the local medical and health needs, and provide higher-quality and more universal medicalproducts and services for less developed areas. By actively participating in industry exhibitions and academic activities, buildingregional product technology training centers, etc., it will promote the advanced medical achievements to benefit more people,and work hand in hand with global partners to create a better future.

Solving the Problem of Vaccine Storage in Nigeria- Haier Biomedical's World's First Solar DirectDrive Cold Storage

Aiming at the public healthand safety issues in Nigeriacaused by unstable powersupply, Haier Biomedicalhas built the world's first solardirect drive cold storagefor the NPHCDA (NationalVaccine Transit Station)under the Nigerian Ministryof Health, effectively solvingthe local vaccine storagesafety hazards. This coldstorage adopts solar cleanenergy technology, gettingrid of the dependence on theunstable power grid, and providing a safe, stable and greenstorage solution for vaccines and drugs distributed acrossthe country, significantly improving Nigeria's public healthprotection capabilities.

Constructed the cold storage project of

the National Vaccine Storage Center ofthe Ministry of Health of Madagascar.The President of Madagascar attended

the ribbon-cutting ceremony and praisedHaier Biomedical's devices.

Madagascar

Countries in Africa, South Asia, Central Asia, etc.

Tanzania

Togo

Supplied solar-powered vaccinerefrigerators and photovoltaic energystorage systems for health centers to thecountries along the "Belt and Road" initiativesuch as Senegal, Mali, Malawi, Ethiopia andLiberia, and provided installation, trainingand after-sales servicesMore than 3,000 health centers benefited

Provided laboratory equipment such

as safety cabinets, low-temperaturecabinets and sterilizersHelped to enhance scientific research

capabilities and supported theconstruction of basic medical facilities

Provided more than 800 blood refrigerators

to the Ministry of Health of Tanzania,covering more than about 60% of thehospitals, blood stations, etc. in the country

Carried out comprehensive cooperationand donations with the local institutions,provided support for vaccine cold chain,medical technology training and scientificresearch capability buildingSigned a memorandum of in-depthcooperation in the field of public health.

Pakistan, Uganda, Nigeria

9091

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Haier Biomedical consistently prioritises green development as its corestrategy, continuously enhancing the internal environmental managementsystem and collaboratively building a green ecosystem with its partners. Weactively address the challenges of climate change by establishing scientificcarbon reduction goals, innovating green technologies, optimizing resourceutilization efficiency, and strictly controlling waste emissions. Simultaneously,we are dedicated to promoting biodiversity protection, assisting global partnersin collectively advancing towards sustainable development, fulfilling our greencommitment through practical actions, and contributing to Haier Biomedical'sefforts to create a better, low-carbon and environmentally friendly future.

SDG-related responses in this Section

Passed ISO 14001 environmental management system reviewOur full lifecycle energy conservation and carbon reductionactions have achieved an annual electricity usage of

9.49

million kWh

Performance Highlights in this Chapter :

accounting for of the Company'stotal electricity usage

12.98

%and were spent onenvironmental protection

2,574hours

The photovoltaic powergeneration in parks reached

1.416

million kWhwas investedRMB350,000

Ecosystem:

Protecting Our Earth

Ecosystem

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixLeadershipCreating an Intelligent Futurewith AI Empowerment2024 Sustainability ReportAbout Haier BiomedicalSustainability GovernanceChairman's StatementAbout This Report

Haier Biomedical's Green Value Chain System

Green Procurement

Environmental protection accessmechanism for suppliers

Joining the Working Group of theSustainable Initiative Health System

Green Manufacturing

Upgraded manufacturing processes,and promoting recycling and circulareconomy

Reducing energy consumption andemissions, and achieve closed-loopmanagement in the production link

Green Products

Enhancing the environmentalprotection characteristics of products

Emphasizing the sustainability andeco-friendliness of products

GreenProcurement

GreenManufacturing

GreenProducts

Support System

Structural Support System Assurance

Establishing an environmentalmanagement mechanism, obtaininginternational environmentalprotection system certification, andconstructing a response system forclimate change risks

Establishing a carbon peakingand carbon neutrality strategycommittee and building a soundenvironmental framework

Achieve carbonpeaking for Scope 1and Scope 2 by 2030Achieve carbonneutrality for Scope 1and Scope 2 by 2060

Green Collaboration

Empowering partners with greenpractices

Supporting the biodiversityconservation

Green Logistics

New energy vehicles Optimizedtransportation routes Reducedtransportation carbon emissions

Green Office

Investment in photovoltaic electricity

Deploying water-saving facilities

Enhancing employees'environmental protectionawareness and implementingenergy-saving measures

Advocate paperless office work

Green Logistics

Green Office

Compliant Operations Goal Driving Philosophical Guidance

Strictly abiding byenvironmental protection lawsand regulations to ensure thelegality and compliance ofoperational activities

Formulating and trackingenvironmental carbon peakingand carbon neutrality to ensurethe implementation of the greendevelopment strategy

Guidance by Green Designand Manufacturing GreenFull Lifecycle of Products andServices

GreenCollaboration

9495

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixLeadershipCreating an Intelligent Futurewith AI Empowerment2024 Sustainability ReportAbout Haier BiomedicalSustainability GovernanceChairman's StatementAbout This Report

EnvironmentalManagement andGreen Collaboration

Green Development PlanningHaier Biomedical continues improving environmentalgovernance and promoting green and low-carbondevelopment. The Company has established anenvironmental management framework composed ofthe Board of Directors, the environmental protectionleading team, and various functional departments toensure the effective implementation of environmentalprotection strategies. It also optimizes the managementsystem around key links such as energy management,resource use, and pollution prevention and control toimprove environmental performance.

To ensure the effective implementation of the company'senvironmental protection work, Haier Biomedical hasalso established a clear environmental compliancemanagement framework to ensure that functionaldepartments at all levels can coordinate and cooperateto jointly promote environmental protection and wastepollution prevention and control work.

Haier Biomedical has always adhered to the conceptof harmonious coexistence between humans andnature and is committed to continuous exploration andinnovation in sustainable development. We continueto improve the green development plan, optimize thegreen compliance system, and actively advocate andpractice green product design.

Formulate the Company's environmentalmanagement strategic direction and targets

Review the implementation of the annualaction plan and environmental managementsystem

Board of Directors

Oversee and coordinate the planning,promotion and implementation of theannual work plan

Improve and optimize the overallenvironmental management policiesto ensure the efficient implementationof various environmental managementmeasures

Environmental Protection Leading Team

Promote and implement environmentalmanagement work

Implement various environmentalmanagement measures

Functional and Business Departments

Environmental Compliance Management Framework

Haier Biomedical sets clear environmental governance objectives to ensure the company's continuous progress on thepath of green development.Environmental Target Goal ProgressCompliant Operations

100% compliance with laws andregulations and relevant requirements

Achieved0 potential chemical leakage incidents AchievedEnergy and Resource-saving

Enhanced energy efficiency

Our full lifecycle energy conservation and carbon

reduction actions have achieved an annual electricity

usage of 9.49 million kWhContinuously increased proportion ofclean energy use

In this year, the proportion of clean energy use is 12.98%,

an increase of 1% compared with the previous yearEmissions Reduction

100% compliance in waste disposal Achieved100% compliance in exhaust emissionsat factory boundaries

Achieved100% compliance in noise emissions atfactory boundaries

AchievedDuring the reporting period, we actively carried out environmental protection governance work, investing a total of2,574 hours and RMB 350,000. We have always adhered to compliant operations and have not received administrativepenalties from the environmental protection department.

Factory LeaderEquipmentDepartment

Cost Office Department of EnergySafety andEnvironmentalProtection Department

EnvironmentalProtectionAdministrator

EquipmentSafety Officer

Cost Manager

Solid WasteAdministrator

Responsibilities of the Environmental Compliance Management Framework

Being responsible for theoverall leadership of wastepollution prevention andcontrol work in their respectivedepartments, ensuring thatenvironmental protection andproduction are carried outsimultaneously, organizingemployees to study andimplement environmentalprotection regulations, andstrictly implementing theCompany's relevant rules andregulations

Being fully responsible for theCompany's environmentalprotection and waste pollutionprevention and control work,establishing and allocatingenvironmental protectionfunctional institutions, andguiding and supervising thework of relevant departments

Presiding over the daily

operation of the environmental

protection functional

institution, organizing

employees to study and

implement national and local

environmental protection

laws and regulations, and

enhancing environmental

awareness

Studying and masteringnational and local wastepollution prevention andcontrol laws and regulations,implementing relevantregulations and companysystems, understanding thesituation of resource utilizationand pollution emissions, andputting forward improvementsuggestions to the superiorleaders and relevantdepartments

Business leaderHead of the Department of

Safety and EnvironmentalProtection

Environmental protectionadministrator

Persons responsible forenvironmental protection inother departments

9697

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Green Compliance FrameworkWe strictly abide by relevant laws, regulations, and industrystandards, such as theEnvironmental Protection Law ofthe People's Republic of Chinaand theWork Safety Law ofthe People's Republic of China, and we have established acomprehensive environmental protection compliance system.During the reporting period, we continuously optimizedthe environmental management system, formulated andimplemented theEnvironmental Operation Management andControl Procedure of Qingdao Haier Biomedical Co., Ltd.,and focused on strengthening the effective management andcontrol of environmental factors such as wastewater, exhaustgas, solid waste and noise, ensuring that they meet thedischarge standards or achieve resource-based treatment,minimizing environmental pollution and improving resourceutilization efficiency. In 2024, we passed the ISO 14001environmental management system review.

ISO 14001 Environmental Management System CertificationSewage Discharge Management and Monitoring Mechanism

Risk Management

Centering around relevant national departments' ecological and environmental standards, we further improved thesewage discharge management system, strengthened the informatized supervision and management of sewagedischarge, and ensured the standardized and orderly management of pollutant discharge outlets.To ensure the effective operation of the environmental management system, we formulated theEnvironmentalMonitoring and Measurement Control Procedure, clarifying the division of responsibilities and working principles of eachdepartment in environmental monitoring.This system stipulates standardized emission detection methods such as solidwaste, noise, exhaust gas and wastewater, assisting the Company in conducting daily monitoring and measurementaccording to the latest emission standards. At the same time, we regularly conduct compliance evaluations of laws andregulations to ensure that the monitoring standards align with national and local requirements and continuously improvethe environmental management level.In 2024, based on comprehensively carrying out risk management assessments,Haier Biomedical formulated and implemented theEmergency Response Planfor Sudden Environmental Incidents. Through systematic risk assessments, theCompany identified potential environmental and safety risks. It took targetedmeasures to strengthen accident prevention, emergency training and rescue drills,ensuring the effective implementation of emergency preparedness and handlingwork for production safety accidents.During the reporting period, the Company completed 87 special rectifications,29 emergency drills, and 1,165 potential hazard inspections, signed 2,460 safetyresponsibility letters, and there were no major environmental incidents throughoutthe year.

Emergency Organization Structure Chart

Emergency RescueCommand Leading TeamEmergency Response OfficeCommunicationContact Group

Alert andEvacuation Group

EmergencyRescue Group

Medical Aid

Group

Material Support

Group

AccidentInvestigation Group

During the reporting period

the Company completedspecial rectifications

Green Product Concept

Adhering to the green and low-carbon strategy, Haier Biomedical has always been committed to green technologyinnovation, has implemented the promotion of green achievements, and has guided the green and standardizeddevelopment of the industry. We always take green development as the strategic direction of the Company. At the beginningof product design, we adopt energy-conserving and low-carbon design solutions, pay attention to process innovation andthe application of low-carbon technologies, and carry out a green design working mechanism around the product lifecyclelinks of "R&D and design - raw material selection - production and manufacturing - logistics and transportation - recyclingand circulation".By establishing the concept of green management throughout the product full lifecycle, we continuously enhance thecompetitiveness and influence of our products in the international market, advocate and take the lead in formulating productenergy conservation standards and technical specifications, and provide Chinese solutions for global green development.

Haier Biomedical practices the concept of green products and empowers the industry through innovative technologiesand solutions to promote industrial partners' green and low-carbon transformation.

Haier Biomedical's Green Product Energy Conservation Series

Yuanxi Constant Temperature andHumidity Chamber

Ultra-Eco Ultra-low TemperatureStorage Cabinet

Wuji New Generation Ultra-lowTemperature Storage Cabinet

Hengyun Temperature and HumidityDual-control Medical RefrigeratorReducedUp to Power80%

Reduced DailyElectricityUsage by50%

RefrigerationEfficiencyCOP>0.4

Daily EnergyConsumption of

3.2 kW-h

Reduced AnnualElectricity Usage by4,400 kWh

Reduced AnnualElectricityUsage by2,843 kWh

Reduced AnnualElectricity Usage by1,309 kWh

Reduced AnnualElectricity Usage by2,500 kWhEquivalent toPlanting Trees

Equivalentto PlantingTrees

Equivalent toPlanting Trees

Equivalent toPlanting Trees

Green Technology BreakthroughsInfinite ultra-green refrigerationcontrol technology

Efficient and reliable large-cooling-capacity refrigeration control of the Stirling refrigerator is achieved, saving50% energy and improving reliability by 100% compared with compressor refrigeration

Hydrocarbon ultra-low-temperature dual-unitrefrigeration technology

Compared with similar international advanced brands, the energy consumption is 26% lower; ultra-low power isobtained, with optimization from industrial 380V power supply to 220V household power supply; the noise is as lowas 45 dB, leading the world among similar products

Dual-stage cooperativevariable-frequency controlalgorithm technology

The energy-conserving effect increases by 10%

Design and productiontechnology of high-uniformitymedical refrigerator

1. A temperature uniformity of ≦±1℃ is achieved, and the electricity usage is reduced by 60%, with internationally

leading temperature uniformity indicators and energy efficiency indicators

2. The first high-performance medical refrigeration evaluation in China is obtained

Active temperature controltechnology for civil aviation

Compared with similar products in the industry, the battery life is extended by about 50%, and the powerconsumption is reduced by 20%

Solar direct drive refrigerationtechnology

With solar direct drive cold storage, the utilization efficiency of energy storage phase change materials reachesover 95%

Green Product Actions

Energy conservation and consumption reduction: Through technological innovation, significantly reducing the energy

consumption of products and improving the operation efficiency of products

Application of environmentally friendly materials: Fully launching the replacement plan of non-environmental-protection

refrigerants and promoting the use of environmental protection refrigerants

Full lifecycle planning: Optimizing product design, reducing processes harmful to the environment, and achieving efficient

utilization of resources

Green packaging: Reducing the use of foam and plastics, and promoting the use of recyclable packaging materials

9899

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

As a world-leading provider of full-scenario solutions for public health, biosafety and low-temperature cold chain, HaierBiomedical has reached a strategic cooperation with SPD Scientific to jointly support NUS's green carbon reductionplan. By replacing high-energy-consuming laboratory equipment with high-efficiency and energy-conserving innovativeequipment, Haier Biomedical helps users significantly reduce the energy consumption of the laboratory and assiststhem in achieving sustainable development goals. This cooperation reflects Haier Biomedical's leading edge in greentechnology innovation, and also demonstrates our firm commitment to collaborating with ecological partners to protectthe natural environment and address climate change.

Haier Biomedical joins hands with SPD Scientific to assist the green transformationof the laboratory of the National University of Singapore (NUS)

Haier Biomedical's mobile laboratory helps C?te D'ivoire alleviate industrial pollution problemsOn March 20, 2024, Haier Biomedical's world's first mobileenvironmental detection laboratory integrating water, air and soildetection was officially delivered in the Republic of C?te d'Ivoire.This mobile laboratory is equipped with advanced detectionequipment and technologies, which can monitor pollutantsin the environment in real time and accurately, providing ascientific basis for local governments and enterprises andhelping solve the problem of toxic industrial waste pollutionthat has plagued the local area for many years. JacquesAssahoré Konan, Minister of Environmental Sustainabilityand Ecosystem Transformation of C?te d'Ivoire, attended theunveiling ceremony and highly recognized the solution of HaierBiomedical's mobile environmental detection laboratory.

Improving the Utilization Efficiencyof Photovoltaic Power Generation

ResourceOptimizationand CircularDevelopment

Haier Biomedical focuses on the efficient utilizationof resources and energy, continuously deepens thegreen operation mechanism, and actively practices theconcept of recycling and circular economy. We improveenergy efficiency by optimizing the energy consumptionstructure. At the same time, we promote recyclable anddegradable packaging materials to reduce resource wasteand introduce water-saving technologies and recyclingsystems to improve water resource efficiency. In addition,we practice the green office concept and promote thegreen development transformation, contributing toachieving the carbon peaking and carbon neutrality goalsand the recycling and circular economy. This helps theconstruction of ecological civilization reach new heights.

Energy ConsumptionManagement

Haier Biomedical strictly adheres to theEnergy ManagementPolicyand continues to promote the application of greenenergy and the optimization of energy efficiency. TheCompany mainly uses electricity, natural gas, and heating asits energy sources. We actively promote energy-conservingrenovation projects to reduce energy waste and continuouslybuild photovoltaic power generation projects in the park toincrease the proportion of clean energy use. In 2024, thephotovoltaic power generation of Haier Biomedical IndustrialPark reached 1.416 million kWh, accounting for 12.98% of thecompany's total electricity usage, significantly reducing thedependence on traditional energy sources.

The monthly power generation of the second-phase photovoltaic power generation project ofHaier Biomedical is nearly 400,000 kWh. To ensurethe effective utilization of the self-generatedphotovoltaic power, the Company has introducedthe second-phase photovoltaic power generation foruse in the first-phase office building and dormitorybuilding by adding new power transmission facilities.This measure can additionally consume 200,000kWh of electricity per month, significantly improvingthe utilization efficiency of photovoltaic power andalso strongly promoting the clean transformation ofthe energy use structure in the park.

2024

2024

1.416

million kWh

The photovoltaic power generation of HaierBiomedical Industrial Park

A total of

energy conservation and environmental protection certificates

Including

models

Approximate

400,000

kWhMonthly power generation of the second-phasephotovoltaic power generation project of HaierBiomedical

200,000

kWhAdditional electricity consumption permonth by this measure

12.98

%

The proportion of the Company's totalelectricity usage

models certified and registered for U.S. Energy Star program in 2024

A total of

certification and registration models

100101

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

In 2024, the energy consumption data of Haier Biomedical is as follows.Haier Biomedical's Energy Consumption and Greenhouse Gas Emissions for 2024

Indicator Value UnitTotal energy consumption 10,908.69 MWhTotal consumption of non-renewable energy 9,492.39 MWhTotal consumption of renewable energy 1,416.30 MWhProportion of renewable energy consumption 12.98%

Optimized Management of the Heating System

We implemented improved management and optimized renovations to the park's heating system. By monitoring theenvironmental temperature in real-time and dynamically adjusting the heating flow, we achieved intelligent heating control.This allowed us to optimize the heating plan based on the actual warming weather conditions, thereby reducing resourcewaste. As a result, under the refined management approach in 2024, we saved 662 GJ of heating consumption compared tothe previous year, actively contributing to local initiatives for energy conservation and reduction of consumption.

Energy Conservation and Emissions Reduction ProjectsEnergy-Conserving Renovation of the Air CompressorThe fixed-frequency air compressor that has been used in HaierBiomedical's factory for many years, due to its aging equipment, frequentlyreleases pressure during operation, resulting in serious energy waste,with an average monthly electricity usage of up to 95,000 kWh. In responseto the call for energy conservation and emissions reduction and forimprovement of operating costs, we carried out a comprehensive upgradeand renovation of the factory's air compressor system, adopting advancedvariable-frequency air compressor technology. After the renovation, thesystem operation efficiency has been significantly improved, with the dailyaverage electricity usage reduced by 700 kWh, and the annual electricitysavings are expected to reach 255,500 kWh.

Haier Biomedical participates in the release of theInitiative for Green Energy Transformation of the

Pharmaceutical and Medical Industrial Chainto boost the green upgrade of the industryOn May 10, 2024, the "Sustainable Markets Initiative" China Council successfully held a plenary meeting of the Health WorkingGroup and the release event of theInitiative for Green Energy Transformation of the Pharmaceutical and Medical IndustrialChain, advocating relevant enterprises to actively carry out actions such as the promotion of green technologies and theapplication of distributed energy sources, and accelerating the green upgrade of the entire industry chain.As one of the first member enterprises to join the Health Working Group of the "Sustainable Markets Initiative" China Council,Haier Biomedical participated in the release of theInitiative for Green Energy Transformation of the Pharmaceutical andMedical Industrial Chainon site, and discussed topics such as the green supply chain and green medical services with othermember organizations at the meeting, contributing to the promotion of the construction of a sustainable medical servicesystem and helping the green and high-quality development of the pharmaceutical and medical industry chain.

Energy-conserving Renovation of theAir Compressor

The statistical scope of the total electricity usage in the energy consumption data is the put-into-production factories and oce buildings ofHaier Biomedical's Qingdao headquarters.

Water-Saving Initiatives

Upgrading of the Domestic Water Tank in the Office Building

The float valve previously used in the domestic water tank of Haier Biomedical's office building was easilycorroded, resulting in the problem of water overflow in the tank and causing a large amount of water resourcewaste. To this end, we renovated the system, using an electric butterfly valve for control and adding a liquidlevel alarm system. After the renovation, we can save 2,000 m

of water per year, which not only protects waterresources but also saves the Company's water expenses.

Usage of Production ResourcesHaier Biomedical has always regarded managing water resources and packaging materials as essential for sustainabledevelopment. Optimizing resource utilization, promoting environmentally friendly materials, and applying innovativetechnologies, improves the efficiency of resource use. We actively practice the concept of circular economy. Byefficiently utilization and recycling resources, we reduce resource consumption and waste generation, helping achieveclosed-loop management of these resources. We are committed to creating a green and low-carbon production andoperation model.

We have implemented theWater Resource ManagementSystemto standardize production and domestic watersupply management and promote the recycling of waterresources. We have set clear water-saving goals, planningto reduce the total water consumption by 1.5% by 2025compared to 2024 to promote water conservation further.During the reporting period, the total water consumptionof Haier Biomedical was 81,736 m

, and the waterconsumption intensity was 0.36 m

/ RMB 10,000.

Water ManagementDuring the reporting period

81,736 m

Total waterconsumption of HaierBiomedical

1.5

%Planned reduction of totalwater consumption by2025 compared to 2024

0.36

m

/ RMB 10,000

the water consumption intensityOptimizationof productiontechnologyReuse of reclaimedwaterCommissioningof pure waterequipmentRenovation ofdomestic watervalvesInternalpublicity

Improving the production process to reduce water consumption.

Collecting rainwater and recycle water from production processes for reuse ofreclaimed water

Reducing the consumption of dirt and cleaning water

Using automatic butterfly valves to reduce the failure rate and water resource waste

Posting water-saving signs to encourage employees to save water and turn off taps

102103

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Management of Packaging Materials

We continue to focus on upgrading green packaging, optimizing and substituting packaging design and materialselection to reduce resource consumption and minimize environmental impact. During the reporting period, HaierBiomedical only used packaging made from biodegradable or recyclable materials. None contained harmful substancessuch as Polyvinyl Chloride (PVC), Polystyrene (PS), or mercury. We actively promote recyclable and degradablematerials, promote the recycling of packaging materials, reduce resource waste, and practice the recycling and circulareconomy concept.

Optimization and Substitution of Packaging Materials

Adhesive Tape and Screw Integration Project

To improve the efficiency of on-site material management and reduce resource waste, Haier Biomedicallaunched the adhesive tape and screw integration project. We sorted out and integrated the types ofadhesive tapes and screws used in 82 series of products, reducing duplicate and redundant materials.According to the integration results, we formulated the usage standards for adhesive tapes and screwsto ensure the standardization and uniformity of material management. Through the implementation of thisproject, we have greatly simplified the types of on-site materials and improved the standardization of materialuse, effectively reducing resource waste and promoting the recycling of resources.Optimization results:

Reduction in the types of adhesive tapes: from 31 to 21. The number of adhesive tape types for a single shift iscontrolled within 5, and the number of adhesive tape types for a single production line is controlled within 15Reduction in the types of fasteners: by 61 types, covering 7 major categories such as machine screws, self-tapping screws, nuts, and washers

Optimization ofcushioning materialsOptimization ofthe wooden palletstructureOptimization ofcarton designSubstitution ofplastic bagsSubstitution ofwooden cases

EPS/EPE plastic foam cushioning materials are replaced with bubble pads in 30models, reducing the use of EPS foam by 0.5 tonsBy optimizing the wooden pallet structure, the use of wood materials in 10 models isreduced, and the wood usage is reduced by 90 m

The heavy-duty cartons of 35 models are replaced with ordinary BC corrugatedcartons, reducing the paper usage by about 2 tonsPlastic bags are used to replace stretch film, reducing the use of PE stretch film by30,000 m

Wooden cases are replaced with carton packaging, reducing the use of wood and thepackaging volume, and lowering the occupied storage and transportation space by 2%

Management of Office ResourcesWe always uphold the concept of green office operations, integrate environmental awareness into every aspect of ourdaily work, and actively promote green practices. We are also committed to creating a sustainable office environment.We actively practice environmentally friendly paper use, efficient office work, energy-saving power consumption, greendining, green travel, and waste recycling to reduce resource consumption and minimize environmental impact withpractical actions.Environmentally Friendly Paper Use and Efficient Office Work

Promoting double-sided paper use, reducing paper consumption, and lowering the printing frequency

Actively promoting paperless office work and paperless financial reimbursement to reduce paper waste andimprove work efficiency

Implementing paperless communication and electronic contracts to simplify office processes while achievingenvironmental protection goals

Energy Conservation and Green Power Consumption Green Dining and Resource Conservation

Require the scientific use of air conditioners andconsciously turn the air conditioner off whenleaving the office

Switching off any unnecessary lights and makethe most of natural light

Upgrading lighting system and promoting theenergy-efficient lightbulbs

Encourage ordering meals on demand toreduce waste, and actively respond to theClean Plate campaign

Improving employees' environmentalawareness, advocating rational dining, andreducing food waste

Green Transportation and Low-carbon Travel Waste Classification and Recycling

Choose eco-friendly modes of transport

Install new energy charging piles within thepark, support and encourage employees touse new energy vehicles for commuting, andpromote low-carbon travel

Implementing the classification and recyclingof office waste to reduce environmentalpollution and promote resource reuse

104105

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Timing renovation of the water chiller air conditioners in the office building

The water chiller air conditioners inthe office building have the problemthat manual control of their openingand closing is prone to delays orforgetfulness, resulting in energywaste. To this end, we installedtimers and relays to automaticallycontrol the operation of the airconditioners according to theworking hours of employees.After the renovation, this projectsignificantly reduced energy waste,and it is expected to save 11,400kWh of electricity per month.

Before Timing Renovation of the WaterChiller Air Conditioners in the OfficeBuilding

After Timing Renovation of the WaterChiller Air Conditioners in the OfficeBuilding

CompliantEmissions and aClean Future

Haier Biomedical regards waste management asan important part of the Company's sustainabledevelopment. It strictly abides by relevant national lawsand regulations, formulates and implements internalwaste management policies to ensure the compliantdischarge and scientific disposal of waste, exhaustgas, and wastewater. At the same time, we attach greatimportance to noise management and are committed toreducing noise emissions to create a good productionenvironment.

Waste ManagementHaier Biomedical strictly complies with laws andregulations such as theEnvironmental ProtectionLaw of the People's Republic of China, theLaw of thePeople's Republic of China on the Prevention and Controlof Environmental Pollution by Solid Wastes, and theMeasures for the Prevention and Control of EnvironmentalPollution by Waste Hazardous Chemicalsto ensurethe compliance of waste management. To implementthe relevant legal requirements, Haier Biomedical hasimplemented theWaste Management Control Procedure,which aims to standardize the definition, classification,storage, and treatment processes of waste and clarifythe responsibilities of each department, controlling thewaste treatment process, and preventing and reducingenvironmental pollution.

During the reporting period, the Company generateda total of 480 tons of general waste and 3.65 tons ofhazardous waste, all of which were disposed of incompliance with regulations. General waste primarilyconsisted of wastepaper, scrap iron, and waste wood,encompassing 29 categories. Hazardous wasteincluded 10 categories, such as waste circuit boards,spent activated carbon, and liquid foaming materials.The Company implements strict classification andtreatment of waste. For waste that cannot be disposedof internally, we entrust a third-party institution withprofessional qualifications to dispose of it in accordancewith the law.

Haier Biomedical's Exhaust Gas and Wastewater Test Report

106107

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

In 2024, we updated the facilities of the hazardous wastestorage, including liquid collection devices and gasextraction devices, to further improve the safety andefficiency of scrap storage and treatment.Haier Biomedical also actively responds to the nationalcall for the construction of a "waste-free city" andpromotes the waste-free factory project. The Companyhas passed the application for the establishment of theQingdao-level "waste-free cell" system and the "waste-free factory" certification.

"Waste-Free Factory" Certification

Management Processes and Division of Responsibilities for Various Types of WasteGeneral wastes:

Production Department - Responsible for the classification, collection, and sealed packaging of waste, andcentrally deliver it to the scrap storage for classified storage

Scrap Storage Administrator - Taking the lead in the collection, storage, and treatment of general waste, andensuring complete record-keeping in the account book

Recycling Vendor - Responsible for confirming the weighing data together with the waste administrator andthe weighing personnel, and cleaning up the site on a regular basis

Hazardous waste management:

Equipment-related Departments - Responsible for disposing of scrap equipment resources, and classifyingand storing hazardous waste such as used oil and oil drums in the hazardous waste storage, with strictlyprohibited mixture with general waste for treatment

Energy Project Administrator - Responsible for sourcing hazardous waste treatment manufacturers, signingcontracts, and docking with environmental protection regulatory departments

Safety and Environmental Protection-related Departments - Responsible for the safety inspection andmaintenance management of the hazardous waste storage and scrap storageDisposal of returned and exchanged market products:

After-sales Repair Department - Responsible for receiving market machines for return and replacement andprototype machines for development testing. Waste materials such as casings, doors, glass, and metal fromdisassembled units must be managed through recycling vendors to ensure that waste is segregated andcontrolled and avoid mixing them together

Exhaust Gas Management

Haier Biomedical manages exhaust gases in strict accordance with theEnvironmental Operation Management andControl Procedureto ensure that exhaust emissions meet environmental protection requirements and reduce theenvironmental impact. The Company effectively controls exhaust emissions through a variety of technical means andmanagement measures to ensure the air quality of the production environment.The exhaust gas generated during the Company's production process mainly comes from welding, foaming, and adsorptionprocedures, including welding fumes, foaming exhaust gas, and Volatile Organic Compounds (VOCs) generated during theadsorption process. To reduce the generation of exhaust gas and ensure compliance with emission standards, we havetaken a series of effective control measures, such as carrying out process improvements, using clean raw and auxiliarymaterials and clean energy, and regularly maintaining exhaust gas treatment equipment. To protect the health of productionpersonnel, we also provide employees with labor protection measures such as respiratory filtration devices.

Exhaust Emission Control MeasuresOrganized emission of industrial exhaust gas

Photo-oxygen catalytic equipment and baghouse filters: Using photo-oxygen catalytic equipment andbaghouse filters for real-time treatment to ensure compliance with emission standards

Welding exhaust gas control: Installing collection hoods and exhaust duct above the welding stations,maintaining sufficient exhaust air volume, reducing the diffusion of welding exhaust gas in the workshop,and discharging it after treatment by the dust collector

Foaming and adsorption exhaust gas control: Sealing and isolating the foaming and adsorption procedures,and installing additional exhaust devices, with the exhaust gas discharged after treatment by the photo-oxygen catalytic equipment

Flammable gas monitoring: Installing flammable gas detection and alarm devices in procedures withflammable gases such as foaming and welding to prevent environmental and safety accidents

Equipment maintenance: Inspecting and maintaining the exhaust fan equipment during the daily equipmentspot checks and maintenance of each procedure to ensure the normal operation of the equipment;replacing the welding exhaust gas pipes, foaming tail gas pipes, dust filter bags, and activated carbon everysix monthsUnorganized emission of industrial exhaust gas

On the premise of meeting the process environment requirements, it is necessary to maintain goodventilation in workshops, reasonably control the opening and closing of the roof exhaust fans and factorywindows, and reduce the diffusion of unorganized exhaust gasKitchen fume and exhaust gas control

The kitchen fume and exhaust gas is treated by a fume purification device and discharged after meeting therequirements

The kitchen fume exhaust system is cleaned and maintained quarterly

108109

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Wastewater Management

Haier Biomedical strictly complies with internal systems such as theEnvironmental Operation Management and ControlProcedureto ensure that wastewater emissions meet national environmental protection standards. The Company'swastewater mainly comes from the domestic sewage of the canteen, office areas, and dormitories, all of which aredischarged in compliance with regulations through the municipal sewage network.

Wastewater Pollution Control

Domestic wastewater management: The domestic wastewater in the factory area is discharged through the

municipal pipeline network. The oily wastewater from the canteen is pre-treated in the oil separation tank andthen uniformly discharged to avoid the impact of oil pollution on the environment; at the same time, we entrusta qualified third-party institution to regularly clean the canteen's wastewater treatment device.New construction and expansion projects: The Company strictly implements national environmentalprotection laws and regulations in new project construction to ensure that the wastewater treatment facilitiesare designed, constructed, and put into use simultaneously with the main project.Treatment of equipment waste oil: The waste oil and oil-containing waste (such as oil gloves and oil-impregnated cotton yarn) generated during the equipment repair process should be sealed and packaged,stored uniformly in the scrap storage, and handed over to a professional institution in a timely manner fortreatment to prevent environmental pollution caused by leakage and volatilization.

Noise Management

Haier Biomedical has adopted strategies to manage the noise and mitigate its impact on our employees and surroundingcommunities, ensuring compliance with national emission standards. We effectively reduce noise pollution during theproduction process by optimizing equipment selection, improving processes, and strengthening daily management. Atthe same time, the Company entrusts a third-party institution to monitor noise levels within our workshops and along theplant boundaries every year to ensure compliance with the limit requirements. When the noise level is found to exceedthe standard, the Company promptly analyzes the reasons and takes corrective measures to protect the health ofemployees and environmental safety.

Noise Control MeasuresEquipment selection and procurement: Giving priority to selecting low-noise equipment, and isolating high-noise equipment or installing mufflers to reduce noise propagation

Daily maintenance: Regularly lubricating and maintaining the equipment to ensure stable operation andreduce noiseReasonable layout and production scheduling: Optimizing the equipment layout, avoiding concentratedarrangement of high-noise equipment, and reasonably arranging the operation time of high-noise equipmentto reduce the impact on the surrounding environmentEmployee protection: Providing professional labor protection supplies for employees working in workstationswith high noise levels to ensure their occupational health

110111

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Green Layout andClimate Transformation

Climate change has become one of the majorchallenges faced globally. Frequent extreme weatherand continuously rising temperatures have profoundlyimpacted human society, the economy, and theecological environment. As a responsible enterprise,Haier Biomedical deeply understands the importanceof green development and is committed to balancingbusiness growth and environmental protection. Weincorporate climate change risks into the Company'srisk management framework and actively practicethe concept of green and low carbon, promoting theenterprise towards net-zero carbon emissions.

Haier Biomedical has established a governancestructure consisting of the Group's Carbon Peakingand Carbon Neutrality Committee - the Carbon Peakingand Carbon Neutrality Professional Committee -functional departments. This structure is led by seniormanagement personnel, and its members are composedof outstanding talents from various departmentssuch as design, R&D, manufacturing, marketing, andprocurement. It aims to give full play to the professionalknowledge and experience in various fields to ensurethat the formulated low-carbon goals and plans alignwith the Company's actual business needs.

Governance System of the Carbon Peaking and Carbon Neutrality Professional Committee

Group's Carbon Peaking and CarbonNeutrality CommitteeCarbon Peaking and Carbon NeutralityProfessional Committee

In terms of formulating climate change strategies, Haier Biomedical has initially establisheda complete risk identification and assessment system, incorporating climate change-related physical risks (such as extreme weather conditions like typhoons, floods, and hightemperatures) and transition risks (such as changes in policies and regulations) into theCompany's overall risk assessment model.

ProductDesignDepartment

Manufacturing

Department

New BusinessDepartment

BrandDepartmentEnergyManagementDepartment

StrategyDepartmentGovernmentAffairsDepartment

ProcurementDepartment

InternationalMarketingDepartment

Among them, regarding physical risks, Haier Biomedical has developed comprehensive emergency response plans forextreme weather conditions, covering various emergencies such as natural disasters, accidents, and incidents. Theseinclude special plans for snow and cold prevention, flood and wind prevention, earthquake prevention and disaster reductionto ensure a rapid response and effective handling of emergencies. In addition, we enhance employees' emergency responsecapabilities through specialized training, ensuring a prompt response when disasters occur and minimizing losses to thegreatest extent possible.At the same time, we actively promote the application of green energy and the optimization of energy efficiency. Throughmeasures such as photovoltaic power generation and energy-conserving renovations, we reduce our dependence ontraditional energy sources and lower greenhouse gas emissions, supporting the low-carbon transition with practical actions.

Indicator Value UnitScope I greenhouse gas emissions 458.12tonnes of CO

e

Scope II greenhouse gas emissions 6,850.95tonnes of CO

eTotal greenhouse gas emissions 7,309.07tonnes of CO

eTotal greenhouse gas emission intensity 32.00kg of CO

e/RMB 10,000

Greenhouse Gas Emission Situation of Haier Biomedical in 2024

In order to effectively deal with the risk of heat stroke and improve employees' emergency response capabilities,Haier Biomedical organized employees to conduct the specialized heat stroke emergency response training inMay 2024. This training focused on the common symptoms of heat stroke, emergency treatment methods, andthe correct use of related medications.By combining theoretical explanations with practical operations, our employees systematically learnedthe identification methods, first aid steps, and preventive measures for heat stroke. The training enhancedemployees' self-protection awareness when working in high-temperature environments, helped them masterscientific methods for preventing heat and cooling down, and improved their emergency response capabilities.

Specialized heat stroke emergency response training

The statistical scope of greenhouse gas emissions is the put-into-production factories and oce buildings of Haier Biomedical's Qingdao headquarters.112113

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

Leadership

Creating an Intelligent Future

with AI Empowerment

Biodiversity andEcological Prosperity

Biodiversity is integral to the Earth's life system and thefoundation for human survival and development. HaierBiomedical takes ecological protection as the core contentof its sustainable development strategy and promises topractice the concept of biodiversity protection in its businessoperations. All of the Company's operation sites strictly complywith the national ecological protection red line policy to ensurethat the selected locations are outside the ecological protectionred line, minimizing the impact on sensitive ecosystems andbiological habitats.

We are committed to reducing the impact on and dependence onecosystems, biological species and their habitats, and biologicalgenetic resources throughout the whole product lifecycle. Throughgreen design, selecting environmentally friendly materials, andtechnological innovation, we reduce resource consumption,waste generation, and pollutant emissions and earnestly protectbiodiversity. In addition, we actively participate in biodiversityprotection initiatives and projects, promote ecological restorationand habitat protection work, and enhance the ecological protectionawareness of employees and the public through environmentaleducation activities, jointly safeguarding the community of life onearth.With its leading technical strength and innovative solutions, HaierBiomedical has continuously made breakthroughs in the fields ofbiological sample management and biodiversity protection. Bydeeply integrating the Internet of Things (IoT), big data, and artificialintelligence technologies, we provide solid technical support forthe scientific protection and efficient utilization of global biologicalresources.Empowering the DigitalIntelligence of BiologicalSample ManagementBy deeply integrating IoT, big data, and artificial intelligencetechnologies, Haier Biomedical directly applies the technologicalbreakthroughs in the digital transformation of smart laboratories andbiobanks to scientific research scenarios, comprehensively improvingthe intelligence, automation, and informatization levels of biologicalsample management. Relying on high-end equipment and smart IoTsolutions, Haier Biomedical is engaging in biodiversity protection workwith its expertise. It is committed to providing strong technical supportfor the long-term preservation, scientific protection, and efficientutilization of global biological resources.

The one-stop digital intelligence panoramic solution for thegermplasm resource bank of livestock and poultry tailoredby Haier Biomedical for the Gene bank of Livestock andPoultry Genetic Resources in Henan Province has beenofficially implemented. This solution covers the wholeprocess of receiving, processing, controlling the quality ofand storing livestock and poultry germplasm resources,innovatively providing a full-scenario and digital intelligencesolution, significantly improving the safety, convenience,and intelligence levels of sample management. Throughprecise temperature control technology and an intelligentmanagement system, the solution effectively ensuresthe long-term and stable storage of livestock and poultrygermplasm resources, laying a solid foundation for thescientific protection and efficient utilization of livestock andpoultry genetic resources in Henan Province, and furtherpromoting the safe storage and sustainable developmentof livestock and poultry germplasm resources.

Helping the Gene bank of livestock andpoultry genetic resources in Henan Provinceachieve upgrades in digital intelligence

Promoting Cross-Scenario Innovation in the IndustryHaier Biomedical's biobank solutions continue to improve biological safety and data quality standards in the contextof different application scenarios and scientific research needs, helping to enhance the country's biological safetygovernance capabilities. With advanced solutions and cutting-edge technological breakthroughs, we continuouslybuild our influence in the industry, appearing at domestic and international academic seminars and technicalexchange conferences and providing Haier Biomedical's solutions for the industrial ecosystem.

Haier Biomedical helps the Anhui Academy of Agricultural Sciences build a new paradigm for germplasmresource protectionIn 2024, Haier Biomedical deeply cooperated with the Anhui Academy of Agricultural Sciences to jointly build a domesticallyleading intelligent germplasm resource central database biobank, safeguarding agricultural biodiversity with innovativetechnologies. This central bank deeply applies automated access technology, providing digital support for the protection of cropgermplasm resources and the rescue and preservation of endangered species in Anhui Province. The project not only helpslocal agricultural scientific research institutions achieve the goals of "comprehensive storage, accurate management, and goodutilization" of germplasm resources, but also strengthens the protection barrier of biodiversity with scientific and technologicalstrength, contributing a Chinese solution to global food security and ecological sustainable development.

Showcasing smart biobank solutions todemonstrate the innovative strength of Chinesebrands in the field of biobanks

Annual Meeting of the International Societyfor Biological and Environmental Repositories(ISBER)

Launching the intelligent germplasm resourcebank construction solution, providing a full-process solution for the protection and utilization ofagricultural germplasm resources, and helping thehigh-quality development of modern agriculture

National Academic Symposium on AgriculturalBiochemistry and Molecular Biology

Launching the Ark series of full-scenariosolutions for biobanks based on the EPS model,promoting the biobanks to move towardsdigitalization, intelligence, and customization, andaccelerating the transformation of the industryfrom sample management to data productization

The 16thChina Conference onIntegrative Biobanking

Releasing the digital and intelligentscenario solution for biological safety,helping to enhance the country'sbiological safety governance capabilities

2024 National Biological SafetyAcademic Conference

Releasing the full-scenario solutionsfor smart laboratories and biobanks,injecting new momentum into thehigh-quality development of medicalscientific research in ShandongProvince

Shandong Research Laboratoryand Biobank Alliance Conference

Sharing the construction solution of theintelligent scientific research biobanks,promoting the standardization process ofbiological resources and data quality and safety

Academic Exchange Meeting of theBiological Resources and FacilitiesCommittee, the China Associationfor Standardization

Showcasing the full-scenario solution of theintelligent biobanks, providing new ideas for theintelligent and safe management and high-qualitydevelopment of biobanks

Academic Conference of the Chinese ResearchHospital Association on Clinical Data andBiobanks

114115

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

AppendixESG Key Performance Indicators

IndicatorsUnit202220232024Operating incomeOne hundred million RMB28.6422.8122.84Net Profit to ParentOne hundred million RMB/4.063.67

IndicatorsUnit202220232024Environmental protection inputInvestment inenvironmental protection

Ten thousand RMB105.0230.5435.00Time in environmentalprotection

hours/2,8602,574

Energy

Total energyconsumption

MWh13,09512,915.8110,908.69Direct energyMWh/1,869.86

1,783.84Indirect energyMWh11,25411,045.9510,383.29 Purchased electricityMWh9,9659,949.839,492.39 Purchased heatMWh1,2891,096.12890.90Total consumption ofnon-renewable energy

MWh11,60611,368.169,492.39Total consumption ofrenewable energy

MWh1,4891,547.651,416.30Renewable energyconsumption

%1311.9812.98Energy intensity

kWh/ten thousand

RMB

45.7256.6347.76

In 2023, we corrected the energy consumption statistics. We incorporated the Photovoltaic power generation into the direct energystatistics.

Economic performance

Environmental performance

IndicatorsUnit202220232024Water

Total water consumptionm

46,00076,26581,736Water intensitym

/ten thousand RMB0.160.330.36Greenhouse gasTotal GHG emissionTon CO

e6,798.626,812.067,309.07Scope 1Ton CO

e63.63

252.07458.12

Scope 2Ton CO

e6,735.006,559.996,850.95GHG intensity

kg CO

e/ten thousandRMB

23.7429.8732.00WasteGeneral wasteTon767.06930.45480.00Hazardous wasteTon7.348.603.65Total Waste DisposalTon/824.46480.00Total Hazardous WasteDisposal

Ton/6.983.65

In 2022, we count CO

emissions from stationary combustion.

In 2024, the company conducted maintenance and refrigerant recharge for all air conditioning systems. The refrigerant usage has been accountedfor in the 2024 fugitive greenhouse gas emissions, resulting in a significant increase in Scope 1 emissions data for this Reporting Period.

IndicatorsUnit202220232024

Product and service

Domestic customer satisfaction%99.8399.9499.96Customer complaint resolving rate%100100100Total patentsitem7951,3211,595New invention patents applicationitem131146143Total software copyrightsitem114296392Number of External Regulatory Inspectionstimes//27

Social performance

116117116117

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

Future

Gathering Talents

for Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

IndicatorsUnit202220232024Number of suppliersChina/437559589Other countries and regions/699EmploymentNumber of employeesperson2,6902,6362,807Maleperson1,9441,8981,967Femaleperson746738840Number of new hiresperson778573462

Maleperson687418281Femaleperson91155181By regionChinaperson2,6612,6072,771Other countries and regionsperson292936

By age group

Under 30person1,07481079330-50person1,5131,7001,904Over 50person103126110By functionTechnicalperson897993835Salesperson569680693Financeperson313341Administrationperson23497248Productionperson959893990Employee diversityNumber of ethnic minority employeesperson//45Percentage of ethnic minority employees%//1.6Percentage of female employees%//29.9

Employee lost time injury frequency LTIFR= Number of work-related injuries *1000000/ Total working hours *100%

IndicatorsUnit202220232024

Percentage of women in senior management%37.537.575Percentage of vacancies filled by internalcandidates

%/38.3030.73Training for employeesAverage training hoursHour/person33.2434.3234.32Training coverage%100100100Anti-corruption training coverage%100100100Fair competition training coverage%100100100

Training coverage by genderMale%/7270Female%/2830Average training hours by gender

MaleHour/person33.5434.6135.58FemaleHour/person32.4933.5934.52Employee engagement and satisfaction

Percentage of highly engaged employees%/87.0089.40Percentage of highly satisfied employees%/83.0088.60Percentage of Employees Covered by CBAs%/100100Per capita revenue generation

Ten thousand

RMB

//81.36

Occupational health and safety

Number of work-related fatalitiesperson000Number of working days lost due to work-related injuryday000Lost time injury frequency rate LTIFR

%000The completion rate of risk rectification%100100100Emergency response rate%100100100

118119118119

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

GRI StandardsDisclosure ItemDisclosure TitleSectionsUniversal StandardsGRI 1: Foundation 2021GRI 2: General Disclosures 2021The organization and its reporting practices2-1Organizational detailsAbout Haier Biomedical - Company Profile2-2Entities included in the organization's sustainability reportingAbout This Report2-3Reporting Period, frequency and contact pointAbout This Report2-4Restatements of information

There were no restatements ofinformation during the Reporting Period2-5External assurance

There were no external assuranceobtained for the ReportActivities and workers2-6Activities, value chain and other business relationshipsAbout Haier Biomedical - Company Profile2-7Employees3.1.1 Diverse and Inclusive Workplace2-8Workers who are not employees3.1.1 Diverse and Inclusive WorkplaceGovernance2-9Governance structure and composition2.1.1 Sound Corporate Governance2-10Nomination and selection of the highest governance bodySee our 2024 Annual Report2-11Chair of the highest governance bodyTan Lixia2-12

Role of the highest governance body in overseeing themanagement of impacts

2.1.1 Sound Corporate Governance

2-13Delegation of responsibility for managing impactsSustainability Governance2-14Role of the highest governance body in sustainability reportingSustainability Governance2-15Conflicts of interestSee our 2024 Annual Report2-16Communication of critical concernsSustainability Governance2-17Collective knowledge of the highest governance bodySustainability Governance2-18Evaluation of the performance of the highest governance bodySee our 2024 Annual Report2-19Remuneration policiesSee our 2024 Annual Report2-20Process to determine remunerationSee our 2024 Annual Report2-21Annual total compensation ratio

Omitted due to confidentialityconstraints

Disclosure ItemDisclosure TitleSectionsStrategy, policies and practices2-22Statement on sustainable development strategyChairman's Statement2-23Policy commitments2.1.2 Adhering to Business Ethics2-24Embedding policy commitments2.1.2 Adhering to Business Ethics2-25Processes to remediate negative impacts2.1.2 Adhering to Business Ethics2-26Mechanisms for seeking advice and raising concerns2.1.2 Adhering to Business Ethics2-27Compliance with laws and regulationsSee sections of the Report for details2-28Membership associationsChairman's StatementStakeholder engagement2-29Approach to stakeholder engagementSustainability Governance2-30Collective bargaining agreementsUnion coverage 100%

GRI 3: Material Topics 20213-1Process to determine material topicsSustainability Governance3-2List of material topicsSustainability Governance3-3Management of material topicsSustainability Governance

Topic StandardsGRI 201: Economic Performance 2016201-1Direct economic value generated and distributed

See 2024 Annual Report for financialinformation. Some data are omitteddue to confidentiality constraints201-2

Financial implications and other risks and opportunities dueto climate change

4.4 Green Layout and Climate

Transformation201-3Defined benefit plan obligations and other retirement plans3.1.3 Caring for Employee Wellbeing201-4Financial assistance received from governmentNot applicable

GRI 202: Market Presence 2016

202-1

Ratios of standard entry level wage by gender compared tolocal minimum wage

Omitted due to confidentiality constraints202-2

Proportion of senior management hired from the localcommunity

Omitted due to confidentiality constraintsGRI 204: Procurement Practices 2016204-1Proportion of spending on local suppliers

2.2.1 Joining Hands with Industrial

PartnersGRI 205: Anti-corruption 2016205-1Operations assessed for risks related to corruption2.1.2 Adhering to Business Ethics120121120121

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Disclosure ItemDisclosure TitleSections205-2

Communication and training about anti-corruption policiesand procedures

2.1.2 Adhering to Business Ethics

205-3Confirmed incidents of corruption and actions taken2.1.2 Adhering to Business EthicsGRI 206: Anti-competitive Behavior 2016

206-1

Legal actions for anti-competitive behavior, anti-trust, andmonopoly practices

2.1.2 Adhering to Business Ethics

GRI 301: Materials 2016

301-1Materials used by weight or volume4.2.2 Usage of Production Resources301-2Recycled input materials used4.2.2 Usage of Production Resources301-3Reclaimed products and their packaging materials4.2.2 Usage of Production Resources

GRI 302: Energy 2016302-1Energy consumption within the organization4.2.1 Energy Consumption Management302-2Energy consumption outside of the organization4.2.1 Energy Consumption Management302-3Energy intensity4.2.1 Energy Consumption Management302-4Reduction of energy consumption4.2.1 Energy Consumption Management302-5Reductions in energy requirements of products and services4.1.3 Green Product Concept

GRI 303: Water and Effluents 2018

303-1Interactions with water as a shared Resource4.2.2 Usage of Production Resources303-2Management of water discharge-related impacts4.2.2 Usage of Production Resources303-3Water withdrawal4.2.2 Usage of Production Resources303-4Water discharge4.2.2 Usage of Production Resources303-5Water consumption4.2.2 Usage of Production ResourcesGRI 304: Biodiversity2016304-1

Operational sites owned, leased,managed in, or adjacent to,protected areas and areas of high biodiversity value outsideprotected areas

4.5 Biodiversity and Ecological

Prosperity304-2

Significant impacts of activities, products and services onbiodiversity

4.5 Biodiversity and Ecological

Prosperity304-3Habitats protected or restored

4.5 Biodiversity and Ecological

Prosperity304-4

IUCN Red List species and national conservation listspecies with habitats in areas affected by operations

4.5 Biodiversity and Ecological

ProsperityGRI 305: Emissions 2016305-1Direct (Scope 1) GHG emissions4.2.1 Energy Consumption Management305-2Energy indirect (Scope 2) GHG emissions4.2.1 Energy Consumption Management

Disclosure ItemDisclosure TitleSections

305-3Other indirect (Scope 3) GHG emissionsNot applicable305-4GHG emissions intensity4.2.1 Energy Consumption Management305-5Reduction of GHG emissions4.2.1 Energy Consumption Management305-6Emissions of ozone-depleting substances (ODS)Not applicable305-7

Nitrogen oxides (NO

x), sulfur oxides (SO

x), and othersignificant air emissions

Not applicable

GRI 306: Waste 2020306-1Waste generation and significant waste-related impacts

4.3.1 Waste Management

4.3.2 Exhaust Gas Management

4.3.3 Wastewater Management

306-2Actions taken to prevent waste generation

4.3.1 Waste Management

4.3.2 Exhaust Gas Management

4.3.3 Wastewater Management

306-3Composition of waste generated4.3.1 Waste Management306-4Recovery operations used to divert waste from disposal4.3.1 Waste Management306-5Disposal operations4.3.1 Waste Management

GRI 308: Supplier Environmental Assessment 2016308-1

New suppliers that were screened using environmentalcriteria

2.2.1 Joining Hands with Industrial

Partners308-2

Negative environmental impacts in the supply chain andactions taken

2.2.1 Joining Hands with Industrial

PartnersGRI 401: Employment 2016401-1New employee hires and employee Turnover3.1.1 Diverse and Inclusive Workplace401-2

Benefits provided to full-time employees that are notprovided to temporary or part-time employees

3.1.3 Caring for Employee Wellbeing

401-3Parental leave3.1.3 Caring for Employee WellbeingGRI 402: Labor/Management Relations 2016402-1Minimum notice periods regarding operational changesNot applicableGRI 403: Occupational Health and safety 2018403-1Occupational health and safety management system3.1.4 Occupational Health and Safety403-2Hazard identification, risk assessment, and incident investigation3.1.4 Occupational Health and Safety403-3Guidance for Disclosure3.1.4 Occupational Health and Safety403-4

Worker participation, consultation, and communication onoccupational health and safety

3.1.4 Occupational Health and Safety

403-5Worker training on occupational health and safety3.1.4 Occupational Health and Safety403-6Promotion of worker health3.1.4 Occupational Health and Safety122123122123

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

Disclosure ItemDisclosure TitleSections403-7

Prevention and mitigation of occupational health and safetyimpacts directly linked by business relationships

3.1.4 Occupational Health and Safety

403-8

Workers covered by an occupational health and safetymanagement system

Applies to all employees403-9Work-related injuries3.1.4 Occupational Health and Safety403-10Work-related ill health3.1.4 Occupational Health and Safety

GRI 404: Training and Education 2016404-1Average hours of training per year per employee3.1.2 Supporting Talent Development404-2

Programs for upgrading employee skills and transitionassistance programs

3.1.2 Supporting Talent Development

404-3

Percentage of employees receiving regular performanceand career development reviews

100% Covered for all staffGRI 405: Diversity and Equal Opportunity 2016405-1

Disclosure 405-1 Diversity of governance bodies andemployees

3.1.1 Diverse and Inclusive Workplace

405-2Ratio of basic salary and remuneration of women to men

Omitted due to confidentiality

constraints

GRI 406: Non-discrimination 2016406-1Incidents of discrimination and corrective actions taken

There were no relevant incidents

during the Reporting Period

GRI 407: Freedom of Association and Collective Bargaining 2016

407-1

Operations and suppliers in which the right to freedom ofassociation and collective bargaining may be at risk

There were no relevant incidents

during the Reporting PeriodGRI 408: Child Labor 2016408-1

Operations and suppliers at significant risk for incidents ofchild labor

There were no relevant incidents

during the Reporting PeriodGRI 409: Forced or Compulsory Labor 2016409-1

Operations and suppliers at significant risk for incidents offorced or compulsory labor

There were no relevant incidents

during the Reporting PeriodGRI 410: Security Practices 2016410-1Security personnel trained in human rights policies or proceduresNot applicableGRI 411: Rights of Indigenous Peoples 2016411-1Incidents of violations involving rights of indigenous peoplesNot applicableGRI 413: Local Communities 2016

413-1

Operations with local community engagement, impactassessments, and development programs

3.2.1 Universal Healthcare

Sustainability Governance

Disclosure ItemDisclosure TitleSections413-2

Operations with significant actual and potential negativeimpacts on local communities

3.2.1 Universal Healthcare

Sustainability GovernanceGRI 414: Supplier Social Assessment 2016

414-1New suppliers that were screened using social criteria

2.2.1 Joining Hands with Industrial

Partners414-2Negative social impacts in the supply chain and actions taken

2.2.1 Joining Hands with Industrial

PartnersGRI 415: Public Policy 2016415-1

Assessment of the health and safety impacts of product andservice categories

Not applicableGRI 416: Customer Health and Safety 2016416-1Political contributions2.2.3 Optimizing User Experience416-2

Incidents of non-compliance concerning the health andsafety impacts of products and services

2.2.3 Optimizing User Experience

GRI 417: Marketing and Labeling 2016

417-1Requirements for product and service information and labeling

2.1.4 Practicing Responsible

Marketing417-2

Incidents of non-compliance concerning product andservice information and labeling

2.1.4 Practicing Responsible

Marketing417-3

Incidents of non-compliance concerning marketingcommunications

2.1.4 Practicing Responsible

MarketingGRI 418: Customer Privacy 2016

418-1

Substantiated complaints concerning breaches of customerprivacy and losses of customer data

2.1.2 Adhering to Business Ethics

124125124125

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment

UNGC PrinciplesHuman RightsCorresponding chapter

Principle 1: Businesses should support and respect the protection ofinternationally proclaimed human rights; and

3.1.1 Diverse and Inclusive Workplace

Principle 2: make sure that they are not complicit in human rights abuses3.1.1 Diverse and Inclusive WorkplaceLaborCorresponding chapter

Principle 3: Businesses should uphold the freedom of association andthe effective recognition of the right to collective bargaining;

3.1.1 Diverse and Inclusive Workplace

Principle 4: the elimination of all forms of forced and compulsory labor;3.1.1 Diverse and Inclusive WorkplacePrinciple 5: the effective abolition of child labor; and3.1.1 Diverse and Inclusive WorkplacePrinciple 6: the elimination of discrimination in respect of employmentand occupation

3.1.1 Diverse and Inclusive Workplace

EnvironmentCorresponding chapterPrinciple 7: Businesses should support a precautionary approach toenvironmental challenges;

4.1.1 Green Development Planning

4.1.2 Green Compliance Framework

Principle 8: undertake initiatives to promote greater environmentalresponsibility; and

4.2 Resource Optimization and Circular

Development

4.3 Compliant Emissions and a Clean

Future

4.4 Green Layout and Climate

Transformation

4.5 Biodiversity and Ecological

ProsperityPrinciple 9: encourage the development and diffusion of environmentallyfriendly technologies

4.1.3 Green Product Concept

Anti-CorruptionCorresponding chapterPrinciple 10: Businesses should work against corruption in all its forms,including extortion and bribery

2.1.2 Adhering to Business Ethics

Reader Feedback

Dear readers:

Thank you for reading "Haier Biomedical 2024 Sustainable Development Report ". In order to provide you and otherstakeholders with more professional and valuable corporate sustainable development information, please help usto complete the relevant questions in the feedback form, so as to help us further improve social responsibility andsustainable development management in the future.

You can call, email or send feedback to us, our contactinformation as follows:

Address: 280 Feng yuan Road, High-tech Zone,

Qingdao. ShandongPostcode:266000Email:haierbiomedical@haierbiomedical.com

Name:

Telephone:

Email address:

Company:

Fax number:

Please rate the following questions on a scale of 1 to 5(1 is the lowest, 5 is the highest).

1. Your general comments on this report.

□ 1 □ 2 □ 3 □ 4 □ 5

2. Do you think this report reflects the significant impact

of Haier Biomedical on the economy?

□ 1 □ 2 □ 3 □ 4 □ 5

3. Do you think this report reflects the significant impact

of Haier Biomedical on the environment?

□ 1 □ 2 □ 3 □ 4 □ 5

4. Do you think this report reflects the significant impact

of Haier Biomedical on society?

□ 1 □ 2 □ 3 □ 4 □ 5

5. Do you think this report can reflect the corporate

governance of Haier Biomedical?

□ 1 □ 2 □ 3 □ 4 □ 5

6. Your overall evaluation of the degree of information

disclosure in this report:

□ 1 □ 2 □ 3 □ 4 □ 5

7. Your overall evaluation of the literal expression in this

report:

□ 1 □ 2 □ 3 □ 4 □ 5

8. Your overall evaluation of the design style in this

report:

□ 1 □ 2 □ 3 □ 4 □ 5

9. What issues in this report concern you most?

10. Do you have any other comments or suggestions on

this report?

126127126127

2024 Sustainability ReportAbout Haier BiomedicalSustainability Governance

IntegrityResponsibility Assuming andSustainable Development

FutureGathering Talentsfor Healthy Life

EcosystemProtectingOur EarthAppendixChairman's StatementAbout This Report

LeadershipCreating an Intelligent Futurewith AI Empowerment